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Superoxide dismutases (SODs) are a highly conserved class of antioxidant 
enzymes that serve on the frontline of defense against reactive oxygen species (ROS). 
SODs, which detoxify superoxide radicals (O2•-) by catalyzing their disproportionation into 
molecular oxygen (O2) and hydrogen peroxide (H2O2), are rather unusual “antioxidant” 
enzymes in that they catalyze the production of one ROS – H2O2 – while scavenging 
another – O2•-. While much is known about the necessity for O2•- detoxification, it is less 
clear what the physiological consequences of SOD-derived H2O2 are. Given that hormetic 
levels of H2O2 are important for physiological redox signaling and also act as a pro-growth 
signal, SODs, especially Cu/Zn SOD (Sod1), which accounts for the majority of 
intracellular SOD activity in eukaryotes and is localized virtually everywhere in the cell 
except the mitochondrial matrix, may be key to promote various redox signaling pathways. 
 My thesis work has been focused on parsing the dual roles of Sod1 in oxidative 
stress protection and redox signaling. I have found that the vast majority of Sod1 is 
dispensable for protection against O2•- toxicity using Saccharomyces cerevisiae and 
human cell lines as model organisms (Chapter 2 and 3, respectively). However, the bulk 
of Sod1 is required for proteome-wide H2O2-based redox signaling, including regulation of 
the of yeast casein kinase (Yck1, Chapter 2), the canonical Wnt signaling pathway 
(Chapter 3) and a molecular circuit that links O2 availability to the production of NADPH, 
a key cellular reductant that regenerates thiol-based antioxidant enzymes (Chapter 4). 
Altogether, my work finally explains the physiological necessity for an “antioxidant” 
enzyme like Sod1 to produce an oxidant – namely that the H2O2 that Sod1 produces is 
used to stimulate NADPH-dependent ROS scavenging and redox regulate a large network 
of metabolic enzymes. 
 xxvii 
 
In the first part of my thesis work, described in Chapter 2, I discovered that < 1% 
of the total cellular Sod1 pool is required for protection against superoxide damage in 
yeast. Superoxide toxicity stems from the oxidative inactivation of 4Fe-4S clusters, 
resulting in defects in a number of pathways containing Fe/S dependent metabolic 
enzymes, and toxicity from the iron released from damaged clusters. The iron leads to 
deleterious redox reactions that oxidatively damage DNA, lipids, and proteins. By profiling 
cell wide markers of superoxide toxicity, including Fe/S cluster enzyme activity, DNA 
damage, and membrane fragmentation, in cell lines expressing a regulatable SOD1 
promoter, I found that an undetectable (< 1%) amount of Sod1 is sufficient for superoxide 
resistance in air. Instead, the bulk of Sod1 is required to promote the stabilization of Yck1, 
a glucose sensing plasma membrane casein kinase previously found to be stabilized in a 
Sod1-dependent manner. This led me to conclude that the majority of Sod1 plays a more 
important role as a source for hormetic H2O2 than for scavenging O2•-.  
 
In Chapter 3, I extend my findings from yeast to mammalian cells, and found that 
~50-80% depletion of Sod1 in human embryonic kidney cells using RNA interference does 
not result in oxidative stress but does impact casein kinase signaling in the Wnt pathway. 
The Yck1 homology in humans, CK1g, is an integral component of the Wnt signaling 
pathway, which is necessary for embryonic development and is prooncogenic when 
hyperactivated. I found that silencing Sod1 does not affect cell proliferation or the 
expression of a panel of antioxidant enzymes, consistent with bulk Sod1 being 
dispensable for oxidative stress protection. However, Sod1 silencing resulted in reduced 
CK1g expression and attenuated Wnt signaling and Wnt-dependent cell proliferation. 
Thus, as in yeast, bulk Sod1 is dispersible for oxidative stress protection but seemingly 
required for redox signaling in human cell lines.  
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Having established that bulk Sod1 is dispensible for protection from superoxide 
toxicity, in the third section of my thesis, described in Chapter 4, I probed the physiological 
roles of Sod1-derived spatio-temporal bursts of H2O2. As part of this effort, I discovered 
that an important but previously unknown antioxidant function of Sod1 is to integrate O2 
availability to stimulate production of NADPH, a key cellular reductant that regenerates 
peroxide-scavenging thiol peroxidases and catalases. The mechanism involves Sod1-
derived H2O2 oxidatively inactivating the catalytic Cys residue in the glycolytic enzyme, 
glyceraldehyde phosphate dehydrogenase (GAPDH), which in turn re-routes 
carbohydrate flux through the oxidative phase of the pentose phosphate pathway (oxPPP) 
to increase NADPH. Sod1 senses O2 via O2.- generated from mitochondrial respiration and 
a NADPH oxidase, Yno1. The oxidation of GAPDH is exclusively dependent on and rate 
limited by Sod1, suggesting that Sod1 provides a highly localized pool of H2O2 in close 
proximity to GAPDH, likely via transient interactions between Sod1 and GAPDH. These 
findings broaden the antioxidant role of Sod1 to include stimulation of NADPH production, 
which offers more expansive protection against redox stress than just defending against 
O2.-, which most Sod1 is dispensable for as determined in Chapter 2. Moreover, in 
collaboration with the laboratory of Matthew Torres, we employed mass spectrometry 
based redox proteomics approaches to identify cell-wide targets of Sod1-dependent 
protein oxidation. This analysis revealed that Sod1 is a master regulator of metabolism 
and the thiol redoxome.  
Overall, my findings shed light on a broader role for Sod1 that extends beyond just 
superoxide scavenging as was previously thought. Given that changes in Sod1 expression 
and activity are a central aspect of the pathogenesis of a number of diseases, including 
many cancers and neurodegenerative disorders, my thesis work highlights how metabolic 
rewiring due to Sod1-based redox control may underlie the progression of human disease 
 xxix 
 
and may inspire new Sod1-based therapeutics and aid to understand the effectiveness of 
anti-Sod1 therapeutic interventions in cancer.  
 1 
CHAPTER 1. INTRODUCTION 
 
1.1. General Thesis Introduction 
 
Over the years, there has been an increasing interest in understanding the role of 
reactive oxygen species (ROS) in physiology and disease. At first, ROS were perceived 
as toxic molecules, and it was not until the early 90s that some ROS, and, in particular 
H2O2, were starting to be recognized as potential signaling molecules. One of the main 
cellular sources of peroxide are superoxide dismutases (SODs) that protect against 
superoxide toxicity by disproportionating superoxide radicals into hydrogen peroxide and 
molecular oxygen. From the different types of SODs, Cu/Zn SOD, or Sod1, constitutes the 
most abundant and widespread SOD and accounts for most SOD activity in the cell. As 
such, Sod1 may have a broader physiological impact, both as an antioxidant and in 
promoting redox signaling. In fact, Sod1 has been implicated in several cancers and 
neurodegenerative diseases, such as familial amyotrophic lateral sclerosis (FALS). 
However, whether the contribution of Sod1 towards pathology is related to its antioxidant 
capacity or perturbed redox signaling is still enigmatic. 
The work described below arose from one simple question: Given that superoxide 
radicals, O2•-, are spontaneously disproportionated at a relatively fast rate, 105 M-1s-1, and 
that Sod1 disproportionates O2•- at a diffusion-limited rate, 109 M-1s-1, why are such large 
quantities of Sod1 generated? This motivated me to establish the relative contributions of 
Sod1 towards superoxide protection versus redox signaling and to identify cell-wide Sod1-
catalyzed H2O2 redox relays. This will shed light on a better perception of the role of Sod1 
in cell biology and disease. My thesis motivation was to challenge how we perceive Sod1 
in physiology.  
 
 2 
1.2. Reactive Oxygen Species (ROS): A Byproduct of Life in Air 
 
Reactive oxygen species (ROS) are the byproduct of aerobic metabolism. ROS result 
from the incomplete 4 electron reduction of oxygen (O2) to water (H2O), producing 
superoxide (O2•-), hydrogen peroxide (H2O2), or hydroxyl radicals (•OH). These ROS can 
oxidize and damage various biomolecules, including [4Fe-4S] cluster-containing 
enzymes, nucleic acids [1], lipids and proteins [2]. One of the main sources of ROS in the 
cell is the mitochondrial electron transport chain (ETC) [3], where electrons are transferred 
across the different respiratory complexes to a final acceptor molecule, oxygen, to 
generate an electrochemical gradient that powers ATP synthesis. Leakage of electrons 
from complex I or complex III in the ETC to the mitochondria intermembrane space (IMS) 
can partially reduce oxygen to generate superoxide radicals. Besides the ETC, there are 
additional sources of O2•- within the cell, such as NADPH oxidase enzymes (NOX). NOX 
generate O2•- from NADPH and O2 and are mainly found tethered to the membranes of 
different compartments in the cell and the plasma membrane, contributing to O2•- build-up 
in the cytosol or outside the cell [4], respectively.  
 Since cells are constantly exposed to ROS, they require a complex network of 
antioxidant systems, including superoxide and hydrogen peroxide scavengers. 
Superoxide dismutases (SODs), which require metals for catalysis, are the main 
antioxidant defense against superoxide in the cell [5] and act to disproportionate two 
molecules of superoxide into hydrogen peroxide and molecular oxygen. Most cells 
express two intracellular SOD isoforms: Cu/Zn superoxide dismutase (SOD1), localized 
virtually everywhere in the cell including the mitochondrial IMS [6, 7], except the 
mitochondrial matrix; and Mn superoxide dismutase (SOD2), exclusively localized in the 
mitochondrial matrix (Figure 1.1). Mammalian cells express a third SOD isoform, SOD3, 
 3 
an extracellular Cu/Zn SOD. Additional antioxidant systems in the cell scavenge H2O2, 
including thiol peroxidases (i.e. peroxiredoxins, Prxs) [8], glutathione peroxidases (GPx) 
[9] and catalases (CAT) (Figure 1.1). All these antioxidant systems rely on NADPH, a vital 
cellular reductant, for their regeneration [10, 11]. This intricate antioxidant network protects 
the cell from oxygen and oxidative insults [12]. However, when these antioxidant systems 
are overwhelmed by the ROS burdens, there is an imbalance between ROS levels and 
the antioxidant capacity that prevent ROS damaging effects, resulting in oxidative stress.  
 
 
Figure 1.1. Antioxidant systems in the cell. Sod2, Mn superoxide dismutase; Sod1, 



















1.2.1. Brief History of Reactive Oxygen Species 
 
Over the last hundred years, there has been an increasing interest in 
understanding the role of free radicals in biology, given their ample involvement in both 
physiology and disease. It is been long known that living organisms have a paradoxical 
relationship with molecular oxygen, in that it is necessary for life but toxic. However, the 
molecular mechanisms underlying oxygen toxicity were not understood until 1954, when 
Gershman proposed the free radical theory of oxygen toxicity, proposing that oxygen is 
toxic due to its ability to form free radicals [13], confirmed later the same year by 
Commoner and co-workers via electron paramagnetic resonance (EPR) [14]. 
Interestingly, they found that the level of free radicals detected via EPR spectroscopy 
correlated with metabolic activity, in alignment with previous hypothesis that suggested 
that free radicals may be involved in biological oxidation-reduction reactions. These 
findings inspired Harman to propose the free radical theory of aging, after observing that 
irradiation of living organisms induced mutations, cancer and aging, speculating that the 
irradiation drove the liberation of free radicals, specifically hydroxyl radicals, that caused 
aging [15]. Given that the concentration of free radicals increased with increasing 
metabolic activity, Harman suggested that hydroxyl radicals may arise from the utilization 
of oxygen by respiratory complexes that contain iron centers in the electron transport 
chain. Not long after, xanthine oxidase, an enzyme capable of generating superoxide 
radicals and reducing cytochrome c, was identified and characterized [16].  
A decade later, in 1969, Mc Cord and Fridovich contributed to the understanding 
of free radical metabolism with the seminal discovery of a novel enzymatic activity for 
erythrocuprein, a Cu-containing enzyme found in erythrocytes. They found that 
erythrocuprein catalytically disproportionates superoxide into hydrogen peroxide to protect 
against superoxide toxicity [17], corresponding to the first description of a superoxide 
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dismutase. Erythrocuprein is now commonly known as Cu/Zn superoxide dismutase or 
Sod1. The high abundance of superoxide dismutase detected across different animal 
tissues, led them to propose that superoxide dismutase may have a vital role in protecting 
the organism against superoxide toxicity. Later findings, including that reactive oxygen 
species (ROS) arise from cellular respiration [18, 19] and that ROS include radical and 
non-radical oxygen species [20] set the stage for the multitude of findings that contribute 
towards understanding the role of ROS in physiology and disease.  
 
1.2.2. Superoxide Radicals  
 
Superoxide is a negatively charged free radical formed via single electron 
reduction of oxygen. It is not very reactive by itself [21], however, its harmful effects arise 
from the secondary ROS species generated as a consequence of superoxide-dependent 
reactions. For instance, superoxide radicals (O2•-) oxidatively inactivate [4Fe-4S] clusters 
in enzymes, by univalently oxidizing the cluster, which perturbs its stability and results in 
degradation and release of a ferrous iron atom (Fe2+). The released ferrous iron, which 
overwhelm the Fe detoxification systems in the cell, generates hydroxyl radicals (•OH) via 
the Fe-catalyzed reduction of H2O2, i.e., Haber-Weiss and Fenton reactions. •OH, is a very 
strong univalent oxidant that non-selectively reacts at diffusion-limited rates with most 
biomolecules that are in close proximity, including DNA, lipids and proteins. As a 
consequence, superoxide build-up induces DNA double strand  (ds) breaks and 
mutations, lipid peroxidation causing membrane fragmentation and protein carboxylation 
that results in protein degradation and inactivation [1]. Moreover, the inactivation of [4Fe-
4S] cluster- containing enzymes in the cytosol, i.e., isopropyl malate isomerase, and the 
mitochondria, i.e. aconitase, ultimately impacts cell metabolism. For instance, in baker’s 
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yeast, oxidative inactivation of Fe-S clusters in homoaconitase and isopropylmalate 
isomerase leads to lysine and leucine auxotrophy, respectively. Notably, endogenous 
superoxide is unlikely to be toxic to cells, since these phenotypes are only observed when 
cells are devoid of superoxide dismutases (SOD). Although cells generate O2•- at a high 
rate, i.e. 5µM/s in E. coli, SODs, which disproportionate superoxide to H2O2 very efficiently, 
maintain very low steady-state levels of O2•-, at only 0.1nM [22]. 
Superoxide is largely generated in the mitochondrial electron transport chain (ETC) 
as a result of aerobic metabolism [3], and its production is practically proportional to 
physiological [O2] within the cell [23, 24]. Leakage of electrons from Complex I, 
predominantly, and Complex III in the ETC, generates superoxide radicals upon reduction 
of molecular O2, especially when the mitochondria is not actively producing ATP via 
respiration [3, 25]. Accidental electron leakage supports the notion that superoxide is toxic; 
however, enzymes capable of producing superoxide support its potential role as a 
signaling molecule. NADPH oxidases (NOX) are transmembrane enzymes that generate 
superoxide by transferring electrons from NADPH to oxygen and account for a major 
source of cellular superoxide, especially after some stimuli. Although superoxide is 
unlikely to be a signaling molecule, due to its intrinsic low stability and solubility, it can be 
disproportionated spontaneously or by Sod1, at a very fast rate, to H2O2 in the vicinity of 
its generation site. H2O2, which is fairly stable, lasting up to 1ms, is a signaling molecule 
that exhibits high reactivity towards thiols in cysteine residues of target proteins and 






1.2.3. Hydrogen Peroxide: Friend or Foe? 
 
Hydrogen peroxide is a cytotoxic molecule due to its reactivity towards ferrous iron, 
that results in the generation of the highly cytotoxic ROS, hydroxyl radical, which readily 
reacts with DNA, proteins and lipids and oxidizes them. This yields DNA double strand 
breaks, protein carbonylation and membrane fragmentation, respectively [26].  
Although initially perceived as a toxic molecule, over the last two decades enough 
evidence has been compiled to prove that H2O2 can also function as a signaling molecule. 
What makes H2O2 recognized as a signaling messenger? Mainly, it is intrinsically stable 
(up to 1ms) and reactive towards cysteine thiols on redox-regulated proteins [27]. 
Moreover, given that H2O2 is a non-charged species, it can diffuse freely through 
membranes, or via aquaporins [28, 29]. This allows H2O2 to easily diffuse throughout the 
cell, where, as a result of the disparate compartmentalization of antioxidant enzymes 
across different organelles, will elicit distinct responses in each cellular compartment.  
How does H2O2 act as a signaling molecule? H2O2 reversibly oxidizes cysteine thiols 
yielding sulfenic acid (R-SOH), which is unstable and susceptible to nucleophilic attack by 
a neighboring cysteine thiol, potentially leading to disulfide bond generation. Alternatively, 
sulfenic acids can be further reversibly or irreversibly oxidized by additional H2O2 
molecules to sulfinic (R-SO2H) and sulfonic acid (R-SO3H), respectively. Redox switches, 
which encompass reversible oxidation of thiols, especially active site thiols, regulate 
protein activity, stability and localization, consequently turning on/off signaling pathways. 
Some of the elucidated H2O2-dependent cellular processes include growth factor signaling 
pathways [30-32], proliferation [33, 34], metabolic switches [35], gene expression [36-38], 
apoptosis [39], cell migration [40] and cell morphology regulation [41]. 
The cytosolic H2O2 concentrations are estimated to be between 1-10nM [42] and can 
transiently rise up to 0.5-0.7µM during redox signaling events [43]; this physiological 
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oxidative stress is referred to as oxidative eustress [42, 44, 45]. Yet, concentrations above 
1µM promote oxidative distress, favoring cellular oxidative damage, cell growth arrest and 
potential cell death [46, 47]. Interestingly enough, concentrations of H2O2 are rather 
constant across life domains, hinting conserved redox switches, as well as similar 
susceptibility to oxidative stress when exposed to higher concentrations of H2O2. 
Even though H2O2 exhibits high reactivity towards many substrates, especially the 
higher the concentration is inside the cell, its concentration is tightly regulated by multiple 
enzymes that reduce and disproportionate H2O2 to H2O, including peroxiredoxins and 
catalases, respectively. Peroxiredoxins are very abundant thiol peroxidases, accounting 
for 1% of total soluble protein, that exhibit high reactivity towards peroxide (with second 
rate constants spanning between 105-108 M-1s-1 [48]). Nonetheless, cysteine thiols in redox 
regulated proteins are much less numerous in the cell and exhibit second rate constants 
towards peroxide of 10-100 M-1s-1. How can redox regulated protein thiols get oxidized in 
a sea of peroxide scavenging enzymes? [49]. This may be explained by cellular spatio-
temporal concentrations of H2O2 in close vicinity of the target redox-regulated protein. On 
one hand, H2O2 can be generated at close vicinity of the redox regulated protein bypassing 
any H2O2 competitors; or peroxiredoxins, although competing with the target protein for 
peroxide, may deliver redox equivalents, once oxidized, via transient intermolecular 
disulfide exchange [36, 50, 51]. This is known as a redox relay (Figure 1.2, left). 
Alternatively, local bursts of H2O2 may lead to transient overoxidation and inactivation of 
peroxiredoxins, facilitating a transient spatio-temporal rise in H2O2 concentration, that 
allows H2O2 to reversibly oxidize the cysteinyl of the target protein. This process is known 
as the floodgate effect [52] (Figure 1.2, right). These two plausible mechanisms are not 






























Figure 1.2. Redox signaling mechanisms. Floodgate effect (right) vs redox relay 
(left). Sod1, Cu/Zn superoxide dismutase; Prdx1, peroxiredoxin 1; Prdx2, peroxiredoxin 2; 
NOX, NADPH oxidase.  
 
 
The necessity for spatio-temporal bursts of peroxide for physiological redox signaling, 
requires superoxide generation at close vicinity. The main sources of cellular superoxide 
are mitochondrial respiration and NADPH oxidases (NOX), membrane tethered enzymatic 
sources of superoxide [53]. NOX are widely distributed throughout the cell, distinctly 
turning on individual redox relays adjacent to specific compartments [54, 55]. There are 
several elucidated mechanisms that illustrate how superoxide and hydrogen peroxide 
work in synchrony to elicit a redox signaling relay. For instance, upon cellular exposure to 
growth factors or other signals, plasma membrane NOX are turned on and subsequently 
yield superoxide generation extracellularly, that can be disproportionated to H2O2 outside 
the cell by Sod3 or inside the cell after influx, through the chloride channel-3 [56], by Sod1. 
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The intracellular H2O2 can oxidize target cysteine thiols to initiate redox signaling cascades 
[57], such as induction of EGFR dimerization and activation [30].  
Why are only unique cysteine thiols oxidized by hormetic concentrations of H2O2? The 
microenvironment of the cysteine thiolate may dictate its reactivity towards peroxide. This 
includes local polarity and neighboring amino acids that influence the redox potential and 
lower the thiol pKa, whereby the thiolate form is favored at neutral pH, enhancing its 
susceptibility to be oxidized by H2O2.   
However, due to the lack of tools to efficiently measure intracellular concentrations of 
H2O2, there is still little understanding on how spatio-temporal bursts are triggered and 
what are the sources of peroxide that promote each redox signaling pathway. Most of the 
studies to this day rely on the addition of exogenous and possibly physiologically irrelevant 
concentrations of peroxide that elicit responses that may not occur under hormetic H2O2 
concentrations. Therefore, it is necessary to identify where peroxide arises from to 
understand how each redox relay is regulated. Given that Sod1 is a major enzymatic 
source of peroxide in most organisms and human cell types, my thesis work has provided 
new insight into Sod1-dependent physiological redox relays, which will influence how we 











1.3. Superoxide Dismutases 
 
Superoxide dismutases catalyze the disproportionation of two superoxide anions into 
hydrogen and molecular oxygen and comprise the cellular frontline defense against 
superoxide toxicity. SODs are unique, compared to the rest of antioxidant enzymes, in 
that they protect against one type of ROS, superoxide, and generate another ROS 
species, hydrogen peroxide, as a byproduct. Although peroxide generation was perceived 
as an incidental reaction and neglected by most, recent work is starting to shed light on 
the physiological significance of SOD catalyzed H2O2. In particular, my thesis work has 
vastly contributed on how we perceive SODs, concretely Cu/Zn superoxide dismutase.    
SODs disproportionate superoxide at diffusion-limited rates, achieved via electrostatic 
guidance towards a transition metal that facilitates superoxide disproportionation. There 
are three different classes of SODs that exhibit different protein folding patterns and 
catalytic metal ions, including the Cu/Zn SOD, also known as Sod1 or Sod3, 
MnSOD/FeSOD and NiSODs. Most eukaryotes express two intracellular superoxide 
dismutases, a Manganese-containing SOD (MnSOD, Sod2) that is exclusively localized 
in the mitochondrial matrix, and a Copper/Zinc SOD (Cu/ZnSOD, Sod1) that is localized 
virtually everywhere in the cell, including the cytosol, mitochondrial intermembrane space 
(IMS), endoplasmic reticulum (ER), nucleus and peroxisomes. Additionally, humans 
express a third extracellular Cu/Zn SOD, Sod3 [58-60]. Regarding MnSOD or Sod2, it has 
recently been found that in eukaryotes a fraction of Sod2 can acquire Fe instead of Mn 
[61] when Sod2 is exposed to high iron concentrations [62, 63] or when Sod2 is acetylated 
at lysine residues 68 and 122 [64, 65]. This Fe-bound Sod2 fraction is either inactive [62] 
or exhibits peroxidase activity, instead of dismutase activity, associated with several 
physiological consequences that are starting to be discerned, such as stem cell 
reprograming and tumorigenesis [64, 65].  
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Iron SOD (FeSOD) and MnSOD appear to have a common ancestor, however, they 
have diverged so much that in most species the metals cannot functionally substitute each 
other. While FeSOD is found in plant plastids, bacteria and in primitive eukaryotes, 
MnSOD is found in most eukaryotes, exclusively in the mitochondria, and some bacteria 
[66, 67]. However, there are some bacterial species that express a cambialistic SOD, 
which can interchangeably use Fe or Mn for catalysis [68, 69]. 
Nickel SOD (NiSOD) is the most recently characterized SOD, and was identified in 
Streptomyces [70, 71] and cyanobacteria [72]. Bioinformatic analysis suggest that NiSOD 
is not only found in actinobacteria from marine and soil environments, but also in 
proteobacterial species, that include pathogenic species, such as chlamydia [67, 73].  
Given that my thesis work is fixated on eukaryotic Sod1 or Cu/Zn superoxide 
dismutase, I will focus the next sections on Sod1 biology and its roles in physiology. 
 
1.3.1. Cu/Zn Superoxide Dismutase (SOD1): More than a Superoxide Scavenger 
 
Sod1 is a highly conserved, from bacteria to humans, and abundant protein that 
accounts for ~80-90% total SOD cellular activity, in yeast and a wide arrange of human 
cell types, and approximately 1% total soluble protein, corresponding to a concentration 
of ~10-40µM in most mammalian cell lines [57, 74, 75]. Sod1, unlike the rest of SODs, is 
localized virtually everywhere in the cell, including the intermembrane space of the 
mitochondria (IMS), nucleus, cytosol and peroxisomes, except the mitochondrial matrix 
where Sod2 resides. Sod1 is a homodimeric protein, with each monomer bound to a 
copper and zinc ions, [76, 77] essential for catalysis, that encompasses disproportionation 
of two superoxide molecules into hydrogen peroxide and molecular oxygen. 
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 The importance of this enzyme for aerobic life has been demonstrated in several 
model organisms; ablation of SOD1 in E. coli, yeast, drosophila [78] and mice [79, 80] 
results in several hallmarks of oxidative stress. For instance, SOD1-/- mice show higher 
incidences of hepatocellular carcinoma and signs of considerable oxidative damage at 
early stages of life (3 months of age) [80], which is also translated into a shorter life span. 
Similarly, SOD1-deficient Drosophila mutants exhibit increased spontaneous DNA 
damage and are unable to tolerate DNA-repair defective mutations, in addition to reduced 
lifespan and infertility [78]. Also, baker’s yeast strains that lack SOD1 (sod1∆) are 
defective in lysine and methionine biosynthetic pathways and show several markers of 
oxidative stress, including protein carbonylation, degradation of Fe/S clusters in enzymes 
and DNA damage (Figure 1.3) [81, 82]. The phenotypes observed in cells devoid of SOD1 
are due to superoxide toxicity, which can oxidize iron-sulfur cluster ([4Fe-4S]2+) cofactors 
in proteins and release of ferrous iron (Fe2+) in the process. Therefore, the hallmarks of 
superoxide toxicity in yeast include amino acid auxotrophy due to inactivation of 4Fe/4S 
cluster enzymes, including aconitase or homoaconitase and isopropyl malate isomerase, 
the inactivation of which causes Lysine and Leucine auxotrophy, respectively. Also, yeast 
sod1∆ exhibit methionine auxotrophy due to NADPH depletion. The Ferrous iron released 
from the oxidation of 4Fe/4S cluster can reduce H2O2 to generate hydroxyl radicals via 
Fenton chemistry, a highly reactive species that oxidizes and damages DNA and 
membrane lipids. The requirement for Sod1 in aerobic cultures is also supported by the 
high rate at which sod1∆ yeast exhibit suppressor mutations, including suppressor 
mutations at the PMR1 locus that rescue most oxygen toxicity phenotypes, which confer 




Figure 1.3. Schematic representation of SOD1 null yeast (sod1∆) characteristic 




 SODs are unique antioxidant enzymes in that they protect against one ROS, O2•-, 
to generate another one, H2O2. Given that Sod1 is so abundant and ubiquitous, that it 
disproportionates superoxide at a diffusion-limited rate (109 M-1s-1), and that superoxide 
itself can be spontaneously disproportionated at a relatively fast rate (105 M-1s-1), there 
may be an additional requirement for Sod1. Besides superoxide protection, Sod1 may 
promote hormetic H2O2 levels to support certain redox relays in signaling pathways. 
During my thesis, I have put my efforts in understanding the relative contribution of Sod1 






1.3.1.1. SOD1 Structure and Maturation 
 
 Sod1 is a homodimeric and relatively small protein, with each monomer bound to 
a copper and zinc ions (Figure 1.4). The copper ion, required for catalysis, is coordinated 
by four or three histidine residues, depending on the Cu oxidation state, and lies at the 
base of the electrostatic loop, where catalysis takes place [84-86]. Zinc, which is 
coordinated by three histidine residues and one aspartate, not only provides structural 










Figure 1.4. Cu/Zn Superoxide dismutase (Sod1) structure and reaction equation. 
Crystal structure of Sod1 homodimer (PDB ID 2C9V). The two monomers are represented 




Nascent Sod1 is monomeric and inactive and requires the copper chaperone Ccs1 
to be converted to its active homodimeric form, where each monomer is forming a disulfide 
bond between cysteine residues 57 and 146. Yeast Sod1 (ySod1) is entirely dependent 
on Ccs1 for maturation and activity [89], except when the culture medium is supplemented 
with exogenous copper [90]. Likewise, Drosophila melanogaster devoid of Ccs1 do not 
exhibit Sod1 activity and are sensitive to oxidative stress [91]. However, expressing 
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human Sod1 (hSod1) in ccs1∆ yeast results in ~ 25% Sod1 activity, due to the ability of a 
subset of hSod1 to acquire copper independently of Ccs1 and oxygen [92, 93]. This is 
also true for Sod1 from various metazoans, all lacking a proline residue at the position 
144. The two major differences between Ccs1 dependent and independent pathways are 
the requirement for copper availability and molecular oxygen [93, 94]. According to this, 
Ccs1 requires copper for Sod1 disulfide bond formation, whereas Ccs1-independent Sod1 
disulfide formation can take place even under copper depleted conditions. Moreover, the 
non-requirement for molecular oxygen allows metazoans to retain Sod1 activity over a 
wide range of pO2, to fit their molecular complexity [93, 95]. How does hSod1 acquire 
copper independently of Ccs1 and O2? The mechanism is still unclear, although it is known 
that this auxiliary pathway requires glutathione (GSH) for copper delivery to Sod1 and is 
dependent on the presence of non-proline residues at positions 142 and 144. Conversely, 
yeast Sod1 contains proline residues at positions 142 and 144 (P142, P144), located at 
the C-terminus of Sod1, which may facilitate Ccs1-dependent copper acquisition by 
limiting the flexibility of the protein. And, given they are juxtaposed to Cys-146 of Sod1 
critical disulfide, they might also affect the pKa of the cysteine residues whereby the 
disulfide is less prone to oxidation [92, 93]. Interestingly, mutating P144 of ySod1, can 
switch ySod1 to a Ccs1-independent molecule [93]. 
 Ccs1 is composed of three domains: D1, which contains a MXCXXC copper-
binding domain that acquires Cu(I) from the copper transporter Ctr1; D2, a domain with 
high sequence and structural analogy to Sod1 that facilitates the interaction with immature 
Sod1 at the homodimeric interface [96, 97]; and D3, the C-terminus domain that contains 
a CXC motif, essential for Sod1 activation [98]. The mechanism by which Ccs1 forms 
active metallated Sod1 involves all Ccs1 domains. First, Ccs1 D3 domain interacts 
between the disulfide beta barrel and the electrostatic loop of Sod1 to expose the 
electropositive cavity, followed by the delivery of Cu(I) from D1 to the entry site, where 
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superoxide radicals are concomitantly attracted to, promoting Cu (I) oxidation to Cu (II) 
and H2O2 formation. H2O2 oxidizes Sod1 Cys-146, yielding sulfenic acid, that subsequently 
forms an intermolecular disulfide bond with Ccs1 Cys229, followed by a disulfide 
exchange reaction between Sod1 Cys146 and Cys57, yielding mature Sod1, terminating 
Ccs1-Sod1 interaction [99]. 
 
1.3.1.2. Sod1 Localization 
 
 While Sod2 is exclusively confined to the mitochondrial matrix, Sod1 is widely 
spread throughout the cell, including the cytosol, mitochondrial intermembrane space 
(IMS) [7, 100], peroxisomes [101], lysosomes [102], ER [103, 104] and nucleus [74, 105]. 
 Although previously thought to be primarily cytosolic, a fraction of Sod1 is localized 
in the IMS, as observed in yeast [7] and mammalian cell lines [6]. The accumulation of 
Sod1 in the IMS is highly dependent on its copper chaperone, Ccs1, also partitioned 
between the cytosolic and mitochondrial pools [7]. Although the regulatory mechanisms 
behind Sod1 partitioning between the two compartments have only begun to unravel, it is 
conceivable that the fraction of Sod1 metallated by cytosolic or mitochondrial Ccs1, which 
prevents mitochondrial import or export, respectively, is an evident contributor. Ccs1 and 
Sod1 are imported through the translocator of the outer membrane (TOM) in its apo form 
and once in the IMS, upon intermolecular disulfide bond with Mia40, Ccs1 forms its 
intramolecular disulfide bond that traps it in the IMS. Mia40 is subsequently reoxidized by 
the sulfhydryl oxidase, Erv1, which relies on active mitochondrial respiratory chain to 
function [106-108]. Imported apoSod1 interacts with oxidized Ccs1, promoting the 
formation of Sod1 intramolecular disulfide bond and its retention in the IMS. 
 What is the physiological function of Sod1 in the mitochondrial IMS? Complex I, 
not present in yeast, and complex III of the respiratory electron transport chain can leak 
 18 
electrons to the IMS yielding superoxide formation upon oxygen reduction [109, 110]. 
Mitochondrial Sod1 may prevent mitochondrial O2•- from exiting the mitochondria and 
damaging extramitochondrial cell components [7, 111]. Indeed, my thesis work has shown 
that expressing IMS-targeted Sod1 is sufficient to protect against cell-wide markers of 
superoxide toxicity in yeast [112].  
 
1.3.1.3. Sod1 Post-Translational Modifications 
 
The intricate regulation of Sod1 via post-translational modifications (PTMs) that 
dynamically regulate both its location and activity, suggests that the role of Sod1 may be 
more significant than just protecting against superoxide toxicity.  
In yeast and human cells, it was found that in response to high concentrations of 
H2O2, the cell cycle checkpoint regulating Mec1/ATM effector Dun1/Cds1 kinase 
phosphorylates Sod1 at residues Serine 60 and 99 to induce Sod1 nuclear import to 
regulate oxidative stress resistance and repair gene expression. This hints a potential 
novel non-canonical function of Sod1 as a transcription factor [105]. Sod1 has been 
additionally found to be phosphorylated at Serine 39 in yeast or Threonine 40 in human 
cell lines by the nutrient sensing mTORC1 in response to nutrient availability to inactivate 
Sod1 [113]. These findings show that mTORC1 intricately regulate redox homeostasis via 
Sod1 in response to nutrient availability. Besides phosphorylation, Sod1 is also found to 
be acetylated at lysine 122 (K122), partially regulated by SIRT5, which regulates its 
partitioning between the mitochondrial IMS and the cytosol, affecting respiratory vs. 
fermentative energy metabolism, as a consequence [114, 115].   
Besides the aforementioned described PTMs, there are many other identified 
PTMs in human Sod1 [114], however, the consequences of such PTMs are still enigmatic 
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or only starting to unfold. These PTMs add a layer of complexity to Sod1 biology and are 
imperative to perceive spatio-temporal Sod1 catalyzed H2O2 signaling.  
 
1.3.1.4. Sod1: A Pivotal Mediator of Cell-wide Redox Signaling 
 
As described above, loss of SOD1 in model organisms evokes oxidative damage 
resulting in reduced lifespan and carcinogenesis. Besides oxidative damage, perturbation 
of Sod1-dependent redox relays, required for cell physiology, may also contribute towards 
the observed phenotypes.  
Sod1 comprises a major source of peroxide that is spread throughout the cell. As 
such, it is conceivable that it may promote cell-wide redox signaling relays. However, until 
recently, very little was known about the relative contributions of Sod1 between superoxide 
protection and redox signaling. My thesis work has significantly contributed on how we 
perceive Sod1 in biology, since we have found that less than 1% of total Sod1 is required 
for superoxide protection in yeast, and that this miniscule fraction is localized in the 
mitochondrial IMS. Instead, large amounts of extracellular Sod1 are required for Sod1-
dependent redox relays [112]. This was further demonstrated in mammalian cell lines, 
showing that while loss of a large fraction of Sod1 does not induce oxidative stress or 
affect cell proliferation; the bulk of Sod1 is required to promote the canonical Wnt signaling 
pathway, and Wnt-induced cell proliferation. Moreover, my later work has identified a novel 
Sod1-dependent redox relay by which Sod1 integrates oxygen availability to inactivate 
GAPDH and promote the pentose phosphate pathway to generate NADPH, a vital cell 
reductant that promotes reduction and regeneration of antioxidant systems, such as 
peroxiredoxins. Altogether, my findings recognize Sod1 as a master regulator of the 
cellular redox landscape by being a direct source of H2O2 to oxidize thiols and by 
promoting NADPH/NADP+ redox balance to facilitate reversible redox signaling.  
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To this day there has been several studies that prove Sod1 to be a key contributor 
of a great variety of redox signaling pathways. According to this, Sod1 catalyzed H2O2 has 
been shown to integrate glucose and oxygen availability to repress respiration [35], 
promote growth factor activation [116],  tyrosine phosphatase inactivation [31], 
transcription of antioxidant genes [105], cell proliferation [117] and differentiation. For 
instance, Sod1-catalyzed H2O2 promotes proliferation by favoring Epidermal Growth 
Factor Receptor (EGFR) dimerization and activation via reversible oxidation of an active 
cysteine thiol. This response is further amplified, due to the ability of a privileged pool of 
Sod1-derived H2O2 to oxidize the active site cysteine thiol in the protein tyrosine 
phosphatase (PTP1B) and inactivate it, preventing it from inactivating EGFR [31, 116]. 
This makes Sod1 a potential oncogene, however, its antioxidant capacity would posit it as 
a tumor suppressor. What role does Sod1 play in cancer, then? We are still far away from 
a definite answer, but something is clear, multiple cancer types rely on Sod1 [118], 
therefore, Sod1 is a potential therapeutic target to suppress carcinogenesis. In fact, 
multiple Sod1 inhibitors have been proven effective in promoting cancer cell apoptosis 
and growth arrest [117, 119-121]. It is conceivable, however, that untargeted Sod1 
inhibition may result in disruption of redox signaling pathways and redox homeostasis in 
healthy tissues. Our work has also shown that Sod1 regulates the prooncogenic Wnt 
signaling pathway, which further poses Sod1 as a key protein in promoting 
carcinogenesis. For this reason, it is imperative that we understand the absolute 
contributions of Sod1 in redox signaling to perceive the advantages of inhibiting Sod1 in 
cancer treatment, as well as the contribution of Sod1 in the progression of other diseases, 





1.4. Scope of Thesis 
 
In this dissertation I will describe our results on i) the discovery that extra-
mitochondrial Cu/Zn superoxide dismutase is dispensable for superoxide protection but 
required to mediate peroxide signaling in Saccharomyces cerevisiae, ii) the finding that a 
small fraction of Sod1 is required for oxidative stress protection, but the bulk of Sod1 
regulates the canonical Wnt signaling pathway in human cell lines and iii) the role of Sod1 
in integrating oxygen availability to redox regulate NADPH production and the thiol 
redoxome. 
 
In Chapter 2, I will describe our published work in which we find that most of the 
superoxide scavenging enzyme Cu/Zn superoxide dismutase (Sod1) is dispensable for 
superoxide protection using Saccharomyces cerevisiae as a model organism. According 
to this, less than 1% of total Sod1 is sufficient to rescue cell-wide markers of superoxide 
toxicity. Moreover, we found that this minuscule necessary fraction is localized in the 
mitochondrial intermembrane space. Instead, large quantities of extramitochondrial Sod1 
are required for redox control of Yck1 signaling. The findings exposed in this chapter force 
us to re-evaluate the physiological role of bulk Sod1, proposing that eukaryotes express 
high levels of Sod1 to promote redox signaling.  
 
In Chapter 3, I will lay out the recently accepted work led by Dr. Bindu 
Chandrasekharan in which we found that Sod1 regulates casein kinase gamma (CK1g) 
expression in human embryonic kidney 293 (HEK293) cells and that it is required for 
canonical Wnt signaling and Wnt-dependent cell proliferation. Moreover, we find that the 
requirement of a minuscule fraction of Sod1 for superoxide protection versus the bulk of 
Sod1 for redox signaling is conserved from yeast to mammalian cell lines.  
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In Chapter 4, I will present our latest, soon to be published, findings in which, using 
Saccharomyces cerevisiae and mammalian cell lines, we discovered that a major new 
aspect of Sod1 antioxidant function is to integrate oxygen (O2) availability to promote 
NADPH production to sustain life in air. In detail, Sod1 senses O2 via O2•- from 
mitochondrial respiration and a yeast NADPH oxidase, Yno1, to oxidatively inactivate the 
glycolytic enzyme glyceraldehyde phosphate dehydrogenase (GAPDH), via Sod1-
catalyzed H2O2. This in turn re-routes the carbohydrate flux towards the oxidative phase 
of the pentose phosphate pathway (oxPPP), where most cellular NADPH is generated, 
necessary to support cellular antioxidant systems. We found that the aerobic oxidation of 
GAPDH is exclusively dependent and rate-limited by Sod1. Moreover, using mass 
spectrometry we identified proteome-wide targets of Sod1-dependent redox signaling. Our 
findings in this chapter confers a new perception on the antioxidant role of Sod1 and posits 
Sod1 as a master regulator of metabolism and the thiol redoxome. 
 
Lastly, in Chapter 5 I will present the conclusions of my work and some future 
directions. I will discuss the implications of my new findings on how we perceive Sod1 and 
redox signaling in biology and will lay out future experiments that will contribute towards 
elucidating additional Sod1-catalyzed H2O2 redox relays and better understanding its 
implication in physiology and pathology.  
 
In short, the findings presented in this thesis indicate that the role of Sod1 in cell 
biology is much broader than just superoxide protection and provide a bright new 






Extra-mitochondrial Cu/Zn-Superoxide Dismutase (Sod1) is Dispensable for 
Protection Against Oxidative Stress but Mediates Peroxide Signaling in 
Saccharomyces cerevisiae 
 
This chapter is adapted from the previously published work: Montllor-Albalate, C., Colin, 
A. E., Chandrasekharan, B., Bolaji, N., Andersen, J. L., Outten, F. W., Reddi, A. R. “Extra-
mitochondrial Cu/Zn-Superoxide Dismutase (Sod1) is Dispensable for Protection Against 
Oxidative Stress but Mediates Peroxide Signaling in Saccharomyces cerevisiae” Redox 
Biology. 21 (2019) 101064. The author of this document contributed to this work by 
conceiving, designing and performing most experiments of the paper, except detection of 
labile iron using EPR spectroscopy, enzyme assays (aconitase and isopropyl malate 
isomerase), TUNEL assay and vacuolar fragmentation analysis, making figures with help 
of the corresponding author and co-writing the manuscript with input from all authors.  
 
2.1. Abstract  
 
Cu/Zn Superoxide Dismutase (Sod1) is a highly conserved and abundant 
metalloenzyme that catalyzes the disproportionation of superoxide radicals into hydrogen 
peroxide and molecular oxygen. As a consequence, Sod1 serves dual roles in oxidative 
stress protection and redox signaling by both scavenging cytotoxic superoxide radicals 
and producing hydrogen peroxide that can be used to oxidize and regulate the activity of 
downstream targets. However, the relative contributions of Sod1 to protection against 
oxidative stress and redox signaling are poorly understood. Using the model unicellular 
eukaryote, Baker's yeast, we found that only a small fraction of the total Sod1 pool is 
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required for protection against superoxide toxicity and that this pool is localized to the 
mitochondrial intermembrane space. On the contrary, we find that much larger amounts 
of extra-mitochondrial Sod1 are critical for peroxide-mediated redox signaling. Altogether, 
our results force the re-evaluation of the physiological role of bulk Sod1 in redox biology; 
namely, we propose that the vast majority of Sod1 in yeast is utilized for peroxide-




Superoxide (O2•−) and hydrogen peroxide (H2O2) are cytotoxic reactive oxygen 
species (ROS) that are also essential for the redox control of a multitude of physiological 
processes. O2•− toxicity is largely due to its ability to oxidize and inactivate [4Fe-4S] 
cluster-containing enzymes, which releases iron (Fe) in the process [26, 57, 122, 123]. 
The liberated Fe, upon complexation by appropriate ligands, promotes deleterious redox 
reactions, and in particular produces hydroxyl radicals (•OH) via the Fe-catalyzed 
reduction of H2O2 i.e. Haber-Weiss and Fenton reactions [123, 124]. Once formed, •OH 
indiscriminately oxidizes lipids, proteins, and nucleic acids, leading to membrane 
disruption, protein misfolding and aggregation, and DNA fragmentation, respectively. 
While O2•− itself is not likely to be a signaling molecule [125], it rapidly disproportionates 
into H2O2 (k ~ 105 M-1 s-1 at pH = 7.0), a well-established signaling molecule [125, 126], 
that can lead to the reversible oxidation of cysteine residues in a number of downstream 
targets[127], including phosphatases  [31, 128, 129], kinases [30, 130], metabolic 
enzymes [131], and transcription factors [132, 133], to regulate protein activity.  
The dual roles of O2•−/H2O2 in oxidative stress and redox signaling necessitates 
that the concentration and localization of these ROS are regulated in a manner that 
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enables signaling but mitigates oxidative damage. In terms of localization, a number of 
metabolic sources of H2O2 and O2•− are present throughout the cell, including O2•−-
generating NADPH oxidases (NOX) that have been found in the nucleus, endoplasmic 
reticulum (ER), cell membrane, and mitochondria [54, 134], mitochondrial respiratory 
Complexes I and III [135-137], and enzymes that release O2•− and/or H2O2, e.g. xanthine 
oxidase (cytosol) [138, 139], monoamine oxidase (mitochondria) [140], cytochrome 
P450’s (ER) [141], and globins (cytosol) [142, 143]. In terms of concentration, 
detoxification systems have evolved to limit the levels of O2•−, e.g. superoxide dismutases 
(SODs), and H2O2, e.g. catalase (CAT), glutathione (GSH) peroxidases (GPx), and 
peroxiredoxins (Prx) [144]. Of these ROS scavenging systems, SODs, which catalyze the 
disproportionation of 2O2•− into H2O2 and O2, are unique in that they simultaneously affect 
both [O2•−] and [H2O2]. As a consequence, SODs play dual roles in both defending against 
O2•− toxicity and regulating H2O2-mediated redox signaling [57, 144].      
 Most eukaryotes express two intracellular SODs, a Mn-containing SOD2 that is 
exclusively localized to the mitochondrial matrix [145], and a highly abundant Cu/Zn SOD1 
that is present virtually everywhere else [17], including the mitochondrial intermembrane 
space (IMS) [100, 146], nucleus [147], endoplasmic reticulum (ER) [148], and 
peroxisomes [149]. SOD1-deficient organisms, from yeast to mice, are oxidatively 
stressed and have reduced life spans. For example, SOD1-/- mice have a higher incidence 
of liver cancer, neuronal damage, and loss of muscle mass [80, 150-154]. Drosophila 
mutants of SOD1 are infertile and have dramatically reduced life spans [155]. In 
Saccharomyces cerevisiae (Baker’s yeast), sod1∆ cells have defects in a number of 
metabolic pathways due to oxidative damage of critical [4Fe-4S] cluster containing 
enzymes [124, 156-158], as well as membrane and DNA fragmentation [147, 158, 159] 
due to increases in “free” or labile iron [160, 161], which promote hydroxyl radical formation 
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[124]. In total, cell biological and biochemical studies across multiple organisms indicate 
Sod1 protects Fe-S cluster enzymes from O2•− damage and further oxidative stress due 
to Fe and •OH toxicity.  
From the perspective of redox signaling, Sod1-derived H2O2 was found to regulate 
the oxidation of protein tyrosine phosphatases [31] and the tyrosine kinase growth factor 
receptor [116]. In addition, Sod1 was also found to provide a source of H2O2 that stabilizes 
a pair of plasma membrane casein kinases, Yck1 and Yck2, that control nutrient sensing 
and energy metabolism [35].  
Sod1 is a highly abundant protein in various organisms [20, 162], and in yeast is 
present at concentrations of ~10-20 μM [163, 164], accounting for ~80-90% of total cellular 
Sod activity[165]. Given that Sod1 disproportionates O2•− at diffusion-limited rates (k ~ 109 
M-1s-1)[166], the rationale for producing such large quantities of Sod1 has been enigmatic. 
Moreover, the relative contributions of Sod1 towards protection against O2•− toxicity and 
H2O2-mediated redox signaling are not well understood [57]. Herein, using Baker’s yeast 
as a eukaryotic model, we find that only a small fraction of total Sod1 is required for 
protection against O2•− toxicity and that this pool is localized to the mitochondrial 
intermembrane space (IMS). Instead, we find that much larger amounts of extra-
mitochondrial Sod1 are critical for peroxide-mediated redox control of Yck1 signaling. 
Given that an exceedingly small fraction of Sod1 is required for protection against O2•− 
and much larger quantities are seemingly required for peroxide-mediated redox signaling, 
our results challenge us to re-evaluate the physiological role of bulk Sod1. We propose 
that eukaryotes express high levels of Sod1 to maintain appropriate peroxide fluxes to 
facilitate redox signaling, whereas superoxide detoxification can be handled by a relatively 





2.3.1. The vast majority of Sod1 is dispensable for protection against superoxide toxicity.  
 
In atmospheric oxygen (21% O2), sod1∆ cells exhibit a number of markers of O2 − 
toxicity. This includes elevated [O2•−] [167], O2•−-mediated inactivation of a number of [4Fe-
4S] enzymes [124, 158, 168], including aconitase (Aco1), isopropylmalate isomerase 
(Leu1), and homoaconitase (Lys4), increased labile Fe due to its release from oxidized 
Fe-S clusters [158, 160, 161], and vacuolar [159] and DNA [147] fragmentation due to 
deleterious Fe-mediated redox reactions. Collectively, these defects lead to reduced 
aerobic growth [165], decreased lifespan  [169], and a number of metabolic defects, 
including perturbations to redox homeostasis [157], energy metabolism [35, 170] and a 
number of amino acid auxotrophies [124, 156-158], e.g. defects in the biosynthesis of 
leucine (due to inhibition of Leu1), lysine (due to inhibition of Lys4), and methionine (due 
to reduced pentose phosphate pathway activity and NADPH). Using the galactose-
inducible GAL1 promoter to drive SOD1 expression in the background of sod1∆ cells, we 
sought to determine the amount of Sod1 required to rescue various cell-wide markers of 
oxidative stress. As shown in Fig. 2.1a, titration of galactose (GAL) resulted in 
undetectable (0.000 - 0.005% w/v GAL), intermediate (0.006% - 0.008% w/v GAL), and 
high (> .01% w/v GAL) levels of Sod1 expression and activity. Concentrations > 0.01% 
GAL consistently resulted in near WT-levels of Sod1 expression and activity. Most 
interestingly, only 0.005% GAL, a concentration that results in the induction of an 
undetectable amount of Sod1 activity and polypeptide (Fig. 2.1a), rescues major 
hallmarks of O2•− toxicity, including sensitivity to paraquat, a O2•−-generating agent (Fig. 
2.1b), lysine auxotrophy (Fig. 2.1c), the activity of mitochondrial and cytosolic [4Fe-4S] 
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cluster containing enzymes, Aco1 (Fig. 2.1d) and Leu1 (Fig. 2.1e), respectively, cellular 
[O2•−] as measured by dihydroethidium (DHE) fluorescence (Fig. 2.1f), electron 
paramagnetic resonance (EPR)-detectable labile Fe pools (Fig. 2.1g), vacuolar 
fragmentation as imaged by FM4-64 (Fig. 2.1h and i), and DNA damage as assessed by 
terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick end labeling (TUNEL) 
(Fig. 2.1j). Parenthetically, it is important to note that at the excitation and emission 
wavelengths chosen to measure DHE fluorescence, there are contributions from both 
superoxide specific, e.g. 2-hydroxyethidium, and non-specific, e.g. ethidium or 
ethidium/ethidine dimers, DHE oxidation products [171]. Thus, while our DHE 
fluorescence measurements are not specific for superoxide per se, the differences in DHE 
fluorescence we observe reflect Sod1-dependent DHE oxidation products. Altogether, 
these results indicate that the vast majority of Sod1 is dispensable for protection against 





Figure 2.1. The vast majority of Sod1 is dispensable for protection against 
superoxide toxicity. (a and b) Titration of galactose (GAL) into cultures of   sod1::LEU2 
(sod1∆) cells expressing the GAL1 driven Sod1 expression vector (prGAL-SOD1; pAR1026) 
results in the expression of low (≤ .005% GAL), intermediate (0.006% - 0.008% GAL), and 
high (≥ 0.009% GAL) expression and activity of Sod1. The immunoblots and activity gels 
depicted are representative of multiple trials across different batches of media. (c) 
Paraquat (PQ) sensitivity of WT and sod1∆ cells compared to sod1∆ + prGAL-SOD1 cells 
expressing none (0% GAL), low (0.005% GAL) or high (0.5% GAL) levels of Sod1 as 
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measured by solution turbidity. (d) Lysine (Lys) auxotrophy, (e) aconitase (Aco1) activity, 
and (f) isopropylmalate isomerase (Leu1) activity of sod1∆ + prGAL-SOD1 cells is 
measured as a function of Sod1 expression and compared to WT and/or sod1∆ cells. (g) 
Representative immunoblot and activity gel from a different batch of media showing the 
reproducibility of the low undetectable induction of Sod1 by 0.005% GAL in sod1∆ + prGAL-
SOD1 cells. (h) DHE detectable superoxide was monitored in WT, sod1∆, and sod1∆ + 
prGAL-SOD1 cells expressing none (0% GAL), low (0.005% GAL), or high (0.5% GAL) 
Sod1. (i) EPR detectable labile Fe, (j and k) FM4-64 visualized vacuolar fragmentation, 
and (l) DNA damage using the TUNEL assay was monitored in sod1∆ + prGAL-SOD1 cells 
expressing none (0% GAL), low (0.005% GAL), or high (0.5% GAL) Sod1. In panels k and 
l, approximately ~100 cells were counted from each culture condition in triplicate and 
scored for (k) having single or multiple fragmented vacuoles, as depicted in panel j, or (l) 
being non-fluorescent or fluorescent in the FITC channel. Error bars indicate the average 
± s.d. of triplicate (c, d, h, k, l) or duplicate (e, f, i) cultures. The statistical significance 
relative to WT (c, h) or sod1∆ cells cultured with 0% GAL (d, e, f, i, k, l) is indicated by 




2.3.2. IMS-targeted Sod1 is sufficient to protect against cell-wide markers of O2•− toxicity.  
 
We next sought to determine if the localization of Sod1 is important for protection 
against cell-wide markers of superoxide toxicity. Mitochondria are a major source of ROS 
and O2•− due to electron leakage during cellular respiration, and in particular from Complex 
III, which can release O2•− into the mitochondrial matrix and IMS [135]. Deletion of Sod1, 
which is in-part localized to the mitochondrial IMS [100, 146], but not Sod2, which 
exclusively resides in the mitochondrial matrix, results in lysine auxotrophy due to the O2•−-
dependent inhibition of matrix-localized homoaconitase (Lys4). This suggests that O2•− 
leakage into the IMS occurs to a greater extent than into the matrix and the ultimate source 
of matrix O2 − is from the IMS. In order to determine the extent to which IMS-localized 
Sod1 protects against oxidative stress, including in the mitochondrial matrix, an allele of 
Sod1 that is exclusively targeted to the IMS, SOD1-IMS, due to fusion of the Sco2 IMS 
localization sequence [35, 172] was expressed in sod1∆ cells (Fig. 2.2a). Interestingly, we 
found that SOD1-IMS rescues cell-wide markers of O2 −-toxicity, including paraquat 
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sensitivity (Fig. 2.2b), lysine auxotrophy (Fig. 2.2c), the activity of mitochondrial and 
cytosolic [4Fe-4S] cluster containing enzymes, Aco1 (Fig. 2.2d) and Leu1 (Fig. 2.2e), 
respectively, cellular [O2•−] as measured by dihydroethidium (DHE) fluorescence (Fig. 
2.2f), Phen Green-detectable labile Fe (Fig. 2.2g), vacuolar fragmentation as imaged by 
FM4-64 (Fig. 2.2h), and DNA damage as assessed by terminal deoxynucleotidyl 
transferase (TdT)-mediated dUTP nick end labeling (TUNEL) (Fig. 2.2i). The effects of 
SOD1-IMS on defending against O2•− toxicity are distinct from mitochondrial matrix 
localized Sod2. Unlike sod1∆ cells, sod2∆ mutants do not exhibit lysine, leucine, or 
methionine auxotrophies, stunted aerobic growth, or growth defects on respiratory carbon 
sources, e.g. 3% glycerol (Fig. 2.2j). Notably, SOD1-IMS expression is sufficient to rescue 
growth of sod1∆ cells on glycerol (Fig. 2.2j). Altogether, these results indicate that IMS-
localized Sod1 alone can protect against cell-wide superoxide toxicity and that the source 




Figure 2.2. IMS-targeted Sod1 is sufficient to protect against cell-wide markers of 
superoxide toxicity. (a) Immunoblot and Sod activity gel of sod1::kanMX4 (sod1∆) cells 
expressing empty vector (EV; pRS415), WT SOD1 (SOD1; pRS415-SOD1), or 
mitochondrial IMS targeted SCO2-SOD1 (SOD1-IMS; pRS415-SCO2-SOD1. (b) 
Paraquat (PQ) sensitivity, (c) lysine (Lys) auxotrophy, (d) aconitase (Aco1) activity, (e) 
isopropylmalate isomerase (Leu1) activity, (f) DHE-detectable superoxide, (g) Phen-
Green detectable labile Fe, (h) vacuolar fragmentation, and (i) TUNEL-detected DNA 
fragmentation in sod1∆ cells expressing EV, SOD1, or SOD1-IMS. (j) Respiratory (3% 
glycerol) versus fermentative (2% glucose) growth of WT, sod1::kanMX4, sod2::kanMX4, 
sod1::kanMX4 + pRS415, sod1::kanMX4 + pRS415-SOD1, sod1::kanMX4 + pRS415-
SCO2-SOD1 was tested by spotting 104, 103, and 102 cells on YP media plates containing 
2% glucose or 3% glycerol for 3 days. In panels h and i, approximately ~100 cells were 
counted from each culture condition in triplicate and scored for (h) having single or multiple 
fragmented vacuoles, as depicted in Figure 1j, or (i) being non-fluorescent or fluorescent 
in the FITC channel. Error bars indicate the average ± s.d. of triplicate cultures. The 
statistical significance relative to EV cells and/or between pairwise comparisons denoted 
by the black lines is indicated by asterisks using a two-sample t-test. * P < 0.05, ** P < 
0.01, *** P < 0.001, n.s. not significant. 
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2.3.3. High concentrations of Sod1 are required for Yck1 signaling.  
 
Given that the vast majority of extra-mitochondrial Sod1 is apparently dispensable 
for protection against superoxide toxicity, we next sought to determine the relative 
contribution of Sod1 towards H2O2-mediated redox signaling. In Saccharomyces 
cerevisiae, the only known case of Sod1-mediated redox signaling to date involves a 
pathway in which Sod1 derived H2O2 regulates the stability of a pair of plasma membrane 
tethered casein kinases, Yck1 and Yck2, that integrate nutrient sensing with energy 
metabolism [35]. Sod1, which physically associates with the C-terminus of Yck1, produces 
a local flux of H2O2 that prevents the degradation of Yck1. In the absence of Sod1, its 
substrate, O2•−, or a O2•−-generating NADPH oxidase, Yno1[173], Yck1 is degraded 
through a mechanism that is currently unknown [35]. The loss of Yck1 shifts energy 
metabolism from fermentation to respiration. Notably, IMS-localized Sod1 does not 
contribute towards the regulation of Yck1 stability [35]. Most interestingly, unlike numerous 
hallmarks of superoxide-toxicity, Yck1 stability is very sensitive to Sod1 expression. 
Titration of Sod1 using the GAL-inducible SOD1 expression system results in a positive 
correlation between Sod1 activity and Yck1 expression at Sod1 levels that exceed the 
minimal threshold required to protect against superoxide toxicity (Fig. 2.3a). Similarly, 
inhibiting Sod1 activity using the copper chelator BCS results in a dose-dependent 
decrease in Yck1 expression (Fig. 2.3b). Altogether, we find that redox signaling via the 
Sod1/H2O2/Yck1 signaling axis is far more sensitive to fluctuations in bulk Sod1 activity 
than protection against cell-wide markers of superoxide toxicity, which only requires a 
vanishingly low amount of Sod1 activity.              
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Figure 2.3. Yck1 expression is more sensitive to fluctuations in Sod1 expression 
and activity than various markers of superoxide toxicity. (a) Titration of galactose 
(GAL) into cultures of sod1::LEU2 (sod1∆) cells co-expressing the GAL1 driven Sod1 
expression vector (prGAL-SOD1; pAR1026) and the TEF1 driven GFP-Yck1 expression 
vector (pAR113) results in a positive correlation between Sod1 activity and Yck1 
expression. (b) Titration of the copper chelator, BCS, into cultures of sod1::LEU2 cells 
expressing the TEF1 driven GFP-Yck1 expression vector (pAR113) results in a positive 
correlation between Sod1 activity and Yck1 expression. In the correlation plots, relative 
GFP-Yck1 expression is measured as the ratio of GFP-Yck1 to GAPDH signal intensities 
as determined from densitometry of the immunoblots. Sod1 activity is expressed as a 
normalized activity relative to the maximal activity observed in each experimental set, i.e. 
0.5% GAL in GAL titrations or 0 mM BCS in BCS titrations.    
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2.4. Discussion  
 
  Since the seminal discovery of Sod1 in 1969 [17], there was great controversy 
surrounding its proposed physiological function in O2•− scavenging due to the low reactivity 
of O2•− with various biomolecules, e.g. nucleic acids, proteins, and lipids, and the short 
lifetime of O2•− due to its rapid un-catalyzed disproportionation, k ~ 105 M-1 s-1 at pH 
7.0[174, 175]. In fact, it was proposed that Sod1 had other unknown functions in biology 
and that it coincidentally catalyzed O2•− disproportionation [175]. This controversy was 
largely put to rest with the realization that [4Fe-4S] cluster containing enzymes are primary 
targets of O2•−, which can oxidize and destroy Fe-S clusters with rate constants up to 107 
M-1 s-1 [26, 57, 122, 123]. In fact, most of the pathological hallmarks of Sod1 deletion and 
O2•− toxicity are due to the diminished activity of certain Fe-S cluster enzymes and 
inhibition of the corresponding metabolic pathways they operate in, increased labile Fe 
due to the destruction of Fe-S clusters, and Fe-mediated oxidative stress that results in 
the damage of lipids, proteins, and nucleic acids. However, given that Sod1 is amongst 
the most abundant proteins, constituting as much as 0.5% of total yeast protein [176], and 
disproportionates O2•− at diffusion-limited rates (k ~ 109 M-1s-1), the rationale for producing 
large quantities of Sod1 has been a mystery. Indeed, herein, using the model unicellular 
eukaryote, Saccharomyces cerevisiae (Baker’s yeast), we find that the vast majority of 
Sod1 is dispensable for protection against numerous cell-wide markers of O2•− toxicity, 
including cellular [O2•−], loss of Fe-S cluster enzyme activity, increased labile Fe, and 
vacuolar and DNA damage (Fig. 2.1).    
As SODs are the only enzymes that simultaneously affect both [O2•−] and [H2O2], 
they play dual roles in defending against O2•− toxicity and regulating H2O2-mediated redox 
signaling. While the bulk of Sod1 is dispensable for protection against O2•− toxicity, we find 
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that Sod1-mediated peroxide regulation of Yck1 and Yck2 is far more sensitive to 
fluctuations in Sod1 expression and activity (Fig. 2.3). However, if anything, logic dictates 
that Sod1 would have more influence on superoxide scavenging than peroxide-mediated 
signaling given that it facilitates the production of 1 H2O2 molecule per 2 O2•− molecules. 
This paradox can be resolved by considering that the biological targets of O2•− toxicity are 
limited in scope, primarily Fe-S proteins, necessitating that very little Sod1 is required to 
protect against O2•− damage. In contrast, peroxide-mediated signaling may require large 
amounts of Sod1 in order to ensure that a sufficient concentration is present in locations 
proximal to sites of O2•− generation, e.g. NADPH oxidases, so as to provide an adequate 
flux of H2O2 for the redox control of downstream targets. Directly testing this hypothesis is 
not trivial due to the technical challenges associated with measuring localized pools of 
H2O2. Moreover, given that sod1∆ cells exhibit profound metabolic changes, including 
increased rates of respiration, it is difficult to parse apart contributions arising from the 
production of H2O2 directly from Sod1 versus various metabolic sources that are affected 
by Sod1 expression, e.g. electron transport chain.      
  In light of the fact that vanishingly little Sod1 is required for defense against O2•− 
toxicity, the primary physiological role of Sod1 as a O2•− scavenger may need to be re-
considered in yeast, and potentially other cell types and organisms; its role in redox 
signaling [31, 35], or non-redox related functions, e.g. Cu buffering [176-178] or as a 
transcription factor [147], may account for the function of most Sod1 in cells. An alternative 
rationale that may account for cells maintaining a high level of Sod1 is that it is required 
to protect against pathological conditions that transiently increase O2•− burdens. Indeed, 
Sod1 over-expression can protect against the oxidative stress associated with post-
ischemic injury in mouse models [179]. In this context, our results from yeast suggest that 
in the absence of redox stress and O2•− toxicity, the majority of Sod1 is more vital for 
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functions unrelated to its role in superoxide scavenging. However, when cells are 
oxidatively stressed, larger amounts of Sod1 that are otherwise utilized for redox signaling 
or non-redox functions can “moonlight” as a O2•− scavenger.  
Another interesting outcome of our study is that Sod1 localized to the IMS is 
sufficient to protect against cell-wide markers of O2•− toxicity. This result suggests that 
different pools of Sod1 may have very different physiological functions. For instance, IMS-
localized Sod1 may be critical for protection against O2•− toxicity whereas extra-
mitochondrial Sod1 may be more important for non-O2•− scavenging related functions, 
such as mediating H2O2-based redox signaling or acting as a transcription factor. The dual 
roles of Sod1 in redox signaling and protecting against O2•− toxicity in different locales may 
necessitate the existence of mechanisms to dynamically regulate the localization and/or 
activity/function of Sod1. Indeed, in human cell lines, it was recently found that acetylation 
of Sod1 at K122, which is in-part regulated by SIRT5, regulates the partitioning of Sod1 
between the cytosol and mitochondrial IMS, which in-turn affects respiratory vs. 
fermentative energy metabolism [115]. In yeast and human cell lines, it was found that in 
response to H2O2, the cell cycle checkpoint regulating Mec1/ATM effector Dun1/Cds1 
kinase phosphorylates Sod1 at S60 and S99 to trigger its nuclear import to regulate gene 
transcription [147]. In addition, it was recently demonstrated that Sod1 is reversibly 
phosphorylated at S39 in yeast or T40 in human cell lines by the nutrient sensing mTORC1 
to regulate redox homeostasis and adaptation to changes in nutrient availability [113].  
Why can IMS-localized Sod1 protect against cell-wide markers of O2•−-toxicity? 
First, our data suggests that the source of matrix and extra-mitochondrial O2•− originates 
in the IMS. How then can O2•− in the IMS damage biomolecules in other compartments, 
including the mitochondrial matrix cytosol, vacuole, and nucleus? One possibility is that 
O2•− or HO2• in the IMS diffuses into the matrix and cytosol, possibly through membrane 
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channels [180], damaging Fe-S enzymes that reside in these locations [168]. The liberated 
labile Fe can then be bound and trafficked in a manner that enables it to catalyze 
deleterious redox reactions throughout the cell. Our results support prior observations that 
ROS derived from Complex III exerts its influence on extra-mitochondrial targets [181, 
182]. 
Sod1 catalyzed O2•− disproportionation is paramount to its biological function. 
However, herein we propose that the majority of Sod1 in yeast, and possibly other cell 
types, is more vital as a source of H2O2 for redox signaling, and potentially other non-
redox functions, than for scavenging O2•−. The concentration and spatio-temporal 
distribution of O2•− encountered in various cells and organisms in vivo are still not well 
understood and will further define the relative roles of Sod1 in redox signaling and 
oxidative stress protection. Moreover, the identification of proteome-wide redox-targets of 
Sod1-derived H2O2 will be a new frontier in the cell biology of Sod1. Our results will have 
implications for understanding the basic redox biology of Sod1 and better inform the 
treatment of diseases in which Sod1 or redox homeostasis can be targeted, including 
certain cancers [31, 183], neurodegenerative disorders, e.g. amyotrophic lateral sclerosis 












2.5.1. Chemicals, media components, and immunological reagents.  
 
Dihydroethidium (Cat. # 50-850-563), FM-4-64 (Cat # T-3166), and Phen Green 
SK diacetate (Cat. # P-14313) was purchased from Thermo Fisher Scientific. Paraquat 
dichloride (Cat # 856177-1G) was purchased from Sigma-Aldrich.  Yeast nitrogen base 
and SC dropout mixtures were purchased from Sunrise Science Products. The Yeast 
Mitochondria Isolation kit was purchased from Bio Vision (#Cat. K259-50). Rabbit 
polyclonal antibodies against GAPDH (Cat. # 89348-232) and GFP (Cat. # 89362-978) 
were purchased from VWR. Rabbit polyclonal antibody against PGK1 (Cat. #PA528612) 
and mouse monoclonal antibody against Porin (Cat. #459500) were purchased from 
Thermo Fisher and Invitrogen, respectively. A previously described rabbit polyclonal 
antibody against Sod1 was obtained from the laboratory of Valeria Culotta (Johns Hopkins 
University) [35]. 
 
2.5.2. Yeast strains, plasmids, and growth. 
 
S. cerevisiae strains used in this study were derived from BY4741 (MATa, his3∆1, 
leu2∆0, met15∆0, ura3∆0). sod1::LEU2 and sod1::kanMX4 strains were generated by 
knocking out SOD1 using the previously described deletion plasmids, pKS1[177] and 
pJAB002 [188]. 
 The GAL1 driven SOD1 expression plasmid (pAR1026) was constructed by PCR 
amplification of the SOD1 open reading frame from BY4741 genomic DNA with primers 
that introduced flanking 5’ and 3’ SpeI and BamHI sites, respectively. The SOD1 amplicon 
was sub-cloned into the SpeI and BamHI sites of pRS316-GAL1 [189] to generate 
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pAR1026. The TEF1-driven GFP-Yck1 expression construct (pAR113) was previously 
reported [35]. Expression constructs for wild type SOD1 (pRS415-SOD1) and IMS 
localized SCO2-SOD1 (pRS415-SCO2-SOD1), which are both driven by the native SOD1 
promoter, were previously described and were provided by the laboratory of Professor 
Dennis Thiele (Duke University) [172].  
Yeast transformations were performed by the lithium acetate procedure[190]. 
Strains were maintained at 30 °C on either enriched yeast extract-peptone based medium 
supplemented with 2% glucose (YPD), or synthetic complete medium (SC) supplemented 
with 2% glucose and the appropriate drop-out mixture to maintain selection. For all 
experiments, cells were streaked from -80 °C glycerol stocks onto solid agar media plates 
and pre-cultured in an anaerobic chamber (Coy laboratories) maintained with an 
atmosphere of 95% N2 and 5% H2. Anaerobically grown cells required supplementing YPD 
or SC media with 15 mg/L of ergosterol and 0.5% Tween-80 (YPDE or SCE, respectively) 
[191].  
For experiments involving the titration of SOD1 using the GAL1 driven SOD1 
expression plasmid, pAR1026, cells were cultured aerobically in SC-URA, with 2% 
raffinose and the indicated galactose concentrations. For typical experiments involving the 
IMS-targeted SCO2-SOD1 expression plasmid, cells were cultured aerobically in SC-LEU, 
with 2% raffinose. In all cases, cells were seeded at an OD600nm ~ .01 and cultured for 14-
17 hours to a density of OD600nm ~ 1.0 at 30 °C in a shaking incubator (220 RPM). Following 
growth, cells were processed as described below for immunoblotting, enzyme assays, 
EPR spectroscopy, or measurements of labile Fe, superoxide, DNA damage, or vacuolar 
fragmentation. For all experiments, SOD1 activity and/or expression was assessed as 
described below. All experiments were conducted using biological replicates arising from 
duplicate or triplicate independent cultures of multiple clones. While the data reported in 
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the figures reflect biological replicates from single experimental trials, all of the data has 




 ~2 x 108 cells were harvested, washed in ice-cold Milli-Q water, and lysed in two 
pellet volumes of lysis buffer (10 mM sodium phosphate, 50 mM sodium chloride, 5 mM 
EDTA, 1.0% Triton X-100, 1 mM PMSF and a protease inhibitor cocktail (GBiosciences) 
as described previously [192]. Lysis was achieved at 4 °C using one pellet volume of 
zirconium oxide beads and a bead beater (Bullet Blender, Next Advance) on a setting of 
8 for 3 minutes[192]. Lysate protein concentrations were determined by the Bradford 
method (Bio-rad) and 14% tris-glycine gels (Invitrogen) were employed for SDS-
PAGE[192]. Anti-GFP (1:4000), anti-GAPDH (1:4000) or anti-SOD1 (1:5000) polyclonal 
antibodies and a goat anti-rabbit secondary antibody conjugated to a 680 nm emitting 
fluorophore (Biotium) were used to probe for GFP-Yck1, GAPDH or Sod1 respectively. All 
gels were imaged on a LiCOR Odyssey Infrared imager [35, 165, 192].   
 
2.5.4. Cell fractionation. 
 
Mitochondria were isolated using the Yeast Mitochondria Isolation Kit (Bio Vision). 
For this purpose, sod1∆ cells expressing an empty vector (pRS415), SOD1 (pRS415-
SOD1) or IMS localized SCO2-SOD1 (pRS415-SCO2-SOD1) were grown to a final 
OD600nm = 1.0 in SC, 2% glucose media. ~4 x 1016 cells of each strain were harvested and 
washed in ice-cold Milli-Q prior to fractionation. After fractionation, the volume 
corresponding to one percent of whole lysate or cytosolic fraction and ten percent of 
mitochondrial fraction were loaded in the previously described gels for SDS-PAGE. The 
 42 
samples were probed with anti-PGK1 (1:1000) and anti-SOD1 (1:5000) polyclonal 
antibodies and a goat anti-rabbit secondary antibody conjugated to a 680 nm emitting 
fluorophore (Biotium), in addition to anti-Porin (1:5000) monoclonal antibody and a goat 
anti-mouse secondary antibody conjugated to a 797nm emiting fluorophore (Thermo 
Fisher). 
 
2.5.5. Enzyme assays.  
 
SOD activity analysis was carried out by native PAGE and nitroblue tetrazolium 
staining as described previously [35, 193, 194] on exponential phase cultures grown to a 
final OD600nm = 1.0 in SC, 2% raffinose media containing the indicated concentration of 
galactose. Yeast cells were washed with ultra-pure H2O, resuspended in lysis buffer and 
lysed as described in the section on immunblotting. Protein samples (~10-30 μg) were 
separated in 14% native PAGE gels. Sod1 activity was visualized by staining gels with 
2.43 mM nitro blue tetrazolium chloride (Sigma), 0.14 M riboflavin-50-phosphate (Sigma) 
and 28mM TEMED (Bio-Rad) for 60 min at room temperature in darkness. To visualize 
Sod1 activity, gels were rinsed with water twice and exposed to light. 
For aconitase (Aco1p) and isopropylmalate isomerase (Leu1p) activity assays, 
cells were subjected to ZrO bead lysis in 50 mM MES, 100 mM KCl, 0.1% Triton X-100, 
pH 7.0 under a nitrogen atmosphere in a COY chamber. Aco1p and Leu1p activity was 
determined spectrophotometrically as described previously[165, 168] using a Biotek 
Synergy Mx multi-modal plate. The assay mixture contained 50–300 μg of lysate protein 
in 200 μL of a buffer containing 50 mM tris(hydroxymethyl) aminomethane (Tris)-HCl, pH 
7.4, and 100 mM NaCl and supplemented with either 0.5 mM cis-aconitate (Aco1 activity) 
or 0.5 mM citraconitate (Leu1 activity). Activities were determined by monitoring the 
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disappearance of cis-aconitate (Aco1p) or citraconitate (Leu1p) at 240 or 235 nm, 
respectively, over the course of 5 minutes.  
 
2.5.6. Superoxide measurements.  
 
Superoxide levels were measured by monitoring the fluorescence of DHE stained 
cells (λex = 485 nm, λem = 620 nm) similarly to what was described previously[35, 167]. 
Briefly, 1 x 107 cells were harvested from duplicate or triplicate cultures, resuspended and 
incubated in 500 μl of fresh media containing 50 μM DHE for 20 min in the dark, washed 
twice with PBS solution, and fluorescence recorded in a Biotek Synergy Mx multi-modal 
plate reader.  
 
2.5.7. Detection of labile Fe using EPR spectroscopy. 
 
 EPR detection of labile Fe in yeast was accomplished as described previously 
[158, 161, 195], but with the following modifications. 50 mL cultures of sod1∆ cells 
expressing prGAL-SOD1 seeded at a density of OD600nm = .01 were grown in 250 mL 
Erlenmeyer flasks containing SC, 2% raffinose media with the indicated galactose 
concentration. Cultures were grown for 16 hours to an OD600nm ~ 1. Cells were washed 2x 
with 10 mL of cold ultrapure H2O and 1x with 10 mL cold 20 mM Tris-Cl, pH 7.4 on ice. 
Finally, the cells were resuspended in 500 μL of cold 20 mM Tris-Cl, pH 7.4, containing 
10% glycerol and transferred into an EPR tube. The sample was flash frozen in liquid N2 
and stored at -80 °C until EPR measurements were performed. Spectra were recorded 
with a Bruker EMX X-band spectrometer equipped with an ESR900 continuous flow 
cryostat (Oxford Instruments, Concord, MA) at 70K. The parameters for EPR were as 
follows: center field,1,560 G; sweep width, 500 G; frequency 9.45 GHz; microwave power, 
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31 mW; attenuation, 10 dB; modulation amplitude, 20 G; modulation frequency, 100 kHz; 
receiver gain, 2· 105 ; sweep time, 20.97 s; time constant, 81.92 ms; resolution, 2,048 
points; number of scans, 16. Fe(III) desferrioxamine (DFO) standards were prepared over 
a range of concentrations in 20 mM Tris HCl, 1 mM DFO, 10% glycerol, pH 7.4.  The Fe(III) 
signal at g = 4.3 was analyzed with the Xenon software (Bruker) and used for quantitation 
of EPR-detectable iron levels.  Calculation of cellular EPR-detectable Fe(III) was 
performed as described previously [195]. 
 
2.5.8. Detection of labile Fe with Phen Green SK.  
 
Labile Fe was detected as described previously using Phen Green SK (λex = 488 
nm, λem = 530 nm), a fluorescent probe for divalent metals that is quenched upon Fe2+ 
binding [196-198]. 5 x 107 cells were resuspended in 300 μL of phosphate buffered saline 
(PBS). The cell suspension was incubated with 3 μL of a 2 mM Phen Green SK DMSO 
stock solution at 30 °C for 15 minutes in the dark. Cells were then washed with PBS, and 
split into 3 x 100 μL aliquots, and were treated with 1 μL of H2O, 1 μL of a 200 mM aqueous 
stock solution of 1,10-phenantroline, a ferrous iron chelator, or treated with 1 µL of a 10 
mM aqueous stock solution of ferrous ammonium sulfate, and incubated in the dark for 10 
minutes, prior to recording fluorescence. Phen Green fluorescence was recorded in a 
Biotek Synergy Mx multi-modal plate reader. After subtracting the background 
fluorescence of unlabeled cells, the percentage of Phen Green bound to Fe2+ (% Bound) 
was calculated using the following formula: 
 
% Bound: (F-Fmin/Fmax-Fmin)*100 
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where, F is Phen Green fluorescence intensity in the test sample, Fmin is the Phen Green 
fluorescence intensity when it is not bound to Fe, and Fmax is the Phen Green fluorescence 
intensity when it is saturated with Fe. Fmin is determined by recording Phen Green 
fluorescence in cells incubated with the iron chelator, 1,10-phenantroline. Fmax is 
determined by recording Phen Green fluorescence in cells incubated with ferrous 
ammonium sulfate. 
 
2.5.9. Vacuolar fragmentation.  
 
Vacuolar fragmentation was assessed as previously described [158]. Briefly, 2 x 
107 cells were resuspended in 50μL of fresh growth media, typically SC media with 2% 
raffinose and appropriate galactose concentration. The cell suspension was incubated 
with 1μL of a 2 mM DMSO stock solution of FM4-64 at 30 °C for 20 minutes in the dark. 
The cells were then pelleted, washed with fresh media, and resuspended in 5 mL of fresh 
SC media with 2% raffinose and appropriate galactose concentration. The cells were 
cultured for an additional 1.5 hours at 30 °C, shaking at 220 RPM in the dark. The cells 
were then washed with PBS and resuspended in PBS to a density of 2 x 108 cells mL-1. 3 
μL of the cell suspension were placed on a glass slide and imaged using a Zeiss LSM 700 
microscope equipped with a 63x, 1.4 numerical aperture oil objective, using the using the 
Texas Red channel. Approximately ~100 cells were counted from each culture condition 
in triplicate and scored for having either single vacuoles or multiple fragmented vacuoles 






2.5.10. TUNEL assays.  
 
TUNEL assays were conducted as previously described[147]. Yeast cells were 
fixed in 4% p-formaldehyde at room temperature for 30 minutes.  The cells were then 
washed three times with PBS.  The cell pellet was then re-suspended in PBS and digested 
with 300 μg / mL of Zymolyase 100T at 37 °C for 60 minutes. After 60 minutes, 10 μL of 
the cell suspension was applied to a clean glass slide and dried at 37 °C for 30 minutes. 
The slides were rinsed with PBS and incubated in a permeabilization solution (0.1% Triton 
X-100 and 0.1% sodium citrate) on ice for 2 min.  The slides were then rinsed twice with 
PBS. The TUNEL reaction mixture (50 μl of enzyme solution and 450 μl of Label solution; 
In Situ Cell Death Detection Kit, Roche Diagnostics) was applied to the slides and 
incubated in the dark for 60 minutes. The cells labeled with fluorescein-dUTP were imaged 
using a Zeiss LSM 700 microscope equipped with a 63x, 1.4 numerical aperture oil 
objective. Approximately ~100 cells were counted from each culture condition in triplicate 






Cu/Zn Superoxide Dismutase (Sod1) Regulates the Canonical Wnt Signaling 
Pathway 
 
This chapter is adapted from the previously accepted work: Chandrasekharan, B., 
Montllor-Albalate, C., Colin, A., Jang, Y. LC., Reddi, A. R. “Cu/Zn-Superoxide Dismutase 
(Sod1) Regulates the Canonical Wnt Signaling Pathway” BBRC. (2020). The second 
author of this document, and author of this thesis dissertation, contributed to this work by 
conceiving, designing and performing the cell proliferation and antioxidant system 
expression experiments of the paper, making figures for such experiments and 




Cu/Zn Superoxide Dismutase (Sod1) catalyzes the disproportionation of cytotoxic 
superoxide radicals (O2-) into oxygen (O2) and hydrogen peroxide (H2O2), a key signaling 
molecule. In Saccharomyces cerevisiae, we previously discovered that Sod1 participates 
in an H2O2-mediated redox signaling circuit that links nutrient availability to the control of 
energy metabolism. In response to glucose and O2, Sod1-derived H2O2 stabilizes a pair 
of conserved plasma membrane kinases - yeast casein kinase 1 and 2 (Yck1/2) - that 
signal glycolytic growth and the repression of respiration. The Yck1/2 homolog in humans, 
casein kinase 1-γ (CK1γ), is an integral component of the Wingless and Int-1 (Wnt) 
signaling pathway, which is essential for regulating cell fate and proliferation in early 
development and adult tissue and is dysregulated in many cancers. Herein, we establish 
the conservation of the SOD1/YCK1 redox signaling axis in humans by finding that SOD1 
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regulates CK1γ expression in human embryonic kidney 293 (HEK293) cells and is 




Up to 1-2% of all molecular oxygen (O2) consumed in cells is incompletely reduced 
to cytotoxic reactive oxygen species (ROS) such as superoxide (O2•-), hydrogen peroxide 
(H2O2), and hydroxyl radicals (•OH) [199, 200]. As a consequence, a number of ROS 
scavenging enzymes evolved to defend against the toxicity of O2•-, e.g.superoxide 
dismutases (SODs), and H2O2, e.g. catalases and peroxidases [144]. H2O2 is unique 
amongst the aforementioned ROS in that it is also a key signaling molecule [125, 126]. 
Peroxide-mediated oxidation of cysteine thiols to disulfides, sulfenic acid, or sulfinic acid 
on downstream targets can alter protein structure and function, leading to changes in cell 
physiology [30, 42, 201, 202]. However, the mechanisms underlying the transmission of 
peroxide-based signals in a cellular sea of H2O2 scavenging and detoxification systems is 
not well understood.  
SODs, which detoxify O2•- by catalyzing its disproportionation into H2O2 and O2, 
constitute a major enzymatic source of signaling peroxides. Most eukaryotes express two 
structurally unrelated intracellular SODs, a Mn-containing SOD (Sod2) that is confined to 
the mitochondrial matrix [145] and a Cu/Zn-containing SOD (Sod1) that is present in 
virtually every subcellular locale except the matrix [17]. Sod1 accounts for the majority of 
SOD activity, > 80% [165], and its importance in oxidative stress protection is underscored 
by reduced proliferation, decreased lifespan, and metabolic defects when SOD1 is deleted 
in various cell lines and organisms [80, 124, 150-158, 160, 161].  
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Until recently, it was unclear what the relative contribution of SOD1 function was 
towards protecting against O2•- toxicity versus regulating H2O2-mediated signaling. O2•− is 
toxic because of its ability to oxidize and destroy Fe/S clusters in certain metabolic 
enzymes, which also releases cytotoxic iron that can catalyze deleterious redox reactions 
[26, 57, 122-124]. Most interestingly, using Baker’s yeast as a model unicellular eukaryote, 
we found that only a small fraction (< 1%) of the total Sod1 pool is required to protect cells 
against cell-wide damage from O2•- [35, 81]. Rather, we found that much larger quantities 
of Sod1 are required to produce peroxides for the redox regulation of a nutrient-sensing 
pathway [81]. Based on these results, we proposed that the primary cellular function for 
bulk Sod1 is to act as a redox amplifier that provides bursts of signaling peroxides [81]. 
Indeed, Sod1-catalyzed O2•- disproportionation occurs with a 104 rate enhancement 
relative to the uncatalyzed reaction (kSOD1 = 109 M-1 s-1 vs. kuncatalyzed = 105 M-1 s-1). In order 
to establish the role of Sod1 as a central mediator of peroxide signaling, we seek to identify 
new pathways and proteins that are regulated by Sod1. Moreover, we question if in 
mammalian cell lines, as observed in yeast, the bulk of Sod1 is required for redox 
signaling, i.e. CK1g stabilization, and dispensable for oxidative protection. 
To date, a small handful of proteins have been identified to be redox regulated by 
Sod1, including protein tyrosine phosphatases [31] and tyrosine kinase growth factor 
receptors [116]. In Baker’s yeast, Sod1 was found to provide a source of H2O2 that 
stabilizes a pair of plasma membrane casein kinases, Yck1 and Yck2, that link 
extracellular glucose availability to repression of respiration and fermentative growth [35] 
(Figure 3.1a). The transcriptional effectors Mth1 and Std1 activate the expression of 
genes required for the metabolic adaptation to low glucose and enhances respiratory 
metabolism. Glucose binding to Snf3 and Rgt2, transmembrane glucose receptors, 
activates the peripheral membrane type I casein kinases, Yck1 and Yck2, which in turn 
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phosphorylate Mth1 and Std1 [203]. Mth1/Std1 phosphorylation induces its ubiquitination 
and proteasomal degradation by the Skp-Cullin-F-box (SCF) E3 ubiquitin ligase (UbL) 
Grr1. In the absence of glucose, Mth1/Std1 is not targeted for degradation and instead 
translocates to the nucleus to regulate gene expression. In the presence of O2, a yeast 
NADPH oxidase (Yno1) catalyzes the formation O2•-, which is converted to H2O2 by Sod1. 
Sod1-derived H2O2 stabilizes Yck1/2, which leads to glucose-mediated repression of 
respiration and fermentative growth. When Sod1 or O2•- is diminished, Yck1/2 is degraded, 
and respiratory metabolism is enhanced. Sod1 regulates Yck1 and Yck2 stability via the 
peroxide-dependent regulation of a still unknown post-translational modification (PTM) on 
conserved lysine (K) residues at the C-terminus of Yck1 and Yck2. Mutation of K383, K386, 
and K390 in Yck1 (K390, K392, and K397 in Yck2) to arginine (R) results in constitutively stable 
Yck1 that is not degraded in the absence of Sod1, O2, or glucose.  
The Yck1/2 homolog in humans, casein kinase 1-γ (CK1γ), is an integral 
component of the Wnt signaling pathway, which is essential for regulating cell fate and 
proliferation in early development and adult tissue and is dysregulated in many cancers 
[204]. The central component of the canonical Wnt pathway is the transcriptional effector 
β-catenin, which activates the expression of Wnt target genes in control of cell 
proliferation, differentiation, migration, adhesion, and energy metabolism. Just as yeast 
Yck1/2 link extracellular glucose availability to energy metabolism (Figure 3.1a), human 
CK1γ links extracellular signals from a family of Wnt proteins to control metabolism and 
physiology (Figure 3.1b). Wnt ligands bind to a heterodimeric receptor complex consisting 
of Frizzled (Frz) and low-density lipoprotein receptor-related proteins LRP5 and LRP6. 
This binding event activates CK1γ, which then phosphorylates LRP5/6, ultimately leading 
to the sequestration of the β-catenin destruction complex. With the destruction complex 
unavailable to target β-catenin for degradation, β-catenin is able to translocate to the 
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nucleus where it can activate Wnt-target genes (Figure 3.1b, left). In the absence of Wnt 
ligands, the β-catenin destruction complex phosphorylates β-catenin, which in turn leads 
to its ubiquitination and proteasomal degradation by the SCF UbL β-Transducin Repeat-
Containing Protein (β-TrCP) (Figure 3.1b, right).  
Having demonstrated previously that Sod1 regulates Yck1/2 expression and 
glucose signaling in yeast [35, 81], we sought to determine if Sod1 regulates CK1γ 
expression and Wnt signaling in mammalian cells. Moreover, we sought to understand if 
the observation that the bulk of Sod1 is required for Sod1-catalyzed H2O2 signaling, 
compared to a minuscule fraction required for oxidative stress protection is constant from 
yeast to humans. Herein, using RNA interference to silence SOD1 in human embryonic 
kidney cell line (HEK293), we report that SOD1 regulates CK1γ expression and is required 
for canonical Wnt signaling and Wnt-dependent cell proliferation in mammalian cells and 
that, as observed in yeast, the vast majority of Sod1 is dispensable for oxidative stress 





Figure 3.1. Comparison of (a) glucose sensing in Baker’s yeast (Saccharomyces 
cerivisaie) and (b) Wnt signaling in humans, with an emphasis on the respective roles of 
Sod1 and plasma membrane casein kinase homologs, Yck1/Yck2 (yeast) and CK1γ 
(humans). See text for a detailed description of the two pathways.  
 
 
3.3. Materials and Methods.   
 
3.3.1. Chemicals, media components, and immunological reagents.  
 
Dihydroethidium (Cat. # 50-850-563) was purchased from Thermo Fisher 
Scientific. Paraquat dichloride (Cat # 856177-1G) was purchased from Sigma-Aldrich. The 
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mammalian nuclear isolation kit was purchased from Thermo Fisher Scientific (Cat. 
#78833). Rabbit polyclonal antibodies against GAPDH (VWR; Cat. # 89348-232), PGK1 
(Thermo Fisher; Cat. # PA528612), LRP6 (Cell Signaling; Catalog # 2560), phospho-β-
catenin S33/S37/T41 (Cell Signaling; Catalog # 9561), β-catenin (Abcam; Cat # 6302), 
Phospho-LRP-6 T1479 (Abnova; Cat. # PAB12632) [205], Lamin A/C (Cell Signaling; Cat. 
# 2032S), CK1g3 (Thermo Fisher; Cat # PA5-99838) [206], Prdx1 (Millipore Sigma; Cat. # 
HPA007730-100UL), Trx1 (Cell Signaling; Cat. # 2429), Gpx1 (Abcam; Cat. # ab22604), 
and Prdx-SO3 (Abcam; Cat. # Ab16830), and mouse monoclonal antibodies against Porin 
(Invitrogen; Cat. #459500) and Prdx2: PRDX2 (Fisher Scientific; Cat. # LF-MA0144) were 
purchased from commercial sources as indicated. A previously described rabbit polyclonal 
antibody against Sod1 was obtained from the laboratory of Valeria Culotta (Johns Hopkins 
University) [35]. Goat a-rabbit (VWR; Cat # 89138-520) or a-mouse (VWR; Cat # 89138-
516) secondary antibodies conjugated to a 680-nm emitting fluorophore were obtained 
from Biotium through VWR. 
 
3.3.2. Cell culture, growth, gene silencing, Wnt stimulation, and nuclear fractionation.  
 
Human embryonic kidney (HEK293) cells were obtained from (American Type 
Culture Collections. ATCC, Cat. # CRL-1573). Cells were cultured in Dulbecco’s Minimal 
Essential Medium/ DMEM media (Thermo Fisher Scientific (Cat. # 3105328) containing 
Heat Inactivated Fetal Bovine Serum (HI-FBS, 10 %, VWR Cat # 89510-188), 
supplemented with L-glutamine in 5% CO2 and 370C with 1% antibiotics (Penicillin-
Streptomycin). Cells were plated in 6 well plates for immunoblotting or qPCR experiments 
(0.25 - 0.3 million cells/ well), or on 13 mm coverslips in 24 well plates for immunostaining. 
SOD1 siRNA (Cat. # 4390824) and Control siRNA (Cat. # 4390843) were purchased from 
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(Thermo Fisher Scientific). SOD1 silencing was accomplished in reduced serum medium 
(Opti-MEM, Cat. # 11058021, Thermo Fischer Scientific) by transfection of SOD1 siRNA 
or scrambled control siRNA (for 72 hours) into 60-70% confluent HEK cellsusing 
Lipofectamine-2000 transfection reagent according to Manufacturer's protocols (Cat. # 
11668019, Thermo Fischer Scientific).  
 Wnt conditioned media was produced by culturing L-Wnt-3A cells (ATCC, Cat. # 
CRL-2647) according to ATCC protocol, and media from L Cells (ATCC, Cat. # CRL-2648) 
was used as the corresponding negative control. Wnt stimulation was achieved by treating 
HEK293 cells with DMEM: Wnt3a conditioned media (1:1 v/v) for 3 hours.   
 
3.3.3. Immunoblotting and SOD activity. 
 
 Immunoblotting was performed exactly as described previously with cells from 6-
well dishes being harvested, washed in ice-cold Milli-Q water, and lysed in two pellet 
volumes of lysis buffer (10 mM sodium phosphate, 50 mM sodium chloride, 5 mM EDTA, 
1.0% Triton X-100, 1 mM PMSF and a protease and phosphatase inhibitor cocktail 
(GBiosciences) [192]. For assessing peroxiredoxin oxidation, cell cultures were quenched 
with 10% trichloroacetic acid (TCA), followed by TCA-precipitating lysate protein and 
washing it in cold acetone. The dried pellet was resuspended in degassed resuspension 
buffer (6M urea, 10mM EDTA, 20mM Tris, 0.5%SDS, 10µM neocuproine, pH 8.5) 
containing 1mM PMSF and a protease inhibitor cocktail (GBiosciences) in an anaerobic 
chamber (Coy laboratories). Lysate protein concentrations were determined by the 
PierceTM BCA protein assay kit (Thermo Scientific). SOD activity was measured using an 
in-gel assay based on  native PAGE and nitroblue tetrazolium staining as described 
previously [35, 112, 193, 207].  
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3.3.4. Immunofluorescence.  
 
HEK293 cells plated on coverslips and transfected with control or Sod1 siRNA (72 
h), were fixed using 4% paraformaldehyde in phosphate buffered saline (PBS) for 30 min 
and blocked with 10% FBS for 1 hour. The coverslips were then incubated with the β-
catenin antibody for 2 h, followed by Cy3-conjugated secondary antibody for 1 hour.  4′, 
6-diamidino-2-phenylindole (DAPI,1:10,000 dilution, Sigma) was used for nuclear staining. 
The mounted coverslips were imaged using Zeiss LSM510 confocal microscopy to assess 
cytoplasmic versus nuclear localization of β-catenin. Results were expressed as percent 
localization relative to the total number of DAPI positive cells. At least 10 fields were 
imaged from each condition from 3 independent experiments.  
 
3.3.5. qRT-PCR.  
 
RNA was isolated from HEK293 cells using the RNAeasy kit (Qiagen). cDNA was 
synthesized from 1 ug of total RNA using iscript cDNA synthesis kit (Biorad). qRT-PCR 
was performed using SYBR Green PCR Master Mix (Biorad) and 7500 Real-Time PCR 












3.4.1. Sod1 regulates the canonical Wnt signaling pathway. 
 
  In order to probe the role of Sod1 in the Wnt signaling pathway, we determined the 
effect of Sod1 silencing on CK1γ expression and its impact on Wnt pathway activation in 
HEK293 cells upon stimulation with the Wnt3a ligand (Figure 3.1b). There are three 
plasma membrane tethered CK1γ isoforms in humans: CK1γ1, CK1γ2, and CK1γ3. We 
chose to focus our efforts on Sod1-mediated regulation of CK1γ3 for the following reasons:   
a. in HEK293 cells, CK1γ3 protein levels are ~4-fold higher than CK1γ2 and > 10-
fold higher than CK1γ1, which is undetectable [208];  
b. CK1γ3 (and CK1γ2) contains a conserved C-terminal K implicated in Sod1 and 
peroxide regulation of Yck1/Yck2 - K383 in Yck1 and K355 in CK1γ3 [35];  
c. Sod1 regulates bovine CK1γ3 heterologously expressed in yeast [35].    
SOD1 expression and activity is consistently reduced by ~60% using siRNA 
against SOD1 in HEK293 cells after 72 hours (Figure 3.2a and 3.2b). This degree of 
SOD1 silencing results in a ~40% decrease in CK1γ3 expression (Figure 3.2a and 3.2c), 
as measured using a CK1γ3-specific antibody. These results are consistent with our 
previous studies in Baker’s yeast that found that sod1∆ cells exhibited a marked loss in 
Yck1/2 expression and heterologously expressed bovine CK1γ3. It is important to note 
that SOD1 silencing does not affect the expression of other cytosolic peroxide 
metabolizing enzymes, including peroxiredoxins 1 and 2 (Figure A.1a-d), thioredoxin 1 
(Figure A.1e and A.1f), and glutathione peroxidase 1 (Figure A.1e and A.1g), thereby 
indicating that other antioxidant enzymes are not compensating for the loss of Sod1 
function. Moreover, silencing of SOD1 does not significantly impact steady-state peroxide 
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levels and oxidative stress as indicated by the lack of significant changes to peroxiredoxin 




























Figure 3.2. Sod1 is required for the Wnt3a-dependent activation of the canonical 
Wnt signaling pathway. (a) Representative immunoblots and SOD activity gel of Wnt 
signaling pathway markers in response to Wnt3a activation and/or silencing of Sod1 with 
siRNA. (b-g) Quantification of the normalized levels of (b) Sod1, (c) CK1γ3, (d) β-catenin 
(β-Cat), (e) phosphorylated β-catenin at residues S33, S37, and T41 (p-β-Cat), (f) LRP6, 
and (g) phosphorylated LRP6 at residue T1479 (p-LRP6) from five independent trials. p-
LRP6 and p-β-Cat is normalized to total LRP6 or β-Cat, respectively. The statistical 
significance relative to – Wnt3a/Ctrl RNAi cells or for the indicated pairwise comparison is 
denoted by grey asterisks and determined by ordinary one-way ANOVA with the 
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Bonferroni multiple-comparison post-hoc test. * P < 0.01, ** P < 0.001, *** P < 0.0001, n.s. 
= not significant. 
 
 
SOD1 silencing and the concomitant decrease in CK1γ3 expression resulted in a 
significant decrease in multiple markers of Wnt pathway activation (Figure 3.1b). Wnt3a 
binding to its cell surface receptor activates CK1γ, which in turn phosphorylates LRP6 at 
T1479, ultimately leading to sequestration of the β-catenin destruction complex [204]. As 
a consequence, cytosolic β-catenin cannot be phosphorylated at residues S33, S37, and 
T41, allowing it to escape proteasomal degradation and translocate to the nucleus to 
regulate gene expression. Accordingly, we find that Wnt3a stimulation results in an 
increase in LRP6 phosphorylation (Figure 3.2a and 3.2g), a decrease in β-catenin 
phosphorylation (Figure 3.2a and 2e), an increase in β-catenin stability (Figure 3.2a and 
3.2d), and increased nuclear β-catenin as measured by immunofluorescence (Figure 3.3a 
and 3.3b) and subcellular fractionation (Figure 3.3c and 3.3d). In contrast, Wnt3a 
stimulation in SOD1 silenced cells does not increase LRP6 phosphorylation (Figure 3.2a 
and 3.2g), decrease β-catenin phosphorylation (Figure 3.2a and 3.2e), increase β-catenin 
stability (Figure 3.2a and 3.2d), or increase nuclear localization of β-catenin (Figure 3.3). 





Figure 3.3. Sod1 is required for the Wnt3a-dependent nuclear localization of β-
catenin. (a) Representative immunofluorescence of β-catenin localization relative to the 
nuclear marker, DAPI, in response to Wnt3a activation and/or silencing of Sod1 with 
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siRNA. Scale bar is 20 µm. (b) Quantification of β-catenin nuclear localization from four 
independent trials. ~200 cells were counted for each condition in each trial. (c) 
Representative immunoblots of β-catenin expression in cytosolic and nuclear fractions of 
HEK293 cells. (d) Quantification of the normalized levels of cytosolic and nuclear β-
catenin (β-Cat) from four independent trials. Cytosolic β-Cat is normalized to the cytosolic 
marker GAPDH and nuclear β-Cat is normalized to the nuclear marker Lamin A. The 
statistical significance relative to – Wnt3a/Ctrl RNAi cells or for the indicated pairwise 
comparison is denoted by grey asterisks and determined by ordinary one-way ANOVA 
with the Bonferroni multiple-comparison post-hoc test. * P < 0.01, ** P < 0.001, *** P < 
0.0001, n.s. = not significant. 
 
 
3.4.2. Sod1 regulates the Wnt-dependent activation of Wnt target genes and cell 
proliferation.  
 
We next determined if Sod1 impacts the expression of Wnt target genes and Wnt-
dependent cell proliferation. Once in the nucleus, β-catenin associates with transcription 
factors from the T cell factor/lymphoid enhancer factor (TCF/LEF) family of transcription 
factors and drives transcription of hundreds of Wnt/β-catenin target genes. Using qRT-
PCR, we determined if silencing SOD1 in Wnt stimulated cells altered the expression of 
Wnt/β-catenin target genes β-catenin, c-Myc, and Cyclin D1. Silencing SOD1 resulted in 
a 50% decrease in SOD1 mRNA (Figure 3.4d), consistent with the decrease in Sod1 
polypeptide (Figure 3.2a and 3.2b). Moreover, silencing SOD1 in Wnt3a stimulated cells 
reversed the Wnt-induced increase in expression of β-catenin (Figure 3.4a), c-Myc 
(Figure 3.4b), and Cyclin D1 (Figure 3.4c) mRNA as expected.  
 Given that Wnt/β-catenin target genes are associated with proliferative 
metabolism, we assessed if SOD1 silencing reversed Wnt-induced cell proliferation. Wnt 
stimulation results in a pronounced enhancement in cell proliferation by 48 hours (Figure 
3.4e). However, in SOD1 silenced cells, the Wnt-mediated stimulation in proliferation at 
48 hours is completely reversed (Figure 3.4e). Notably, simply silencing SOD1 in the 
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absence of Wnt3a stimulation does not cause growth defects at any time point, indicating 
that the ~50% depletion in SOD1 does not result in overt oxidative stress. Altogether, our 
data support a role for SOD1 in regulating the Wnt signaling pathway.  
  
 
Figure 3.4. Sod1 regulates Wnt3a-dependent gene expression and HEK293 cell 
proliferation. (a-d) Normalized mRNA expression of (a) β-catenin, (b) c-Myc, (c) Cyclin 
D1, and (d) SOD1 relative to GAPDH as measured by qRT-PCR in response to Wnt3a 
activation and/or silencing of Sod1 with siRNA. The indicated values represent the mean 
± s.d. from triplicate cultures. (e) Cell proliferation in response to Wnt3a activation and/or 
silencing of Sod1 with siRNA. The statistical significance relative to – Wnt3a/Ctrl RNAi 
cells or for the indicated pairwise comparison is denoted by grey asterisks and determined 
by ordinary one-way ANOVA with the Bonferroni multiple-comparison post-hoc test. * P < 





Wnt signaling critically regulates cell fate, proliferation, motility, and differentiation 
during development and in adult tissues. Dysregulation of the Wnt pathway is associated 
with many diseases, including various cancers and neurodegenerative disorders [209]. 
The plasma membrane casein kinases, Yck1/2 in yeast and CK1γ in humans, integrate 
extracellular ligand binding events to an intracellular signaling cascade that ultimately 
results in changes in gene expression and cell physiology (Figure 3.1). Herein, we report 
that SOD1 regulates CK1γ expression in human embryonic kidney 293 (HEK293) cells 
and is required for canonical Wnt signaling and Wnt-dependent gene expression and cell 
proliferation. The hardwiring of Yck1/CK1γ stability to Sod1 tightly links redox homeostasis 
and peroxide signaling to nutrient and cytokine sensing pathways in control of cell 
physiology and metabolism. Our findings have a number of implications for the redox 
regulation of the Wnt pathway, redox signaling, and Sod1 biology. 
H2O2 has long been known to regulate Wnt signaling, albeit its effects are 
paradoxically associated with being both activating and inhibitory [210, 211]. For instance, 
supplementation with high doses of exogenous peroxide (~100 μM) was found to inhibit 
Wnt signaling in HEK293 cells [212] lines. On the other hand, it was also found that low 
doses of H2O2 rapidly stabilize β-catenin and increases the expression of Wnt target genes 
[213]. Thus, both physiological redox signaling and pathological oxidative stress have the 
potential to modulate Wnt signaling, with very different physiological consequences. 
The activating effects of H2O2 were first ascribed to the redox regulation of 
nucleoredoxin (Nrx) mediated control of Dishevelled (Dvl) [211]. Dvl inhibits the GSK3β 
mediated phosphorylation of β-catenin in the β-catenin destruction complex, leading to the 
proteasomal degradation of β-catenin [214] (Figure 3.1b). Nrx is a thioredoxin-like 
enzyme that reduces oxidized thiols on target proteins. Reduced Nrx interacts with and 
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inhibits Dvl and this regulation is inhibited by treatment with H2O2 due to its ability to oxidize 
Nrx. The physiological source of peroxides for Wnt signaling is in part dependent on the 
NADPH oxidase, Nox1 [215]. Our finding that Sod1 regulates Yck1/CK1γ stability places 
an additional layer of redox control upstream of Dvl and the β-catenin destruction complex.  
There may multiple physiological benefits for two-tiered regulatory control for 
peroxide signaling in a single pathway. Spatial and temporal control of peroxide signals 
acting on two separate targets would allow for a greater degree of pathway regulation and 
fine-tuning. Additionally, two separate targets of redox signaling, either through the 
upstream Sod1/CK1γ axis or the downstream Nrx-Dvl axis, would allow for Wnt-
dependent or Wnt-independent peroxide control of β-catenin signaling, respectively. Also, 
since CK1γ functions in other pathways, including TGF-β signaling [216], Sod1/peroxide 
control of CK1γ would allow for the redox regulation of these other pathways while 
peroxide regulation of the Nrx-Dvl axis would ensure H2O2 maintains control of β-catenin 
signaling.   
Our work continues to expand our understanding of the redox cell biology of Sod1. 
The canonical role for Sod1 is to detoxify superoxide radicals. However, we previously 
discovered that in Saccharomyces cerevisiae, < 1% of the total Sod1 pool is sufficient to 
protect against cell wide markers of superoxide toxicity [81]. Rather, much larger quantities 
of Sod1 are apparently required for redox signaling, and, in particular, control of Yck1/2 
stability and nutrient sensing and signaling pathways [35, 81]. Thus, we proposed that the 
vast majority of Sod1 is required to provide a high localized flux of peroxide to control 
various redox signaling pathways rather than to combat superoxide stress [81]. Our 
studies in HEK293 cells are consistent with this hypothesis. Silencing of SOD1 using RNA 
interference, which resulted in a ~50-80% decrease in Sod1 expression and activity, did 
not result in increased expression of antioxidant enzymes to account for loss of SOD1, 
including peroxiredoxin 1 and 2 (Prx1, 2), thioredoxin (Trx1) and glutathione peredoxidase 
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(GPx), or enhanced peroxiredoxin hyperoxidation (Prx-SO3) (Figure A.1). This indicates 
that loss of the bulk of Sod1 does not have any effect on cellular oxidative stress status, 
suggesting that the vast majority of Sod1 is dispensable for oxidative stress protection in 
mammalian cell lines, analogous to yeast.  Moreover, loss of ~60% Sod1 does not affect 
cell proliferation. A Sod1-dependent growth defect was only observed when cells were 
stimulated with Wnt3a, a condition requiring the Sod1-mediated redox control of Wnt 
signaling (Figure 3.4e).  
In light of the totality of our studies in yeast [81] and human cell lines herein, we 
propose that many of the physiological defects associated with diminution of Sod1 
expression or activity are tied to loss of peroxide signaling rather than superoxide toxicity. 
Consistent with this hypothesis, Gomez et. al. found that SOD1 is essential for oncogene-
driven mammary tumor formation but dispensable for normal development and 
proliferation [217]. While the authors suggested this was due to increased superoxide 
burden in tumor cells, we would argue that this is due to the requirement for SOD1-derived 
peroxide to signal proliferative growth and metabolism.  
From a signaling perspective, Sod1 is most typically associated with integrating 
redox and nutrient/growth factor signaling to control proliferation and metabolism. For 
instance, Sod1-derived peroxides oxidatively inactivate cysteine dependent tyrosine 
phosphatases, which otherwise act to inhibit growth factor signaling pathways [31]. In 
another example, we previously found that SIRT5 can deacetylate Sod1 at K122, which 
enables Sod1 to translocate to the mitochondrial IMS and suppress respiratory 
metabolism [115]. Given that nutrient status can alter NAD+ levels, the sirtuin SIRT5-
dependent regulation of Sod1 may be a mechanism to link nutrient availability to energy 
metabolism and proliferation [115]. In addition, it was recently demonstrated that Sod1 is 
reversibly phosphorylated at S39 in yeast or T40 in human cell lines by the nutrient sensing 
mTORC1 to regulate redox homeostasis and adaptation to changes in nutrient availability 
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[113]. Thus, the growth and metabolic defects associated with inhibition of Sod1 activity 
or expression may be a consequence of suppressing peroxide-dependent pro-growth 
pathways. By extension, we posit that significant toxicity from superoxide only ensues 
when SOD1 expression or activity is completely abolished, as in knockout models.  
 Altogether, our results have implications for understanding the basic redox biology 
of Sod1 and may better inform the treatment of diseases associated with aberrant Wnt 
signaling. Indeed, some cancers have a marked overexpression in CK1γ [216], providing 
the impetus to develop CK1γ inhibitors [218]. In addition, certain cancers, including head 
and neck, lung and breast cancers, exhibit elevated Wnt signaling and Sod1 expression 
[121, 217, 219-223], suggesting that there may be feed-forward mechanisms of Sod1-
dependent Wnt pathway activation.  Indeed, Wnt3a stimulation of HEK293 cells is 
associated with elevated Sod1 transcription (Figure 3.4d). In total, our results suggest 
that inhibiting Sod1 in cancers associated with elevated CK1γ and/or Wnt activation may 
















Sod1 Integrates Oxygen Availability to Redox Regulate NADPH Production and the 
Thiol Redoxome 
 
This chapter is adapted from the previously submitted work: Montllor-Albalate, Kim, H., 
Jonke, A. P., Torres, M. P., Reddi, A. R. “Sod1 Integrates Oxygen Availability to Redox 
Regulate NADPH Production and the Thiol Redoxome”. The author of this document 
contributed to this work by conceiving, designing and performing all the experiments of 
the paper, except the mass spectrometry and bioinformatic analysis, making all figures, 
except the mass spectrometry figures, making all supplementary materials, and co-writing 
the manuscript with input from all authors.  
The experiments and data analysis for the proteomics section of this chapter were 
performed by Hyojung Kim, a graduate student in the Reddi and Torres lab, with the help 




Cu/Zn superoxide dismutase (Sod1) is a highly conserved and abundant 
antioxidant enzyme that detoxifies superoxide (O2−) by catalyzing its conversion to 
dioxygen (O2) and hydrogen peroxide (H2O2). Using Saccharomyces cerevisiae and 
mammalian cells, we discovered that a major new aspect of the antioxidant function of 
Sod1 is to integrate O2 availability to promote NADPH production. The mechanism 
involves Sod1-derived H2O2 oxidatively inactivating the glycolytic enzyme, glyceraldehyde 
phosphate dehydrogenase (GAPDH), which in turn re-routes carbohydrate flux to the 
oxidative phase of the pentose phosphate pathway (oxPPP) to generate NADPH. The 
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aerobic oxidation of GAPDH is exclusively dependent on and rate-limited by Sod1. Thus, 
Sod1 senses O2 via O2− to balance glycolytic and oxPPP flux, through control of GAPDH 
activity, for adaptation to life in air. Importantly, this new mechanism for Sod1 antioxidant 
activity requires the bulk of cellular Sod1, unlike for its role in protection against O2− 
toxicity, which only requires < 1% of total Sod1. Using mass spectrometry, we identified 
proteome-wide targets of Sod1-dependent redox signaling, including numerous metabolic 
enzymes. Altogether, Sod1-derived H2O2 is important for antioxidant defense and a 




Superoxide dismutases (SODs) are a highly conserved class of antioxidant 
enzymes that serve on the frontline of defense against reactive oxygen species (ROS). 
SODs, which detoxify O2− by catalyzing its disproportionation into O2 and H2O2, are unique 
amongst antioxidant enzymes in that they also produce a ROS byproduct. While much is 
known about the necessity of scavenging O2−, it is less clear what the physiological 
consequences of SOD-derived H2O2 are. Paradoxically, increased expression of Cu/Zn 
SOD (Sod1), which accounts for the majority of SOD activity in cells [224], is actually 
associated with reduced cellular H2O2 levels [225], suggesting there may be additional 
unknown mechanisms underlying Sod1 antioxidant activity.  
The cytotoxicity of O2− is largely due to its ability to oxidize and inactivate [4Fe-
4S] cluster-containing enzymes, which results in defects in metabolic pathways that utilize 
[4Fe-4S] proteins and Fe toxicity due to its release from damaged Fe/S clusters [57, 122, 
123, 226]. The released Fe can catalyze deleterious redox reactions, and, in particular, 
production of hydroxyl radicals (OH) via Haber-Weiss and Fenton reactions, which 
indiscriminately oxidizes lipids, proteins, and nucleic acids [123, 124]. The importance of 
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Sod1 in oxidative stress protection is underscored by reduced proliferation, decreased 
lifespan, and numerous metabolic defects, including cancer, when SOD1 is deleted in 
various cell lines and/or organisms [80, 82, 124, 156, 227]. It was previously proposed 
that Sod1 limits steady-state H2O2 levels because of its ability to prevent the O2−-mediated 
one-electron oxidation of Fe/S clusters, which results in the concomitant formation of H2O2 
[225, 228, 229]. However, since vanishingly small amounts of Sod1, < 1% of total cellular 
Sod1, is sufficient to protect cells against O2− toxicity, including oxidative inactivation of 
Fe/S enzymes [35, 112, 159], any changes in Sod1 expression is not expected to alter 
H2O2 arising from O2− oxidation of Fe/S clusters. How then can Sod1, an enzyme that 
catalyzes H2O2 formation, act to reduce cellular H2O2 levels? 
Two previously reported but unexplained metabolic defects in sod1∆ strains of 
Saccharomyces cerevisiae point to a potential role for Sod1 in regulating the production 
of NADPH, a key cellular reductant required for reductive biosynthesis and the reduction 
and regeneration of H2O2 scavenging thiol peroxidases [10] and catalases [11, 230]. Yeast 
strains lacking SOD1 exhibit increased glucose consumption [170] and defects in the 
oxidative phase of the pentose phosphate pathway (oxPPP) [157], the primary source of 
NADPH. Inhibition of key rate-limiting enzymes in glycolysis, including phosphofructose 
kinase [231], glyceraldehyde phosphate dehydrogenase (GAPDH) [232, 233], and 
pyruvate kinase [234, 235], reduces glucose uptake [236-238] and increases the 
concentration of glucose-6-phosphate (G6P), a glycolytic intermediate that is also the 
substrate for the first enzyme in the oxPPP, G6P dehydrogenase (G6PDH), which in turn 
increases oxPPP flux and NADPH production [239-244]. Taken together, we surmised 
that Sod1 negatively regulates a rate determining enzyme in glycolysis, thereby 
accounting for the observed metabolic defects in glucose utilization and the oxPPP in 
sod1∆ cells [157, 170].  
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GAPDH, which catalyzes a rate-determining step in glycolysis [245, 246], is very 
abundant [247], and contains a H2O2-reactive catalytic Cys (k ~ 102-103 M-1s-1), represents 
a critical redox regulated node that can toggle flux between glycolysis and the oxPPP 
[241]. As such, we hypothesized that a novel aspect of the antioxidant activity of Sod1 is 
to oxidatively inactivate GAPDH using Sod1-catalyzed H2O2, which would in turn stimulate 
NADPH production via the oxPPP and enhance cellular peroxide scavenging by thiol 
peroxidases. This novel mechanism for Sod1 mediated antioxidant activity would explain 
a number of prior observations, including the findings that elevated Sod1 expression 
decreases peroxide levels and loss of SOD1 increases glucose consumption and 
attenuates oxPPP activity. In addition, more generally, since Sod1-derived H2O2 has 
previously been implicated in the redox regulation of other enzymes, including protein 
tyrosine phosphatases [31] and casein kinases [35, 112], we also sought to identify 
proteome-wide redox targets of Sod1.  
In the present report, we provide evidence highlighting a new antioxidant function 
for Sod1-derived H2O2 in integrating O2 availability to control NADPH production to support 
aerobic growth and metabolism. The mechanism involves the conversion of O2 to O2− by 
mitochondrial respiration and an NADPH oxidase, followed by the Sod1-catalyzed 
conversion of O2− to H2O2, which in turn oxidatively inactivates GAPDH. The inhibition of 
GAPDH serves to re-route metabolism from glycolysis to the oxPPP in order to maintain 
sufficient NADPH for metabolism in air. The aerobic oxidation of GAPDH is exclusively 
dependent on and rate-limited by Sod1, suggesting that it provides a privileged pool of 
peroxides to inactivate GAPDH under physiological conditions. Lastly, we revealed a 
larger network of cysteine-containing proteins that are oxidized in a Sod1-dependent 
manner using mass spectrometry-based redox proteomics approaches. Altogether, these 
results highlight a new mechanism for O2 sensing and adaptation, reveal an important but 
previously unknown antioxidant role of Sod1 that goes beyond O2− scavenging to include 
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the stimulation of aerobic NADPH production, and places Sod1 as a master regulator of 




4.3.1. Sod1 regulates glycolysis.  
 
In many eukaryotes, including Saccharomyces cerevisiae, glucose uptake 
negatively correlates with pO2 [248-251]. Indeed, we find that batch cultures of WT yeast 
cells grown anaerobically consume more glucose per cell than aerobically grown cultures 
(Figures 4.1A and 4.1B). Media glucose concentration is plotted versus cell density, 
rather than time, to correct for differences in growth rate (Figure B.1A). Consistent with 
previous studies [170], aerobic cultures of sod1∆ strains consume more glucose than WT 
cells (Figures 4.1A and 4.1B). However, in the absence of oxygen, both WT and sod1∆ 
cells consume similar amounts of glucose (Figures 4.1A and 4.1B).   
Since defects in glycolytic enzymes, including hexokinase 2 or GAPDH, decrease 
glucose uptake [236, 237], we sought to determine if the increased glucose consumption 
of sod1∆ cells was associated with altered glycolytic flux. Intracellular cytosolic pH is an 
excellent reporter of glycolytic activity and can be monitored using the GFP-based 
ratiometric pH sensor, pHluorin. Glucose starved yeast exhibit an intracellular cytosolic 
pH of ~7.0. Upon exposure to glucose, there is a rapid decrease in cytosolic pH to a value 
of ~6.6 within 3 minutes, corresponding to proton release in phosphorylation reactions 
associated with hexokinase, phosphofructose kinase, and GAPDH (Figures 4.1C and 
4.1D, phase 1) [252]. The initial acidification is followed by a slower alkalization phase that 
brings the cytosolic pH up to ~7.3 over 15 minutes (Figures 4.1C and 4.1D, phase 2), 
which is due to activation of Pma1, a cell surface H+-ATPase that pumps H+ into the 
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extracellular space [252]. In response to glucose, sod1∆ cells exhibit more rapid rates of 
intracellular acidification, indicating that glycolysis is more active compared to WT cells. 
Moreover, sod1∆ cells exhibit slightly diminished rates of re-alkalization, indicating that 
PMA1 is less active in response to glucose. Indeed, prior work found that sod1∆ cells 
exhibit a defect in PMA1 activity [35, 253]. To rule out that the intracellular acidification 
phase is unaffected by PMA1-dependent re-alkalization, glucose-dependent changes in 
intracellular pH were monitored in a strain expressing a hypomorphic allele of PMA1, 
pma1-tap, containing a C-terminal tandem affinity purification (TAP)-tag (Figure B.1B). In 
pma1-tap cells, the rate of glucose-induced acidification is similar to WT cells (Figure 
4.1D, Phase 1), but there is a significant decrease in the rate of re-alkalization (Figure 
4.1D, Phase 2). Taken together, the data demonstrate that Sod1 negatively regulates 
glucose uptake and glycolytic activity. 
 
4.3.2. Extra-mitochondrial Sod1 regulates GAPDH oxidation and activity.  
 
We hypothesized that Sod1-derived H2O2 may negatively regulate glucose uptake 
and glycolytic activity through the oxidative inactivation of GAPDH, which catalyzes a rate-
determining step in glycolysis and contains a peroxide-sensitive active site Cys [232]. 
Saccharomyces cerevisiae encodes three GAPDH isoforms, TDH1, TDH2, and TDH3, 
with TDH3 being the most highly expressed in log phase cultures, accounting for > 50% 
of total cellular GAPDH [192]. Yeast GAPDH has only two cysteines, catalytic C150 and 
C154, which sensitizes C150 to oxidation by H2O2 (Figure 4.1E). In order to probe the 
Sod1-dependence of GAPDH oxidation, we employed a thiol alkylation assay that exploits 
the reactivity of methoxypolyethylene glycol maleimide (mPEG-mal) with reduced but not 
oxidized thiols [254]. The extent of GAPDH labeling with mPEG-mal, which is 5 kDa, is 
assessed by determining the changes in electrophoretic mobility of PEGylated GAPDH, 
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corresponding to single and double labeled GAPDH at reduced C150 and/or C154 
(Figures 4.1F, 4.1G and B.1C). Thus, the fraction of GAPDH oxidized in vivo can be 
determined by quantifying the ratio of the intensity of unlabeled GAPDH (oxidized GAPDH) 
to total GAPDH (Figures B.1D and B.1F-B.1M). The mPEG-mal approach was validated 
by treating cells with H2O2 and observing a 2-fold increase in GAPDH oxidation (Figure 
B.1D and B.1E). Moreover, the identity of the specific sites of mPEG-mal labeling was 
confirmed by observing that a yeast strain expressing a single allele of Tdh3C154S was 
found to have only two GAPDH proteoforms corresponding to single and unlabeled 
GAPDH (Figure B.1N).  
To determine if Sod1 oxidizes GAPDH in vivo, we analyzed GAPDH PEGylation 
in sod1∆ cells expressing empty vector (EV) (sod1∆ + EV) or WT SOD1 (sod1∆ + SOD1). 
Interestingly, sod1∆ + EV cells exhibit an increase in mPEG-mal labeling compared to 
sod1∆ + SOD1 cells (Figures 4.1G-1I), indicating that GAPDH is more oxidized in cells 
expressing SOD1. Over 4-independent trials, we found that cells expressing SOD1 exhibit 
a ~2-fold increase in GAPDH oxidation compared to cells not expressing SOD1 (Figure 
4.1H). Due to variations in the absolute levels of GAPDH oxidation across multiple trials 
(Figure 4.1H), we also chose to normalize oxidation levels to SOD1 expressing cells 
within each trial (Figure 4.1I). Such an analysis accounts for trial-to-trial variation in 
GAPDH oxidation and increases the statistical significance of the results between various 
strains. 
We next evaluated the effect of Sod1-mediated GAPDH oxidation on GAPDH 
catalytic activity. GAPDH catalyzes the oxidative phosphorylation of GAP to 1,3 BPG and 
requires Cys150 for activity. GAPDH activity is 3-fold greater in cells lacking SOD1 (sod1∆ 
+ EV) (Figures B.1J, B.1O and B.1P), which correlates with the 2-fold decrease in 
GAPDH oxidation relative to SOD1 expressing cells (Figures 4.1G and 4.1I).  
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Notably, Sod1-mediated GAPDH oxidation is not dependent on the carbon source. 
In yeast, glucose represses mitochondrial respiration and promotes fermentation. 
Galactose is a fermentable carbon source that alleviates respiration repression, resulting 
in more mitochondrial respiratory activity [35]. The absolute (Figure B.1R) and relative 
(Figure 4.1L) amounts of GAPDH oxidation in sod1∆ + EV and sod1∆ + SOD1 cells 
cultured in 2% galactose is similar to cells cultured in 2% glucose. (Figures 4.1K, 4.1L, 
B.1Q and B.1R).  
We next evaluated the effect of Sod1 localization on GAPDH oxidation. Sod1 is 
primarily cytosolic but is also present in the mitochondrial IMS. sod1∆ cells expressing an 
IMS-targeted allele of Sod1, Sco2-SOD1 [35, 112, 255], exhibit comparable GAPDH 
oxidation to sod1∆ + EV cells, both of which are significantly lower than cells expressing 
WT SOD1 (Figures 4.1M, 4.1N and B.1S). Altogether, these results indicate that 
extramitochondrial Sod1-derived H2O2 oxidizes GAPDH and decreases its catalytic 
activity, thereby explaining the previous observations that sod1∆ cells exhibit increased 




Figure 4.1. Cytosolic Sod1 regulates glycolysis via the redox regulation of GAPDH. 
(A-B) Extracellular glucose measurements as a function of culture density for WT and 
sod1∆ cells grown aerobically (O2) or anaerobically (N2) (A) and glucose consumption per 
cell as derived from the slope of the linear regions of the plot (B). The data represent the 
average ± SD from two biological replicates (See also Figure B.1A). 
(C-D) Time-resolved intracellular pH measurements of glucose starved cells upon pulsing 
WT, sod1∆, or pma1-tap cells expressing a GFP-based pH sensor, pHluorin, with 2% or 
0% glucose (GLU) (C). The cytosolic acidification rate, a proxy for glycolytic activity (Phase 
1), and the rate of re-alkalization of the cytosol, a proxy for Pma1 activity (Phase 2), is 
shown for the indicated strains (D). The data represent the average ± SD from triplicate 
cultures. See also Figure B.1B. 
(E) The structure of Saccharomyces cerevisiae GAPDH, Tdh3 (PDB file 4IQ8), with 
catalytic Cys150 and resolving Cys154 represented in red, and a depiction of the Cys150 
thioester covalent intermediate with glyceraldehyde-3-phosphate.  
(F-I) Analysis of Sod1-dependent GAPDH oxidation as assessed by labelling GAPDH with 
thiol reactive methoxypolyethylene glycol maleimide (mPEG-mal). (F) Schematic 
representation of all possible redox-dependent GAPDH (green spheres) Cys-mPEG-mal 
adducts and their respective electrophoretic mobilities. (G) Representative immunoblot 
analysis of GAPDH-mPEG-mal adducts in sod1∆ cells expressing yeast Sod1 (SOD1) or 
empty vector (EV) cultured in 2% GLU. (H) % GAPDH oxidation, as assessed by 
quantifying the ratio of mPEG-mal labelled GAPDH to total GAPDH, in the indicated 
strains from multiple trials. (I) Relative GAPDH oxidation in the indicated strains as 
assessed by normalizing to the % GAPDH oxidation of SOD1 expressing cells from each 
trial. Data represents the average ± SD from 4 independent trials.  
(J) Measurements of GAPDH enzymatic activity in sod1∆ cells expressing SOD1 or EV. 
Data represents the average ± SD from quadruplicate cultures. See also Figures B.1O-P.  
(K-L) Assessment of GAPDH oxidation in sod1∆ cells expressing yeast Sod1 (SOD1) or 
empty vector (EV) cultured in 2% galactose (GAL). Representative immunoblot analysis 
of GAPDH-mPEG-mal adducts (K) and normalized GAPDH oxidation from multiple trials 
(L). Data represents the average ± SD from 3 independent trials. See also Figures B.1Q 
and B.1R. 
(M-N) Assessment of GAPDH oxidation in sod1∆ cells expressing yeast Sod1 (SOD1), 
mitochondrial IMS targeted Sod1 (Sco2-SOD1), or empty vector (EV). Representative 
immunoblot analysis of GAPDH-mPEG-mal adducts (M) and normalized GAPDH 
oxidation from multiple trials (L) in the indicated strains. Data represents the average ± 
SD from 3 independent trials. See also Figure B.1S. 
The statistical significance is indicated by asterisks using two-tailed Student’s t-tests for 
pairwise comparisons (panels H, I, J, and L) or by one-way ANOVA for multiple 
comparisons with Dunett’s post-hoc test (panels B, D and N); *p<0.05, **p<0.01, 








4.3.3. Yno1 and mitochondrial respiration are sources of superoxide for GAPDH oxidation.  
 
Sod1 requires a superoxide source to catalyze peroxide production for the control 
of GAPDH oxidation and activity. As with higher eukaryotes, two primary sources of 
superoxide in yeast include mitochondrial respiration and the yeast NADPH oxidase, Yno1 
[256]. Both sources contribute towards GAPDH oxidation as respiration deficient rho0 and 
yno1∆ cells exhibit a ~3-fold lower degree of GAPDH oxidation relative to WT cells and 
phenocopy the sod1∆ mutant (Figures 4.2A, 4.2B and B.2A). Furthermore, 
overexpression of Yno1 on a galactose-inducible promoter (pYES-YNO1, 3%GAL), which 
resulted in a ~30% increase in DHE-detectable superoxide (Figure B.2B), promoted 
GAPDH oxidation by 2-fold as compared to cells expressing empty vector (pYES2-EV, 0 
and 3%GAL) or that were cultured in non-inducing media (pYES2-YNO1, 0%GAL) 
(Figures 4.2C, 4.2D and B.2C). In total, these results indicate that both Yno1 and 
mitochondrial respiration are sources of the superoxide substrate required by Sod1 to 




Figure 4.2. Yno1 and mitochondrial respiration are sources of superoxide for 
GAPDH oxidation. 
(A-B) Representative immunoblot analysis of GAPDH oxidation as assessed by mPEG-
mal labeling of GAPDH in WT, rho0, yno1∆ and sod1∆ cells cultured in 2% GLU (A) and 
normalized GAPDH oxidation from multiple trials (B). Data represents the average ± SD 
from 3 independent trials. See also Figure B.2A. 
(C-D) Representative immunoblot analysis of GAPDH oxidation as assessed by mPEG-
mal labeling of GAPDH in WT cells expressing GAL1-driven YNO1 (pYES2-YNO1) or 
empty vector (pYES2-EV) cultured in 2% raffinose, supplemented with non-inducing (0%) 
or inducing (3%) GAL concentrations and (C) the normalized GAPDH oxidation from 
multiple trials (D). Data represents the average ± SD from 3 independent cultures. See 
also Figures B.2B-B.2C. 
The statistical significance relative to WT (panel B) or pYES2-EV 0%GAL (panel D) is 
indicated by asterisks using ordinary one-way ANOVA or two-way ANOVA with Dunett’s 
post-hoc test for the indicated pairwise comparisons in panel B and D, respectively; 










4.3.4. O2 dependent GAPDH oxidation is exclusively dependent on and rate limited by 
SOD1.  
 
All metabolic sources of superoxide and peroxide are ultimately derived from O2. 
We therefore sought to determine if Sod1 is the sole enzymatic adapter that links oxygen 
availability to the control of GAPDH oxidation and if GAPDH oxidation is rate-limited by 
Sod1. Towards this end, we first asked if Sod1 mediates O2-dependent GAPDH oxidation. 
Since WT Sod1 is transcriptionally and post-translationally down-regulated in response to 
hypoxia and anoxia (Brown et al., 2004; Leitch et al., 2009; Leitch et al., 2012; White et 
al., 2009), we utilized sod1∆ cells expressing ADH1-driven Sod1P144S, which is a mutant 
previously engineered to constitutively express mature enzymatically active Sod1 even in 
the absence of O2 [35, 188]. Indeed, the Sod1P144S mutant is enzymatically active in lysates 
derived from both aerobic and anaerobic cultures, whereas WT Sod1 is only fully active in 
lysates derived from aerobically cultured cells (Figures 4.3A and 4.3B). sod1∆ cells 
expressing WT or Sod1P144S exhibit a nearly 2-fold decrease in GAPDH oxidation when 
cultured anaerobically, consistent with the requirement for O2 as the metabolic origin of 
superoxide and peroxide (Figures 4.3C, 4.3D and B.2D). However, remarkably, the O2-
dependence of GAPDH oxidation is completely lost in cells lacking SOD1. Furthermore, 
we determined that the oxidation of GAPDH is rate limited by Sod1, finding that GAL-
regulated titration of Sod1 levels results in a dose-dependent increase in GAPDH 
oxidation (Figures 4.3E, 4.3F and B.2E). Altogether, these results indicate that the 




Figure 4.3. O2 dependent GAPDH oxidation is exclusively dependent on and rate 
limited by Sod1. 
(A-D) Assessment of the Sod1-dependence on the aerobic oxidation of GAPDH. (A) 
Representative SOD activity gel to assess aerobic and anaerobic Sod1 maturation in 
sod1∆ cells expressing empty vector, WT SOD1, or the P144S sod1 mutant and (B) 
normalized levels of mature Sod1 from multiple trials. Data represents the average ± SD 
from 3 independent cultures. (C) Representative immunoblot analysis of GAPDH oxidation 
as assessed by mPEG-mal labeling of GAPDH in aerobic or anaerobic sod1∆ cells 
expressing empty vector, WT SOD1, or the P144S sod1 mutant and (D) the normalized 
GAPDH oxidation from multiple trials. Data represents the average ± SD from two or three 
independent trials. See also Figure B.2D. 
(E-F) Representative immunoblot analysis of GAPDH oxidation in WT or sod1∆ cells 
expressing GAL-driven SOD1 cultured with increasing concentrations of galactose (GAL) 
(0%, 0.005%, 0.0075%, 0.01% and 0.1% GAL) and (E) the positive correlation between 
Sod1 expression and GAPDH oxidation from two independent trials (F). Sod1 expression 
and GAPDH oxidation were normalized to that of the WT cells and the linear regression 
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analysis of the two trials gives coefficients of determination (r2) of .81 and .77, with p-
values of .01 and .02, respectively. See also Figure B.2E. 
The statistical significance relative to the aerobic SOD1 expressing cells is indicated by 
asterisks using 2-way ANOVA for multiple comparisons with Dunett’s or Bonferroni post-
hoc test for the indicated pairwise comparisons in panel B and D, respectively; *p<0.05, 




4.3.5. Sod1-mediated oxidative inactivation of GAPDH results in increased NADPH 
production and oxidative stress resistance. 
 
 We next determined if the Sod1-dependent oxidative inactivation of GAPDH 
results in re-routing of glycolytic metabolism towards oxPPP to produce NADPH and 
increase resistance to oxidative stress. Titration of Sod1 expression using a GAL-driven 
SOD1 allele results in both a dose dependent increase in GAPDH oxidation as well as 
NADPH levels (Figures 4.4A-4C and B.3A-B.3F). Control experiments in which GAL is 
titrated into cells expressing a non-GAL-driven SOD1 allele indicate that GAL alone does 
not alter NADPH levels (Figure B.3G). Moreover, tdh3∆ cells, which express ~60% less 
GAPDH than WT cells, exhibit increased NADPH levels, consistent with our finding that 
oxidative inactivation of GAPDH increases NADPH (Figures 4.4D-4.4F).  
Since NADPH is required for the reduction and regeneration of numerous cellular 
antioxidant systems, we also determined if the alterations in Sod1-mediated NADPH 
production correlated with the oxidation state of Tsa1, a yeast peroxiredoxin important for 
oxidant defense and redox signaling that is maintained in a reduced state using reducing 
equivalents from NADPH. Consistent with a role for NADPH in maintaining reduced Tsa1, 
zwf1∆ cells lacking glucose-6-phosphate dehydrogenase (G6PD), which catalyzes the 
first committed step of the oxPPP, exhibit decreased NADPH levels and elevated Tsa1 
oxidation as assessed by immunoblotting using an antibody that recognizes sulfinic acid 
oxidized peroxiredoxins (Prx-SO3) (Figure 4.4G-4.4I). Titration of Sod1 using a GAL-
 82 
regulated promoter results in a dose dependent decrease in Tsa1 oxidation, consistent 
with the role of Sod1 in promoting NADPH production due to oxidative inactivation of 
GAPDH (Figure 4.4J and 4.4K). In order to determine if the oxidative inactivation of 
GAPDH by Sod1 provides a physiological benefit for cells, we measured the aerobic 
growth and oxidative stress resistance of cells expressing low and high levels of GAPDH. 
Although WT and tdh3∆ cells have similar aerobic and anaerobic growth rates in 2% GLU 
(Figure 4.4L), when cultured in 2% GAL, a fermentable carbon source that promotes 
respiration in yeast, tdh3∆ cells have a marked enhancement in growth rate compared to 
WT cells (Fig. 4.4M). Moreover, tdh3∆ cells exhibit a modest, but significant, resistance 
to peroxide stress (Figure 4.4N). Altogether, the enhanced aerobic fitness and peroxide 
tolerance of cells depleted of GAPDH is consistent with a beneficial role for the Sod1-




Figure 4.4. Sod1-mediated oxidative inactivation of GAPDH results in increased 
NADPH production and resistance to oxidative stress. 
(A-C) Sod1 expression positively correlates with GAPDH oxidation and NADPH 
production. (A) Immunoblot analysis of GAPDH oxidation as assessed by mPEG-mal 
labeling of GAPDH in sod1∆ cells expressing GAL-driven SOD1 cultured with increasing 
concentrations of galactose (GAL) (0.005%, 0.0075%, 0.01% and 0.1% GAL). See also 
Figure B.3A (B-C) The NADP+/NADPH ratio inversely correlates with normalized Sod1 
expression (B) and normalized GAPDH oxidation (C). The linear regression analysis in 
panels B and C gives coefficient of determinations (r2) of .98 and .99 and p-values of .01 
and .007, respectively. See also Figures B.3B-B.3H. 
(D-F) Depletion of intracellular GAPDH decreases the NADP+/NADPH ratio. (D) 
Representative immunoblot analysis of GAPDH expression in WT and tdh3∆ cells and (E) 
normalized GAPDH expression from multiple trials. (F) Measurements of the 
NADP+/NADPH ratio in WT and tdh3∆. Data represents the average ± SD from triplicate 
cultures. 
(G-I) Ablation of glucose-6-phosphate dehydrogenase (Zwf1) increases peroxiredoxin 
oxidation (Prdx-SO3) and the NADP/NADPH ratio. Representative immunoblot analysis of 
Prdx-SO3 (G), normalized Prdx-SO3 levels from replicates, and NADP+/NADPH ratios 
from WT and zwf1∆ cells. Data represents the average ± SD from triplicate cultures. 
(J-K) Sod1 expression inversely correlates with Prdx-SO3. (J) Representative immunoblot 
analysis of peroxiredoxin oxidation (Prdx-SO3) and Sod1 expression in WT or sod1∆ cells 
expressing GAL-driven SOD1 cultured with increasing concentrations of galactose (GAL) 
(0%, 0.005%, 0.0075%, 0.01%, 0.025%, and 0.1% GAL). (K) Sod1 expression inversely 
correlates with Prdx oxidation, with a linear regression analysis giving a coefficient of 
determination (r2) of 0.75 and a p-value of .01. 
(L-N) Aerobic and anerobic growth rates in 2%Glucose media (L), aerobic growth rate in 
2%GAL media (M) and peroxide sensitivity of WT and tdh3∆ cells (N). Data represent the 
average ± SD from triplicate cultures.  
The statistical significance relative to WT is indicated by asterisks using two-tailed 























4.3.6. SOD1 regulates GAPDH oxidation in human cells.  
 
Both Sod1 and GAPDH are highly conserved from yeast to humans. To establish 
the conservation of the Sod1-GAPDH redox-signaling axis, we employed human 
embryonic kidney HEK293 cells. It is worth noting that human GAPDH has an additional 
peroxide reactive Cys, which would result in 3 PEGylated proteoforms, corresponding to 
triple-, double-, and single-labeled GAPDH in immunoblots (Figures B.4A-B.4C). As 
expected, cells treated with H2O2 exhibited less mPEG-mal labelling, indicating a larger 
fraction of oxidized GAPDH compared to non-treated cells (Figure B.4B). To determine if 
Sod1 promoted GAPDH oxidation, we depleted Sod1 in HEK293 cells using small 
interfering RNA against Sod1 (siSOD1) or scrambled control RNAi (siCTRL). Across 
various trials, we consistently observed a depletion of ~60-80% of Sod1 (Figures 4.5A 
and 4.5B) and a corresponding decrease in GAPDH oxidation (Figures 4.5C, 4.5D, B.4C 
and B.4D). The extent to which Sod1 promotes GAPDH oxidation ranges from ~7 to 16%, 
which is comparable to the contribution observed from exogenous peroxide treatment 
(Figure B.4B). Moreover, as with yeast, we find that Sod1 expression levels across 
multiple trials positively correlate with GAPDH oxidation (Figure 4.5E). The correlation 
coefficient (r2) from a linear regression analysis is 0.7605, with p = .0022. Notably, the y-
intercept of the linear regression is close to 0, indicating that in the complete absence of 
Sod1, GAPDH oxidation is expected to be ~0% (Figure 4.5E). Furthermore, cell lines that 
overexpress Sod1, such as the breast cancer cell line MCF7 [257], exhibit a nearly 3-fold 
increase in GAPDH oxidation compared to HEK293 cells (Figure B.4E and B.4F). 




Figure 4.5. Sod1-mediated GAPDH oxidation is conserved in human cells.  
(A-B) Representative immunoblot analysis of Sod1 and GAPDH from human embryonic 
kidney HEK293 cells that have SOD1 silenced with small interfering RNAi (siSOD1) or 
control scrambled RNAi (siCTRL) (A) and normalized ratios of Sod1/GAPDH expression 
from multiple trials (B). Data represents individual values from five or six biological 
replicates.  
(C-D) Representative immunoblot analysis of GAPDH oxidation as assessed by mPEG-
mal labeling of HEK293 cells with silenced (siSOD1) or unsilenced (siCTRL) Sod1 (C) and 
normalized GAPDH oxidation from multiple trials (D). Data represents the average ± SD 
from five or six biological replicates. See also Figures B.4C-B.4D. 
(E) The correlation between %GAPDH oxidation and relative Sod1 expression, as 
assessed by measuring the ratio of Sod1/GAPDH levels, from the multiple trials depicted 
in panel D. A linear regression analysis gives a coefficient of determination (r2) of .76 and 
a p-value of 0.002 (black line). If the x and y-intercept of the linear regression is fixed at 
0% oxidation and no Sod1 expression (gray line), the correlation remains significant 
(p<0.0001). 
In panels B and D, the statistical significance relative to siCTRL is indicated by asterisks 
using two-tailed Student’s t-test for pairwise comparison; *p<0.05, **p<0.01, ***p>0.001, 
****p<0.0001, n.s.= not significant.  
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4.3.7. Redox proteomics identifies additional putative targets of Sod1 redox regulation.  
 
Many non-biased proteome-wide studies in the literature have used a combination 
of thiol alkylating agents with mass reporters, such as iodoTMT [258], to identify cysteine 
thiolates in proteins that are susceptible to oxidation upon treatment with exogenous H2O2 
[233, 259-261]. Though these studies are instrumental to understand potential redox 
targets, there is still a necessity to understand the degree to which the identified protein 
thiols are oxidizable under physiological levels of H2O2, without requiring the addition of 
exogenous oxidants that may yield a physiologically irrelevant degree of thiol oxidation. 
Recent studies, however, have significantly contributed towards how we perceive the 
physiologically relevant protein thiol oxidation cell and tissue-wide [262]. Still, until now, 
there isn’t any body of work that gauged the effect of intracellular sources of peroxide. 
Given that Sod1 is the main source of intracellular peroxide, is widely distributed 
throughout the cell and is highly abundant, it may redox regulate a broad variety of 
substrates cell-wide, besides GAPDH. Therefore, in order to further understand the 
implication of Sod1-derived peroxide in redox signaling, in collaboration with the Torres 
Lab, we executed a non-biased proteome-wide approach. For this purpose, we used 
iodoacetyl tandem mass tag (iodo-TMTTM) reagents (Thermo Scientific) in combination 
with single isoptope labeling with amino acids in cell culture (SILAC) in wild type (WT) and 
sod1∆ yeast cells. Iodo-TMT, which consist of a mass reporter, a mass normalizer and a 
iodoacetyl cysteine reactive group, selectively labels and enable duplex to sixplex mass 
spectrometry quantitation of free thiols in cysteines of target proteins from complex 
biological samples due to the six different mass reporters (126-131 Da) [263]. The 
combination of SILAC and iodo-TMT, enables the identification of Sod1-dependent 
changes in protein expression and reversible cysteine oxidation before and after DTT 
treatment between strains, respectively. 
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Briefly, lys1∆ (WT) and lys1∆ sod1∆ (sod1∆) yeast cultures are grown in media 
containing heavy and light lysine, respectively. Growth is stopped by adding trichloroacetic 
acid (TCA) to the culture followed by TCA lysis, which at its low pH prevents oxygen from 
reacting with the free sulfhydryl groups in cysteine residues and favors a real “snapshot” 
of the protein redox status in vivo [264]. After lysis and protein quantification, equal 
amounts of protein lysate from both samples are mixed using a 1 to 1 ratio. Proteins are 
first labelled with iodoTMT126 (Figure 4.6A, iodo-TMT1), which will covalently label the 
reduced sulfhydryl in thiols from cysteine residues in proteins. Next, the oxidized thiols, 
yielding a disulfide bond or sulfenic acid, are reduced using the reducing agent 
dithiothreitol (DTT) followed by labeling of the newly formed free sulfhydryl with 
iodoTMT129 (Figure 4.6A, iodo-TMT2). After labelling, the proteins are fractionated using 
high pH reverse phase liquid chromatography (RPLC) and subsequently analyzed via 
liquid chromatography coupled to tandem mass spectrometry (LC-MS-MS) (Figure 4.6A). 
Protein lysis, labeling, mass spectrometry and data analysis was executed by Hyojung 
Kim, with the help of Alex P. Jonkee in the Torres lab. For this study, we used three 
biological replicates, and three different pairs of iodo-TMT reporters, allowing statistical 
analysis of our results. In total, 4,409 unique proteins (Figure 4.6B) were confidently 
detected and quantified, revealing proteins that undergo significant changes in 
abundance, cysteine oxidation, or both when cells are lacking SOD1 (Figure 4.6C). 
Protein expression of each protein is analyzed via SILAC, whereby each peptide 
corresponding to WT or sod1∆, can be distinguished by a mass shift, which allows 
quantitation of the same peptide, and its corresponding protein, in each strain.  The protein 
expression difference between both strains is calculated using the following formula; 
Protein expression difference = log2 (sod1Dlight/WTheavy). From the 4,409 proteins detected, 
~9% of these (373) exhibit significant differences between the two strains. Concretely, of 
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these, 114 (30.6%) are significantly less expressed in sod1∆, in contrast to 259 (69.4%) 
that exhibit a significant increase in sod1∆ cells (Figure 4.6B, 4.6C and 4.6D). The 
changes in protein expression reflect known metabolic defects associated with loss of 
SOD1, including alleviation of glucose repression, increased mitochondrial mass, 
induction of the iron starvation and antioxidant responses, and diminished plasma 
membrane casein kinase expression (Figure 4.6E). 
Besides protein quantification with SILAC, the peptides that contain a cysteine 
residue, release a TMT reporter ion that enables the quantification of the cysteine 
oxidation percentage in each strain (oxidation difference= sod1∆%Ox – WT%Ox). As a 
consequence, this study reveals the effect of SOD1 expression on cell-wide cysteine 
redox status. In particular, a total of 2,077 cysteine residues were confidently detected 
ranging in oxidation extent from 1 to 100% and a median level of 28.9% across all sites 
measured (Figure 4.6B). Approximately 5% of the quantified cysteine sites (99 sites, 96 
proteins) undergo significant changes in oxidation between WT and sod1D cells, and of 
these, we found that 65% exhibit reduced oxidation levels in the absence of SOD1 (left) 
(Figure 4.6F). This suggests that Sod1-catalyzed H2O2 oxidizes and potentially regulates 
a wide array of proteins. It is intriguing, however, that most of the cysteine thiolates that 
are oxidized in a Sod1-dependent manner, unlike in GAPDH, are not catalytic cysteines. 
It is feasible that Sod1 redox regulates cysteine residues located in allosteric sites of some 
proteins, ultimately affecting protein activity, or cysteine residues involved in protein-
protein interactions, which may interfere/facilitate key interactions for signaling cascades. 
Therefore, future work is required to understand the effect of Sod1-catalyzed H2O2 on the 
non-catalytic cysteines of the identified proteins. Besides, the enhanced oxidation 
observed in some cysteine residues in sod1∆ compared to WT cells (Figure 4.6F, right), 
may be due to oxidative stress caused by the lack of sod1∆. However, we are most 
interested in the proteins that exhibit increased cysteine oxidation in WT cells, which 
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encompass potential targets of Sod1 metabolism (Figure 4.6F, left) that will be further 
studied in detail.  
 
Our non-biased proteome wide study addresses this need to elucidate how a key 
intracellular source of peroxide, namely Sod1, contributes towards redox signaling cell-
wide; and to identify the proteins that are redox regulated under oxidative stress, such as 
it encountered when cells lack SOD1. The role of Sod1 on cell-wide redox signaling can 
be dual; on one hand it acts as a direct source of peroxide that directly oxidizes a target 
cysteine thiolate, and, on the other hand, it may promote redox signaling by supporting 
the regeneration of antioxidant systems involved in redox relays, such as peroxiredoxins. 
Moreover, the combination of SILAC with iodo-TMT reports changes in cysteine oxidation 
between WT and sod1∆ cells, and shifts in protein expression, which also provides 
information on the transcriptional and translational adaptations that cells devoid of SOD1 
undergo. For instance, we observe that cells lacking SOD1, which are more oxidatively 
stressed, express more antioxidant enzymes, as expected (Figure 4.6G). This study 
identifies redox targets of a physiological endogenous source of H2O2 and supports Sod1 




Figure 4.6. Redox proteomics identifies additional putative targets of Sod1 redox 
regulation. (A) SILAC-TMT redox proteomics workflow. SILAC labels distinguish the 
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cellular origin of each peptide. Cysteine-reactive and isobaric iodoTMT reporters, 
undetectable during the first MS stage (MS1) and released during peptide fragmentation 
in MS2, enable unique cysteine %oxidation calculation in WT and sod1∆ cells. (B) Data 
obtained from the proteome wide mass spectrometry study, including protein expression 
and cysteine oxidation data. (C) Plot of aggregated average cysteine oxidation difference 
relative to protein expression difference in sod1∆ versus WT cells. Points near the origin 
(0,0) undergo less change in relative abundance and cysteine oxidation compared to 
points further from the origin. Cysteine coverage indicates the fraction of cysteine residues 
detected for each protein. (D) Volcano plot of -Log10(P-value) relative to protein expression 
difference [Log2(sod1∆/WT)] calculated from aggregate SILAC data. Proteins above -
Log10(P-value) 1.3 are significantly different in abundance between the two strains 
(p<0.05). Positive and negative values of log2(sod1D/WT) indicate proteins that are more 
expressed in sod1∆ and WT, respectively. Proteins with a single detected label are 
indicated as +/- infinity. (E) Volcano plot of -Log10(P-value) relative to protein expression 
difference [%Oxsod1D - %OxWT] calculated from iodoTMT data aggregated at the cysteine 
level. -Log10(P-value) of 1.3 or above indicate significantly different Cysteine oxidation 
between the two strains (p<0.05). (F) Subset of data from D, showing expression change 
for proteins associated with bioprocesses functionally associated with loss of SOD1. (G) 
Subset of data from D, showing expression change for proteins associated with 
antioxidant responses, overexpressed when cells are devoid of SOD1.  
 
 
4.4. Discussion.   
 
Life in air necessitates that cells sense and detoxify ROS generated from aerobic 
metabolism. As a consequence, a number of enzymatic antioxidant defenses evolved to 
combat ROS, including O2−-scavenging SODs and H2O2-scavenging thiol peroxidases 
and catalases. SODs are unusual “antioxidants” in that they catalyze the production of 
one ROS, H2O2, as a byproduct of detoxifying another ROS, O2−. Rather curiously, prior 
studies found that increased expression of Sod1 reduces cellular H2O2 levels [225], hinting 
at additional unknown mechanisms underlying Sod1 antioxidant activity. Herein, we 
sought to understand if there were physiological roles for Sod1-derivied H2O2 in redox 
regulating antioxidant defenses and the thiol proteome. Indeed, we identified a novel redox 
circuit in which Sod1 senses the availability of O2 via metabolically produced O2− radicals 
and catalyzes the production of H2O2 that oxidatively inactivates GAPDH. GAPDH 
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inactivation in turn promotes flux through the oxPPP to generate the NADPH required for 
aerobic metabolism and antioxidant defenses [239, 240]. Moreover, using mass 
spectrometry-based redox proteomics approaches, we identified a larger network of 
proteins whose redox state, like GAPDH, is sensitive to Sod1 levels. Altogether, our 
results highlight a new mechanism for the antioxidant activity of Sod1 – namely that Sod1-
derived H2O2 can stimulate NADPH production – and place Sod1 as a master regulator of 
the cellular redox landscape through two potential mechanisms; either by providing a 
direct source of thiol oxidizing H2O2 or by altering the NADPH/NADP+ redox balance 
through the Sod1/GAPDH signaling axis (Figure 4.7).  
GAPDH catalyzes a rate determining step of glycolysis and is amongst the most 
abundant peroxide reactive enzymes in eukaryotes [232]. Prior to our work, the oxidative 
inactivation of GAPDH and subsequent increase in NADPH via the PPP to combat redox 
stress was exclusively associated with high concentrations of  exogenous oxidants [233, 
239-242, 265]. Our studies found that endogenous H2O2, specifically derived from Sod1, 
is responsible for the aerobic oxidation of GAPDH (Figure 4.3D). These results indicate 
that only a highly localized and privileged pool of peroxide is capable of physiological 
GAPDH oxidation and control of glycolytic flux. As GAPDH and Sod1 are amongst the 
most abundant soluble proteins in cells, we propose that there may be transient 
interactions between there proteins that facilitate Sod1-dependent GAPDH oxidation. 
While we could not detect the co-immunoprecipitation (Co-IP) of endogenous Sod1 and 
Tdh3 from yeast cells, we did observe that purified recombinant bovine Sod1 and yeast 
Tdh3 do interact as assessed by co-IP (data not shown). By extension, we suggest that 
signaling H2O2 is channeled between Sod1 and down-stream targets via protein-protein 
interactions, rather than through diffusion. This model for Sod1-based redox signaling 
complements other paradigms of peroxide signaling such as the transfer of oxidizing 
equivalents through thiol-disulfide exchange [51] or the “flood-gate” effect, which posits 
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that a burst of H2O2 inactivates antioxidants like peroxiredoxins so that sufficient peroxide 
may diffuse far enough to transmit redox signals [52].  
The aerobic oxidation of GAPDH is rate limited by Sod1 (Figure 4.3E and 4.3F), 
suggesting that the oxidative inactivation of GAPDH and glycolytic flux may be dynamically 
regulated by Sod1 expression, maturation, which itself is O2 dependent, its interactions 
with GAPDH, or post translational modifications (PTMs) that regulate Sod1 localization 
and/or activity [105, 113-115]. With respect to Sod1 PTMs, it is tempting to speculate that 
the O2 sensing redox circuit we identified herein may be integrally linked to the nutrient 
sensing TOR pathway. TOR-dependent phosphorylation at Ser38 in yeast (Thr39 in 
humans) suppresses Sod1 activity in response to nutrient abundance to promote cell 
growth, whereas starvation promotes Sod1 activity [113]. TOR/Sod1 signaling may be 
coupled to the redox regulation of GAPDH and glycolytic flux, thereby providing a means 
to integrate oxygen and nutrient availability to control metabolism. With respect to Sod1 
expression, since many cancer cells over-express Sod1, it is conceivable that the 
Sod1/GAPDH signaling axis promotes cancer cell survival and drug resistance due to its 
potentiation of NAPDH production via the PPP [266]. Thus, our work also sheds new light 
on the benefits of anti-Sod1 therapeutic interventions [113, 117, 120, 121, 217]. Indeed, 
we find that the breast cancer MCF-7 cell line exhibits greater levels of GAPDH oxidation 
relative to HEK293 cells, correlating with its higher levels of Sod1 expression. 
 The integration of O2 availability through the Sod1/GAPDH redox signaling axis is 
dependent on key sources of O2−, including the yeast NADPH oxidase Yno1 and 
mitochondrial respiration (Figure 4.2). Given that Sod1 and GAPDH are primarily cytosolic 
enzymes, it is not surprising that we found Yno1, which is localized at the ER membrane 
and produces O2− on the cytosolic side, is required for transducing O2 availability to the 
O2− signal required for Sod1/GAPDH signaling [256]. Indeed, Yno1 was previously found 
to regulate Sod1-mediated redox regulation of yeast casein kinase Yck1/2 signaling, which 
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also occurs in the cytosol in proximity to the plasma membrane. However, it was rather 
surprising to find that mitochondrial respiration, as assessed in a respiratory incompetent 
yeast mutant lacking mitochondrial DNA, could also contribute O2− for Sod1 mediated 
GAPDH oxidation in the cytosol. Complex I (missing in S. cerevisiae) and III are the 
primary sources of electron leakage from the electron transport chain and produce O2− in 
the mitochondrial IMS [135]. Yet, IMS targeted Sod1 does not mediate GAPDH oxidation 
(Figure 4.1M and 4.1N). Thus, IMS O2−, which is charged and membrane impermeable, 
must exit the mitochondria for Sod1/GAPDH signaling via voltage-dependent anion 
channels (VDACs) [180] or as membrane-permeable neutral hydroperoxyl radicals (HO2). 
Our results highlight how mitochondrial respiration may be an important sensor for O2, 
providing a source of O2− that can act as a retrograde signal to control extra-mitochondrial 
metabolism for adaptation to increasing pO2. The current study complements prior work 
that found mitochondrial respiration is a key source of ROS required for adaption to 
hypoxia via HIF signaling [267].     
The 104-rate enhancement of Sod1-catalyzed O2− disproportionation relative to 
the uncatalyzed reaction suggests that Sod1 acts as a redox amplifier that provides a 
localized burst of H2O2 within the vicinity of Sod1 for specific redox signaling events. 
Indeed, the O2-dependent redox regulation of GAPDH and casein kinase signaling are 
exclusively dependent on Sod1. These findings prompted us to determine if other redox 
targets of Sod1 exist. Indeed, mass spectrometry-based redox proteomics identified a 
number of proteins that, like GAPDH, are more oxidized in the presence of Sod1. 
Interestingly, enzymes associated with pathways orthogonal to glycolysis and the PPP, 
namely involved in amino acid biosynthesis, were prominently enriched over other groups 
(Figures 4.6H), and suggest that Sod1-dependent growth control may also be modulated 
through additional targets within these pathways that may have evolved Sod1-sensitive 
cysteine oxidation sites. On the other hand, all but one of these proteins (Nbp35) are 
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oxidized at Cys residues not associated with a direct role in catalysis or function, raising 
the possibility that oxidation of such sites may function allosterically. For instance, the E1 
ubiquitin activating enzyme Uba1 is differentially oxidized at C447 (Table B.1J), which is 
immediately adjacent to the ATP binding site, and the cysteine desulfurase Nfs1 is 
differentially oxidized at C199, which is adjacent to the site of pyridoxal phosphate cofactor 
attachment. Future work will probe the functional consequences of Sod1-dependent 
protein oxidation. We also identified proteins that are more oxidized in sod1∆ cells, which 
we interpret as arising due to oxidative stress associated with the loss of GAPDH/Sod1 
signaling and the concomitant decrease in NADPH levels and/or O2− toxicity. It is worth 
noting that although past redox proteomics studies revealed much about potential targets 
of redox regulation, they typically involved treatment with exogenous oxidants mimicking 
pathological stress levels outside the physiological range [233, 258, 259, 261, 268]. Our 
study is notable in that we have identified redox targets of a physiological endogenous 
source of H2O2.  
 To what degree does Sod1 regulate thiol oxidation in animal models? A recent 
elegant redox proteomics study from Couchani and co-workers, termed “Oximouse”, 
describes tissue specific protein thiol oxidation in a mouse model [269]. Since active Sod1 
requires the formation of an intramolecular disulfide bond between Cys 147 and Cys 56, 
we plotted % Sod1-Cys147 oxidation as a proxy for mature active Sod1 against overall 
average Cys oxidation in each tissue and found a statistically significant linear correlation 
(r2 = 53; p = .04) (Figure B.5A). To determine if this correlation between active Sod1 and 
overall thiol oxidation was unique to Sod1, we also plotted tissue Cys oxidation against 
the oxidation of active site Cys residues in other peroxide metabolizing enzymes, including 
peroxiredoxins 1 and 5 (PRDX1, PRDX5) or glutaredoxin 3 (GLRX3). Unlike Sod1, the 
activity of these other enzymes, as assessed by their active site oxidation, do not 
significantly correlate with overall Cys oxidation (Figure B.5B-B.5F). Moreover, we also 
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found that the oxidation of other enzymes known to be redox regulated by Sod1, including 
tyrosine phosphatases PTP1N (PTP1B in humans) and PTPN11 [270, 271] and a GTPase 
involved in vesicular protein transport from the ER to the Golgi, Rab1a [272] (Figures 
B.5G-B.5I), exhibit a linear correlation between active Sod1 and their active site oxidation. 
Notably, there is no correlation with PRDX1 Cys oxidation, which is typically associated 
with the transmission of oxidizing equivalents to regulate redox signaling [51] (Figures 
B.5J-B.5L). Together, the data we extracted from the Oximouse study supports our 
principal findings from yeast that Sod1-derived peroxide regulates proteome-wide thiol 
oxidation.    
Our studies have also finally explained a mystery regarding the role of Sod1 in 
antioxidant defense. Prior to the current work, the primary role of Sod1 in antioxidant 
defense was thought to be O2− scavenging. However, we previously found that the vast 
majority of Sod1, > 99%, was dispensable for protection against cell wide markers of O2− 
toxicity [112]. We surmised that exceedingly low amounts of Sod1 were sufficient to 
protect against O2− because the targets of O2− toxicity are limited in scope, primarily Fe-
S cofactor containing proteins. Indeed, all O2−-related toxicity phenotypes arise from 
diminished activity of Fe-S enzymes and iron toxicity due to iron release from damaged 
clusters. Our work indicates that a broader role for Sod1 in oxidant defense is to promote 
the production of NADPH via the GAPDH/Sod1 signaling axis. As a major cellular 
reductant for numerous antioxidant systems, NADPH offers more expansive protection 
against redox stress than just defending against O2−. Since GAPDH and Sod1 are 
amongst the most ancient and highly conserved enzymes in aerobic life, we propose that 
this new reported function of Sod1 to produce NADPH via GAPDH oxidation was a key 
requirement for O2 sensing and integration for adaptation to life in air.  
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Figure 4.7. Proposed model for how Sod1 integrates O2 availability to regulate 





4.5.1. Chemicals, media components and immunological reagents.  
 
Dihydroethidium (Cat. # 50-850-563) was purchased from Thermo Fisher 
Scientific. Methoxypolyethylene glycol maleimide, 5kDa (Cat. # 63187) was purchased 
from Sigma Aldrich. SC and YPD dropout mixtures were purchased from Sunrise Science 
Products and VWR, respectively. The yeast GAPDH activity assay kit (Cat. # K680-100) 
and the NADP/NADPH quantification kit (Cat. #K347-100) were purchased from Bio 
Vision. Rabbit polyclonal antibody (Cat. # G4595) and mouse monoclonal antibody against 
GAPDH (Cat. # G8795) were purchased from Sigma Aldrich. Rabbit polyclonal antibody 
against Peroxiredoxin-SO3 (Cat. # ab16830) was purchased from Abcam. Goat Anti-
Rabbit (Cat. #89138-520) and anti-mouse CF680 (Cat. # 20067) secondary antibody were 
purchased from Biotium. Goat anti-rabbit DyLight 800 secondary antibody was purchased 
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from Thermo Fischer Scientific (Cat. # SA5-35571). A previously described rabbit 
polyclonal antibody against Sod1 was obtained from the laboratory of Valeria Culotta 
(Johns Hopkins University)[35]. RevertTM 700 Total protein stain kit for protein 
normalization was purchased from (LI-COR). 
 
4.5.2. Yeast strains, plasmids, and growth.  
 
S. cerevisiae strains used in this study were derived from BY4741 (MATa, his3Δ1, 
leu2Δ0, met15Δ0, ura3Δ0). sod1::KANMX4 strains were generated by knocking out SOD1 
using the previously described deletion plasmid pJAB002 [188]. Expression constructs for 
wild type SOD1 (pRS415-SOD1) and IMS localized SCO2-SOD1 (pRS415-SCO2-SOD1), 
which are both driven by the native SOD1 promoter, were previously described and were 
provided by the laboratory of Professor Dennis Thiele (Duke University) [255].  
The previously described GAL1 driven SOD1 expression plasmid (pAR1026) 
[112] was constructed by PCR amplification of the SOD1 open reading frame from 
BY4741 genomic DNA with primers that introduced flanking 5′ and 3′ SpeI and BamHI 
sites, respectively. The SOD1 amplicon was sub-cloned into the SpeI and   sites of 
pRS316-GAL1 [189] to generate pAR1026. 
The ADH driven SOD1 expression construct (pCMA002) was constructed by PCR 
amplification of the SOD1 open reading frame from BY4741 genomic DNA using plasmids 
that introduced 5’ and 3’ flanking regions with the BamHI and XhoI restriction sites, 
respectively. The SOD1 amplicon was cloned into the BamHI and XhoI cloning sites of 
p415ADH to generate pCMA002. The plasmid expressing CCS1-independent SOD1 
mutant (pCMA010, p415ADH-SOD1-P144S) was generated using site directed 
mutagenesis on the pCMA002 plasmid (Table B.1).  
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 Expression constructs for Yno1 (p416YES2-YNO1) or EV (p416YES2-EV), which 
are driven by a strong galactose inducible promoter were previously described and were 
provided by the laboratory of Michael Breitenbach (University of Salzburg) [256]. These 
constructs were cloned in the previously described sod1::kanMX4 strain expressing wild 
type SOD1 (pRS415-SOD1). 
 A previously described 3∆ (312) TDH3 strain (BY4742 Δtdh3::kanMX4 
Δtdh1::natNT2 Δtdh2::hphNT1 + pDP8) expressing wild type TDH3 (pDP8, p415TEF-
TDH3) was provided by the laboratory of Tobias P. Dick (dkfz) [232]. The resolving 
cysteine TDH3 mutant (p415TEF-TDH3-C154S) was generated via site directed 
mutagenesis (Table B.1). 
 Yeast transformations were performed by the lithium acetate procedure [273]. 
Strains were maintained at 30 °C on either enriched yeast extract-peptone based medium 
supplemented with 2% glucose (YPD), or synthetic complete medium (SC) supplemented 
with 2% glucose and the appropriate drop-out mixture to maintain selection. For all 
experiments, cells were streaked from -80 °C glycerol stocks onto solid agar media plates 
and pre-cultured in an anaerobic chamber (Coy laboratories) maintained with an 
atmosphere of 95% N2 and 5% H2. Anaerobically grown cells required supplementing SC 
media with 15mg/L of ergosterol and 0.5% Tween-80 (SCE) [274]. 
For typical experiments involving the IMS-targeted SCO2-SOD1 expression 
plasmid, cells were cultured aerobically in SC-LEU, with 2% glucose. In all cases, cells 
were seeded at an OD600nm ~ .01 and cultured for 14-17 hours to a density of OD600nm ~ 
1.0 at 30 °C in a shaking incubator (220 RPM). Following growth, cells were processed as 
described below for immunoblotting and enzyme assays. For experiments involving the 
CCS1-independent mutant SOD1-P144S, cells were cultured aerobically or anaerobically 
in previously degassed SCE-LEU with 2% glucose. Anaerobic cultures were seeded at an 
OD600nm~ .08 and cultured for 14-17 hours to a density of OD600nm ~ 1.0 at 30 °C shaking 
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in the anaerobic chamber (200 RPM). For this experiments, Sod1 activity and/or 
expression was assessed as described below. For experiments involving the titration of 
YNO1 and SOD1 using the GAL-driven YNO1 and SOD1 expression plasmids, cells were 
cultured aerobically in SC-URA with 2% raffinose and the indicated galactose 
concentrations.  
Human embryonic kidney HEK293 cells were obtained from the laboratory of Loren 
D. Williams (Georgia Institute of Technology). Cells were cultured in Dulbecco Modified 
Eagle’s Medium (DMEM, VWR), with 4.5g/L glucose and without L-Glutamine or Sodium 
Pyruvate, supplemented with 10% fetal bovine serum (FBS). SOD1 silencing was 
accomplished using 50µM SOD1 silencer (Ambion, Cat. # 4390824) or scrambled control 
(Ambion, #Cat AM4611). Cells were transfected in Opti-MEM (Fisher) with Lipofectamine 
2000 (Invitrogen) for 72h. MCF7 cells were cultured in DMEM without Phenol Red or L-
glutamine (VWR).   
All experiments were conducted using biological replicates arising from duplicate, 
triplicate or more independent cultures of multiple clones. All of the data has re-produced 
on multiple occasions in independent experimental trials. 
 
4.5.3. TCA precipitation and thiol alkylation with mPEG-mal in yeast cultures.  
 
10 mL aerobic or anaerobic overnight yeast cultures were quenched at a density 
of OD600nm mL-1 ~ 1 by adding cold 100% trichloroacetic acid (TCA) to a final concentration 
of 10% (v/v). The TCA-stopped cultures were incubated on ice for 1h before pelleting and 
washing in 20%TCA. The final pellet was stored at -80ºC. For experiments involving H2O2 
treatment, H2O2 was added to a final concentration of 1 mM to yeast cultures and 
incubated for 2 minutes while shaking prior to TCA precipitation.  
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Pellets were thawed on ice and lysed at 4ºC in TCA lysis buffer (12.5% v/v TCA in 
1 mM Tris-HCl, pH = 8.0, 25mM NH4Ac,1mM Na2EDTA pH 8.0) using half pellet volume 
of zirconium oxide beads and a beat beater on a setting of 8 for 3 minutes, twice (Bullet 
Blender, Next Advance) [192]. The TCA lysate was transferred to a fresh tube by poking 
a hole 45º from the cap using a hot needle and pelleted, washed in cold acetone (-20ºC) 
and dried. The dried pellet was resuspended in 200 µL degassed resuspension buffer (6M 
urea, 10mM EDTA, 20mM Tris, 0.5% w/v SDS, 10µM neocuproine, pH 8.5) containing 
1mM PMSF and a protease inhibitor cocktail (GBiosciences) in the anaerobic chamber 
(Coy laboratories). Lysate protein concentrations were determined by the PierceTM BCA 
protein assay kit (Thermo Scientific).  
Alkylation of free thiols was accomplished by diluting the lysate to a protein 
concentration of 0.18 µg/µL in resuspension buffer with 7.5 mM mPEG-mal (dissolved in 
DMSO) or DMSO and incubated for 1h shaking in the anaerobic chamber protected from 
exposure to light. The excess mPEG-mal was discarded using PD SpinTrap G-25 columns 
(GE Healthcare) and the resulting lysates were electrophoretically separated by SDS-
PAGE in 14% tris-glycine gels (Invitrogen). Anti-GAPDH (1:4000) polyclonal rabbit 
antibody and a goat secondary antibody conjugated to a 680nm emitting fluorophore were 
used to visualize GAPDH in the immunoblot. All gels were imaged on a LiCOR Odyssey 
Infrared imager. Immunoblot quantitation was conducted using the LIC-COR Odyssey 
imager software (Image Studio Lite). %GAPDH oxidation was calculated dividing the 
intensity of the bottom band (unlabeled oxidized GAPDH) by both top and bottom bands 






4.5.4. Enzyme assays.  
 
SOD activity analysis was performed by native PAGE and nitroblue tetrazolium 
staining as described previously [35, 112, 193, 207] on exponential phase aerobic and 
anaerobic cultures grown to a density of OD600nm ~ 1.0 in degassed SCE-LEU, 2% glucose 
media. Yeast cells were washed in ultrapure H2O, resuspended in cold (4ºC) lysis buffer 
(10mM sodium phosphate, 50 mM sodium chloride, 5 mM EDTA, 0.1% Triton X-100, 1 
mM PMSF and protease inhibitor cocktail). Lysis was achieved at 4ºC using half pellet 
volume of zirconium oxide beads and a beat beater as described before [112]. Lysate 
protein concentrations were quantified by the Bradford method (Bio-Rad) and 15 µg of 
each protein sample was loaded and separated in 14% native PAGE gels. Sod1 activity 
was visualized by staining the gel with SOD activity staining solution (2.43 mM nitro blue 
tetrazolium chloride, Sigma, 0.14M riboflavin-50-phosphate, Sigma, 45mM dipotassium 
phosphate buffer, 4.5mM monopotassium phosphate buffer) with 28mM TEMED (Bio-
Rad) for 60 minutes at room temperature in darkness. After the incubation, gels were 
rinsed with water twice and exposed to light.  
 GAPDH activity was measured using the GAPDH activity assay kit (Bio vision) 
according to the manufacturer’s specifications.  For this purpose, sod1∆ cells expressing 
an empty vector (pRS415) or SOD1 (pRS415-SOD1) were grown in 10mL SC-LEU 2% 
glucose cultures to a density of OD600nm=1.0. Cells pellets were washed in ultrapure water 
and lysed in cold degassed lysis buffer as described for the SOD activity analysis. 
Increasing concentrations of protein lysate within a linear detection range were diluted in 
assay buffer to a final volume of 50 µL and mixed with 50 µL of reaction mix. Activities 
were monitored by spectrophotometrically measuring the generation of 1,3-
bisphosphoglycerate (BPG) at 450 nm over the course of 60 minutes using a Biotek 
Synergy Mx multi-modal plate reader.  
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 ATPase activity was assayed in membrane fractions with or without a 5 min 
preincubation with 50 mM vanadate. ATPase activity was determined by quantitating the 
phosphate released during vanadate-sensitive ATP hydrolysis by molybdate reactivity 
[275], and activity was normalized to WT cells. 
 
4.5.5. NADPH measurements.  
 
NADP/NADPH ratio measurements were conducted using the NADPH kit (Bio 
vision) according to the manufacturer’s specifications. Briefly, yeast 10 mL cultures were 
split in half after reaching an OD600/mL~1.0, and 5 OD600 were TCA precipitated, as 
previously described, to assess peroxiredoxin oxidation (Prdx-SO3) and the other 5 OD600 
were harvested and lysed in the NADP/NADPH extraction buffer provided by the 
manufacturer. Half the lysate was incubated on ice to assess total [NADP] and [NADPH], 
and the other half was heated for 30 minutes at 60ºC in a heat block to assess [NADPH]. 
Increasing concentrations of protein lysate within a linear detection range were diluted in 
assay buffer to a final volume of 50µL and mixed with 100µL of reaction mix and 10µL of 
Developer. NADPH was monitored after 1h incubation every 20 minutes for 4h at 450nm 
using Biotek Synergy Mx multi-modal plate reader. 
 
4.5.6. Superoxide measurements.  
 
Superoxide levels were measured by monitoring the fluorescence of DHE stained 
cells (λex =485 nm, λem =620 nm) as previously described [112]. Briefly, 1 x107 cells were 
harvested from triplicate cultures, resuspended and incubated in 500µL filter-sterilized 
1xPBS solution containing 50µM DHE for 20 minutes at 30ºC in the dark, washed twice in 
1xPBS. The fluorescence was recorded in a Biotek Synergy Mx multi-modal plate reader. 
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4.5.7.  Growth test.  
 
Growth tests of WT and tdh3∆ aerobic and anaerobic cultures were performed 
growing three biological replicates anaerobically overnight and diluting each biological 
replicate to 0.15 OD600/mL in duplicate 10mL cultures the next morning. Each replicate 
was cultured aerobically or anaerobically for 12h. OD600/mL readings were taken every 
hour or 2h from aerobic and anaerobic cultures, respectively, using a UV/vis 
spectrophotometer (Agilent). For peroxide sensitivity tests, WT and tdh3∆ aerobic cultures 
were grown overnight and diluted to 0.15 OD600/mL with increasing concentrations of H2O2 
(0, 100µM, 250µM, 500µM, 1mM). Readings were taken every hour using a UV/vis 
spectrophotometer (Cary 60, Agilent). 
 
4.5.8. HEK293 and MCF7 TCA precipitation and thiol alkylation with mPEG-mal.  
 
For assessing Sod1-dependent GAPDH oxidation in HEK293 cells, cells were 
silenced by adding 50µM SOD1 silencer (Ambion, Cat. # 4390824) or scrambled control 
and Lipofectamine 2000 (Invitrogen) in Optimem to cells seeded in 6 well plates and 
incubated for 72h. GAPDH oxidation was assessed by lysing cells via TCA precipitation 
72h-post transfection where 100% cold TCA was added to the collected cell suspension 
to a final concentration of 10% and incubated for 1h on ice. After TCA lysis, cells were 
pelleted and washed in cold acetone and dried. Dried pellet resuspension, thiol alkylation 
and immunoblotting were carried out as described in the section on TCA precipitation and 
thiol alkylation in yeast cultures, using a concentration of 0.5µg/µL lysate protein for thiol 
alkylation.   
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SOD1 silencing was assessed via immunoblotting from the cell lysates used for 
mPEG-mal labeling using a Sod1 a polyclonal rabbit antibody (1:1000) and a goat 
secondary antibody conjugated to a 680nm emitting fluorophore. GAPDH was used as the 
loading control and was visualized using a GAPDH mouse monoclonal antibody (1:4000) 
and a goat antibody conjugated to an 800nm emitting fluorophore. Silencing efficiency 
was calculated by normalizing Sod1 expression (measured normalizing the Sod1 band 
intensity to the GAPDH band intensity) from siSOD1 or siCTRL treated cells to the average 
Sod1 expression value from siCTRL treated cells.  
For assessing GAPDH oxidation via exogenous peroxide addition, ~105 cells were 
seeded in a 6-well plate in a reduced-serum media (Optimem, Gibco), grown for 24h and 
treated with 100µM H2O2 dissolved in Optimem (37ºC) for 2 minutes prior to cell harvesting 
and TCA lysis. As a control, cells were incubated with 2mL Optimem containing the same 
volume in H2O. 
For assessing GAPDH oxidation in MCF-7 cells, cells were seeded in a 6 well plate 
and harvested and lysed via TCA precipitation 24h after the cells were seeded, as 
previously described. 
 
4.5.9. Quantification and Statistical analysis.  
 
Data and statistical analysis were performed using GraphPad Prism, Pymol and 
Studio Lite software. P values were calculated using two-tailed Student’s t-test for pairwise 
comparisons, One-way Anova and Dunett’s post-Hoc test for multiple comparisons or 
Two-way Anova for multiple comparisons with more than one variable. The P value for 




4.5.10.  SILAC labeling and cell lysis.  
 
Three biological replicates were analyzed each for WT and sod1D cells. For each 
replicate, lys1∆ and lys1∆ SOD1::KANMX4 single colonies were inoculated in 3mL starter 
cultures and grown to saturation in synthetic complete (SC). The following day, starter 
cultures were diluted to ~0.1 OD600 in 10mL dropout SC media to reach 0.8 OD600/mL and 
then seeded at an OD600 0.0075 in 50mL SC media containing heavy (WT) or light (sod1D) 
lysine, respectively. Culture growth was stopped after ~10 doublings by adding 100% cold 
TCA to a final concentration of 10%. The cells were incubated on ice in 10%TCA for 1h 
and pelleted for 10 minutes at 4,000 rpm, 4ºC. The cell pellets were then washed in 20% 
TCA and pelleted for 10 minutes at 16,000 G, 4ºC. After discarding the supernatant, the 
pellets were stored at -80ºC.  
To prepare extracts, the SILAC-labelled cell pellets were separately thawed on ice 
and resuspended in 20% TCA followed by vortexing with glass beads for 10 min at 4 °C. 
Lysates were transferred to new centrifuge tubes followed by centrifugation at 16,000 × g 
for 10 min at 4 °C. Pellets were washed with ice cold acetone followed by centrifugation 
at 16,000 × g for 5 min at 4 °C. Pellets were resuspended in freshly prepared 6 M urea, 
200 mM Tris pH 8.0, 2% SDS, 10 mM EDTA, 10 µM neocuproine. Protein concentrations 
for both WT and sod1∆ resuspensions were determined by DC protein assay (Bio-Rad 
Laboratories) and mixed equivalently generating 400 µg total. 
 
4.5.11.  iodoTMT labeling.  
 
The combined SILAC-labeled protein samples (heavy/light) were labeled using 
iodoTMT sixplex Isobaric Label Reagent Set (Thermo Scientific) according to the 
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manufacturer specifications. Each bio-replicate was labeled with two different iodoTMT 
labels (either 126/129, 127/130, or 128/131). For pre-reduction iodoTMT-labeling, each 
replicate was labeled overnight followed by removal of unreacted TMT label by chloroform-
methanol precipitation as previously described [276]. Following the first labeling reaction, 
oxidized thiols were reduced in 50 mM DTT at 37 °C for 1 hr followed by excess DTT 
removal by chloroform-methanol precipitation. Post-reduction iodoTMT-labeling was 
carried out as before with overnight incubation followed by the unreacted TMT label 
reagent removal. Each replicate was washed with ice cold acetone followed by 
resuspension in 100 mM Tris pH 8.0, 1 M ABC, 6 M urea and incubation at 37 °C for 1 hr. 
Lys-C protease (Thermo) was added to each replicate (1:20; enzyme:protein) followed by 
overnight incubation at 37 °C with shaking at 600 rpm. 
 
4.5.12. High pH RPLC fractionation.  
 
SILAC-TMT labeled peptides were pre-fractionated by high pH reverse phase 
liquid chromatography using an Agilent 1100 HPLC system with Gemini C18 reverse 
phase column (2 × 150 mm, 5 µM, 110 Å; Phenomenex Inc.) with solvents A (10 mM 
ammonium formate) and B (10 mM ammonium formate in 90% acetonitrile) adjusted to 
pH 10 using ammonium hydroxide. A gradient method (from 0% to 70% B in 150 min, then 
from 70% to 0% in 20 min) was applied at a flow rate of 100 µl/min. Fractions were 
collected every 5 min and frozen at -80 °C followed by lyophilization by CentriVap. 
 
4.5.13. LCMS.  
 
Peptide fractions were analyzed by LCMS using a Q-Exactive Plus orbitrap mass 
spectrometer equipped with Dionex UltiMate 3000 LC system (Thermo). The lyophilized 
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fractions were resuspended in 0.1% FA in 5% ACN and loaded onto a trap column, 75 µm 
I.D. x 2 cm, packed with Acclaim PepMap100 C18, 3 µm, 100Å (set of 2) nanoViper and 
resolved through an analytical column, 75 µm I.D. x 15 cm, packed with Acclaim PepMap 
RSLC C18, 2 µm, 100Å, nanoViper at a flow rate of 0.3 µl/min with a gradient solvent A 
(0.1% FA in 2% ACN) and a gradient solvent B (0.1% FA in 90% ACN) for 150 minutes. 
MS analysis was conducted in a data dependent manner with full scans in the range from 
200 to 1800 m/z using an Orbitrap mass analyzer at a mass resolution of 70,000. The top 
fifteen most intense precursor ions were selected for MS2 with the isolation window of 4 
m/z. Isolated precursors were fragmented by high energy collisional dissociation (HCD) 
with normalized collision energies (NCE) of 28, 31, and 33 for each analytical replicate. 
This led to the acquisition of 3 analytical replicates for each bio replicate for a grand total 
of 9 detection attempts per peptide fraction.  
 
4.5.14.  MS data analysis.  
 
For SILAC data evaluation for protein expression, a total of 33,289 proteins of 3 
biological replicates with 3 different NCEs of 28, 31, and 33 analyzed by PD 2.0 (Table 
A.2K). Of these, 32,630 proteins were further evaluated excluding transposable elements. 
Protein SILAC ratios (sod1DLight / WTHeavy) were calculated as the ratio of integrated MS1 
peak areas for light and heavy peptides. Statistical significance in the difference between 
WT and sod1D data were determined using Response Screening (JMP 15.0) wherein up 
to 9 average responses per protein per yeast strain (18 total) were possible. Cases in 
which only one channel of a SILAC pair was present (heavy or light) were processed 
separately are reported as +/- infinite change in protein abundance. 
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For iodoTMT data evaluation a total of 307,894 peptides represented by 2,398,648 
PSMs were identified using PD 2.0 (Table A.2L). Of these, 35,476 unique peptides 
(259,936 PSMs) corresponded to iodoTMT-labeled cysteine-containing peptides, again 
with transposable elements excluded. These data were processed at the peptide level to 
calculate percent cysteine oxidation level by dividing the reporter ion signal of TMT2 by 
the sum of signals from TMT1 and TMT2, producing an oxidation percentage for WTHeavy 
and sod1DLight peptide isoforms. Statistical significance in the difference between WT and 
sod1D data were again determined using Response Screening (JMP 15.0) for oxidation 
percentages measured between the two strains wherein up to 9 average responses per 
protein per yeast strain (18 total) were possible. Cases in which only one SILAC peptide 
was present were processed separately. To examine overall differential oxidation levels 
of proteins, the cysteine coverage of a protein (# detected Cys / # total Cys in a protein) 
was calculated using the non-redundant UniProt Yeast (BY4741) proteome database. 
Custom scripts necessary to organize data in the context of cysteine native position and 




 SILAC-iodoTMT proteomics data were further analyzed using PANTHER, an 
ontology-based database equipped with data analysis tools. GO enrichment of biological 
processes, molecular functions, and cellular components was performed for proteins with 
greater than +1 or less than -1 log2 SILAC ratio (sod1ΔLight / WTHeavy), representing 
differential protein abundance. Separately, similar GO enrichment analysis was performed 
for proteins with observed TMT-labeled cysteine residues falling greater than 5% (or 10%) 
or less than -5% (or -10%) differential oxidation (sod1D – WT). Enriched terms with 
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statistical significance above the 95% confidence level were considered further. GO 
enrichment bins were defined by first identifying GO terms with fold enrichment values 
that were statistical outliers (>90th percentile), which resulted in well-defined bins reported 
in Figures 6E, 6H and Tables S5B, S5H. The mean fold enrichment for the GO Terms 
embedded with each bin was reported to allow comparison of fold enrichment values 
within each bin. 
Evaluation of cysteine oxidation site bio-process outliers (Figure 6I, 6J, S6A, and 
Table S5I) was performed as follows. First, SGD GO analysis and EBI QuickGO were 
utilized to generate the list of bio-process GO terms for proteins undergoing statistically 
significant changes in oxidation (99 proteins in total). Second, GO terms were searched 
individually by AmiGO 2 to retrieve proteins in each of the GO terms filtered by S. 
cerevisiae S288C (see Figure S6). Third, the resulting list was filtered against proteins 
where cysteine oxidation in WT and sod1D cells could be quantified, and then further 
filtered to retrieve bio-processes in which any of the 99 significant ox changers were found 
to be a statistical outlier from other cysteine residues in the bio-process. Outlier responses 
of any cysteine oxidation change were highlighted by determining the distribution of 
observed responses within the bio-process. Outliers defined by this process were used to 
highlight specific proteins shown in Figures 6I and 6J. 
Pathway analysis of significant ox changers was further analyzed via the Kyoto 
Encyclopedia of Genes and Genomes (KEGG) Brite and Pathway analysis tools (see 
Figure 6G; Tables S5F, S5G). Identification of functional cysteine residues was achieved 
using UniProt curated data with restriction to “Binding Site”, “Active Site”, “DNA Binding”, 











 My thesis work challenges how we have perceived Sod1 in biology. It shows that 
the function of the bulk of Sod1 is not superoxide protection, as previously thought, since 
only a minuscule fraction is needed for that purpose, but to promote peroxide-based redox 
signaling relays cell-wide. Given that Sod1 is the most prominent source of H2O2 in most 
organisms and human cell types and is widely distributed throughout the cell it facilitates 
localized redox signaling relays. Our proteome-wide mass spectrometry data suggests 
that a large fraction of the identified Sod1-redox regulated proteins corresponds to 
metabolic enzymes and places Sod1 as a master regulator of metabolism and redox 
signaling. This forces us to re-direct most of the previous conclusions and hypothesis 
towards a new direction.  
 The presented work suggests that Sod1 is a key cellular component that drives 
cell adaptation to oxygen by turning on certain pathways when cells are exposed to 
increasing pO2, via H2O2 generation from O2-dependent O2.- generation, including 
promoting generation of NADPH redox equivalents to sustain all antioxidant systems in 
the cell. Until now, the phenotypes observed with cells devoid of Sod1 or expressing 
inactive Sod1 mutants have been associated with damaging effects of superoxide build-
up [183]. But is it just that? Our work defies this assumption and suggests that the 
damaging effects of lacking Sod1 is not mere superoxide build-up, but the lack of the key 
element that integrates oxygen availability to sustain adequate NADPH levels that 
maintain antioxidant systems that protect from a wide variety of reactive oxygen species, 
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not just superoxide. Besides, the perturbation of physiologic Sod1-driven redox relays may 
further contribute to the damaging effects of lacking Sod1. It turns out, we may have had 
a reductionist perception of Sod1 until now.  
 Recently Sod1 has been regarded as an important therapeutic target for cancer 
treatment. There has been more than one reported Sod1 inhibitor that effectively arrests 
cancer cell growth and promotes apoptosis. But why does Sod1 inhibition have such 
“conventional” effects? There is not still a clear answer, however, it is suggested that it 
may be due to superoxide toxicity associated with the lack Sod1. Our new findings indicate 
that it may be because the regeneration of cell-wide antioxidant systems is impaired, 
contributing to higher ROS levels that can trigger apoptosis. Moreover, it is conceivable 
that the role Sod1 plays in redox signaling may also have an effect in proliferation. For 
instance, it is known that Sod1-catalyzed H2O2 promotes the activation of the epidermal 
growth factor receptor (EGFR) by inducing its dimerization and further prolongs its activity 
by redox inactivating the protein tyrosine phosphatase that inhibits it [116]. This particular 
pathway, along with many soon-to be discovered Sod1 redox-regulated pathways, might 
be significant in promoting cancer cell tumorigenesis. Moreover, the role of Sod1 in 
glucose sensing via CK1g stabilization may additionally support cancer cell proliferation, 
given the heavy reliance of cancer cells in glucose and fermentative metabolism for growth 
[35, 277]. Regarding the role of Sod1 on CK1g stabilization, given that CK1g is a key factor 
in the Wnt signaling pathway, we also found that Sod1 is necessary for canonical Wnt 
signaling, a pathway that many cancer cells rely on for carcinogenesis. Hence, Sod1 is 
required for many signal-stimulated prooncogenic pathways and to boost cell antioxidant 
capacity, posing it as a pivotal factor to support tumorigenesis and cancer cell survival. 
However, although this dissertation covers the identification of many Sod1 sponsored 
pathways, that support cancer progression and other diseases, we are still far from 
 114 
understanding the complete contribution of Sod1. Therefore, there is a necessity to further 
explore the role of Sod1 in cell motility, proliferation and epidermal to mesenchymal 
transition (EMT) [278], a key mechanism for metastasis, to understand the role Sod1 plays 
in carcinogenesis and why it has such potential as a target for cancer treatment. 
 This novel perspective on the role of Sod1 should be applied to study other Sod1 
related diseases, such as familial amyotrophic lateral sclerosis (FALS), and diseases that 
are potentially associated with Sod1, such as metabolic diseases. Additionally, Sod1 
should be taken in account as a key element in a wide array of redox signaling pathways 
necessary for cell physiology and pathology.   
 
5.2. Future Directions 
 
 The work presented on this thesis, has been just the inception of re-framing the 
role of Sod1 in biology. The next steps of the work presented would involve investigation 
on how Sod1 regulates the most relevant proteins identified in the mass spectrometry 
study. Understanding how Sod1 regulates these proteins will further expand the horizons 
on the role of Sod1 in redox signaling and would contribute towards elucidating novel 
signaling networks. For instance, understanding how Sod1 regulates Uba1, the E1 ligase 
required for protein ubiquitination, would shed light on potential redox regulation of protein 
degradation pathways, which may ultimately help identify the pathway by which Sod1 
promotes yeast casein kinase 1 (Yck1) stabilization.  
 Future work may also encompass repeating the mass spectrometry study in 
different human cell lines to identify potential Sod1-dependent redox regulated pathways 
that are conserved across phylogeny, which would help unveil novel significant networks 
for life in air, and potentially additional Sod1-dependent oxygen sensing mechanisms.  
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 Additionally, it would be interesting to explore the different requirements for Sod1 
in cancer cell lines that overexpress Sod1 under normoxia and anoxia. Understanding the 
requirement for Sod1 when oxygen is scarce versus when it is abundant, would aid to 
further understand the role of Sod1 in cell biology and cancer under different pO2. In 
addition to that, it would be compelling to study to which extent the ability of Sod1 to 
promote NADPH production has an effect in carcinogenesis. The Sod1-driven NADPH 
generation may be tightly regulated by the allosteric inhibition of G6PD by NADPH when 
the levels of NAPDH are sufficient to maintain a physiologic reducing potential. This 
negative feedback loop may act to prevent further re-routing towards the PPP, conferring 
an additional level of complexity and regulation to this pathway. Given that cancer cells 
rely on glycolysis, understanding whether this is just for rapid energy requirements and to 
have cellular building blocks; or if it is also because they rely heavily on Sod1-dependent 
re-routing from glycolysis to the oxidative phase of the pentose phosphate pathway to 
generate NADPH, would shed light on the implications of our newly discovered pathway 
in disease. Additionally, it would further suggest that Sod1 inhibitors may be significant for 



















Figure A.1. Sod1 silencing does not affect the expression of other cytosolic peroxide 
metabolizing enzymes or peroxiredoxin oxidation. (a) Immunoblots of peroxiredoxins 
Prdx1 and Prdx2 and Sod1 in response to silencing of SOD1 with siRNA. (b-d) 
Quantification of the normalized levels of (b) Sod1, (c) Prdx1, and (d) Prdx2. (e) 
Immunoblots of glutathione peroxidase Gpx1 and thioredoxin Trx1 in response to silencing 
of SOD1 with siRNA. (f-g) Quantification of the normalized levels of (f) Trx1 and (g) Gpx1. 
(h) Immunoblots of sulfenic acid oxidized peroxiredoxin (Prdx-SO3) and Sod1 in response 
to silencing of SOD1 with siRNA. (i-j) Quantification of the normalized levels of (i) Sod1 
and (j) Prdx-SO3. Expression of the indicated proteins is normalized to total protein as 
assessed by the Revert stain from Licor. The statistical significance is assessed using an 










Figure B.1. Development and validation of key strains, reagents, and techniques to 
establish Sod1-dependent GAPDH oxidation; related to Figure 4.1. 
(A) Aerobic (O2) and anerobic growth (N2) of WT and sod1∆ cells. Data represent the 
average ± SD from duplicate cultures.  
(B) Normalized Pma1 activity in WT cells and cells expressing a hypomorphic allele of 
PMA1 (pma1-tap). Data represent the average ± SD from triplicate cultures and is 
normalized to the average activity of WT cells.  
(C) Schematic representation of Cys-mPEG-mal adducts upon covalent modification with 
methoxypolyethylene glycol maleimide (mPEG-mal) and the corresponding 
electrophoretic shift. 
(D) Representative immunoblot analysis of GAPDH-mPEG-mal adducts in sod1∆ cells 
expressing yeast Sod1 (SOD1) or empty vector (EV) cultured in 2% GLU and treated with 
1mM H2O2 (+ H2O2) or H2O (- H2O2) for three minutes prior to treatment with mPEG-mal. 
Immunoblot quantitation was conducted using the LIC-COR Odyssey imager software 
(Image Studio Lite) (middle), yielding the values exhibited in the blue squares and the 
bottom table. The percentage of GAPDH oxidation is displayed in the bottom table and 
obtained dividing the intensity of unlabeled bands by the sum of the intensity of labeled 
and unlabeled bands. 
(E) % GAPDH oxidation, as assessed by quantifying the ratio of mPEG-mal labelled 
GAPDH to total GAPDH, in the indicated strains. 
(F to M) Peak profiles (Y location, top; X location, bottom) corresponding to the blue 
shapes displayed in panel D (middle) used to identify the intensity of the immunoblot 
bands accounting for background. The quantitation is performed using the Studio Lite 
software.   
(N) Representative immunoblot analysis of GAPDH-mPEG-mal adducts in 
tdh1∆tdh2∆tdh3∆ cells expressing yeast GAPDH (TDH3, left) or C154S-TDH3 (right). The 
arrows indicate the TDH3 or TDH3-C154S-mPEG-mal adducts.  
(O-P) Measurements of time-dependent (O) or average (P) GAPDH enzymatic activity in 
sod1∆ cells expressing SOD1 (blue) or EV (gold). Data represents the average ± SD from 
2 (O) and 4 (P) independent trials.  
(Q-R) Assessment of GAPDH oxidation in sod1∆ cells expressing yeast Sod1 (SOD1) or 
empty vector (EV) cultured in 2% glucose (GLU) or 2% galactose (GAL). Representative 
immunoblot analysis of GAPDH-mPEG-mal adducts (Q) and absolute %GAPDH oxidation 
from multiple trials (R) in the indicated strains. Data represents the average ± SD from 3  
(S) Assessment of GAPDH oxidation in sod1∆ cells expressing yeast Sod1 (SOD1), 
mitochondrial IMS targeted Sod1 (Sco2-SOD1), or empty vector (EV).  
The statistical significance is indicated by asterisks using two-tailed Student’s t-test 
pairwise comparison (panels B and P) or two-way ANOVA for multiple comparisons with 
Dunett’s post-hoc test for the indicated pairwise comparison (panel R). *p<0.05, **p<0.01, 




Figure B.2. The effect of Yno1, respiration, O2, and Sod1 expression on % GAPDH 
oxidation; related to Figures 4.2 and 4.3.  
(A) % GAPDH oxidation assessed by mPEG-mal labeling of GAPDH in WT, rho0, yno1∆ 
and sod1∆ cells cultured in 2% GLU (Fig. 2A) from multiple trials. Data represents the 
average ± SD from 3 independent trials. 
(B-C) DHE-detectable superoxide (B) and percentage GAPDH oxidation (C) in in WT cells 
expressing GAL1-driven YNO1 (pYES2-YNO1) or empty vector (pYES2-EV) cultured in 
2% raffinose, supplemented with non-inducing (0%) or inducing (3%) GAL concentrations 
from multiple trials. Data represents the average ± SD from 3 independent cultures. 
(D) Assessment of the Sod1-dependence on the aerobic oxidation of GAPDH. Percentage 
GAPDH oxidation in aerobic or anaerobic sod1∆ cells expressing empty vector, WT 
SOD1, or the P144S SOD1 mutant (Fig. 3.3C). Data represents the average ± SD from 
two or three independent trials. 
(E) Representative immunoblot of Sod1 from sod1∆ cells expressing GAL1 driven SOD1 
or WT cells transformed with empty vector (EV) cultured in the indicated concentrations 
of galactose (GAL).   
The statistical significance is indicated by asterisks using two-tailed Student’s t-test 
pairwise comparison (panel B), one-way ANOVA for multiple comparisons with Dunett’s 
post-hoc test for the indicated pairwise comparison (panel A) or two-way ANOVA for 
multiple comparisons with Dunett’s post-hoc test for the indicated pairwise comparison 




Figure B.3. Titration of Sod1 results in a dose-dependent increase of [NADPH] and 
NADP+/NADPH ratio; related to Figure 4.4.  
(A) Immunoblot analysis of Sod1 expression and total protein quantification in sod1∆ cells 
expressing GAL-driven SOD1 cultured with increasing concentrations of galactose (GAL) 
(0.005%, 0.0075%, 0.01% and 0.1% GAL).   
(B) The NADP+/NADPH ratio inversely correlates with cellular [NADPH]. The linear 
regression analysis in three independent trials gives coefficient of determinations (r2) of 
.96, .992 and .9968 and p-values of .12, .057 and .0036, respectively.  
(C-D) The [NADPH] correlates with normalized Sod1 expression (C) and normalized 
GAPDH oxidation (D). Each color indicates two individual trials used for both correlation 
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with Sod1 expression and GAPDH oxidation. The linear regression analysis in panel C 
gives coefficient of determinations (r2) of .9054 and .9046 and p-values of .0485 and .0489, 
respectively. The linear regression analysis in panel D gives coefficient of determinations 
(r2) of .9121 and .98 and p-values of .0449 and .0471, respectively.  
(E-F) The NADP+/NADPH ratio correlates with normalized Sod1 expression (E) and 
normalized GAPDH oxidation (F). Each color indicates individual trials used for both 
correlation with Sod1 expression and GAPDH oxidation. The linear regression analysis in 
panel E gives coefficient of determinations (r2) of .9801, .9726 and .998 and p-values of 
.01, .0159 and .0209, respectively. The linear regression analysis in panel F gives 
coefficient of determinations (r2) of .9865 and .994 and p-values of .0068 and .0492, 
respectively.  
(G) Increasing concentrations of GAL do not positively correlate with [NADPH] in sod1∆ 
cells expressing a non-GAL regulated allele of yeast SOD1 (pADH1-SOD1). The linear 
regression analysis in panel G gives coefficient of determinations (r2) of .11 and .772 and 





Figure B.4. Validation of H2O2 and Sod1-mediated GAPDH oxidation in human cell 
lines; related to Figure 4.5.  
(A) Schematic representation of all possible redox-dependent GAPDH (green spheres) 
Cys-mPEG-mal adducts and their respective electrophoretic mobilities. 
(B) Representative immunoblot analysis of GAPDH oxidation as assessed by mPEG-mal 
labeling from human embryonic kidney HEK293 cells that have been treated with 100µM 
100µM H2O2 (+H2O2) or H2O (-H2O2) and the %GAPDH oxidation (bar graph). 
(C-D) Representative immunoblot analysis of GAPDH oxidation as assessed by mPEG-
mal labeling of HEK293 cells with silenced (siSOD1) or unsilenced (siCTRL) SOD1 (C) 
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and % GAPDH oxidation from multiple trials (D). Data represents the average ± SD from 
five or six biological replicates. 
(E-F) Representative immunoblot analysis of GAPDH oxidation as assessed by mPEG-
mal labeling of MCF-7 cells (C) and % GAPDH oxidation from multiple trials compared to 
HEK293 cells (D). Data represents the average ± SD from two and six biological replicates. 
The statistical significance relative to siCTRL or HEK293 cells is indicated by asterisks 
using two-tailed Student’s t-test for pairwise comparison. *p<0.05, **p<0.01, ***p>0.001, 







Figure B.5. Sod1 maturation correlates with overall and specific protein percentage 
cysteine oxidation in mice tissues quantified in the Oximouse study. 
(A - F) The correlation between the average of percentage cysteine oxidation (Y axis) and 
Sod1 Cys147 (A), Peroxiredoxin 1 (PRDX1) Cys173 (B), Peroxiredoxin 5 (PRDX5) Cys96  
(C), Peroxiredoxin 5 (PRDX5) Cys200 (D), Glutaredoxin 3 (GLRX3) Cys148 (E) and   
Glutaredoxin 3 (GLRX3) Cys231 (F) percentage cysteine oxidation (X axis) form individual 
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tissues is represented as an XY graph. A linear regression analysis gives a coefficient of 
determination (r2) of .5538, 0.09604, 0.02306, 0.01477, 0.02727 and 0.3227, respectively, 
and a p-value of 0.0395, 0.3835,0.6965, 0.7744, 0.1844 and 0.1834, respectively.   
(G - L) Sod1 Cys147 oxidation correlates with oxidation of PTP1N (Tyrosine-protein 
phosphatase non-receptor type I) Cys32, mouse homolog of PTP1B (protein tyrosine 
phosphatase 1B) (G), Rab1a Cys26 (H) and PTPN11 (Tyrosine-protein phosphatase non-
receptor type 11) Cys490 (I). (J to L) PRDX1 Cys173 oxidation does not correlate with 
oxidation of PTP1N Cys32, mouse homolog of PTP1B (J), Rab1a Cys26 (K) and PTPN11 
Cys490 (L). A linear regression analysis gives a coefficient of determination (r2) of 0.9788, 
0.0999, 0.6227, 0.2121, 0.3676 and 0.01051, respectively, and a p-value of 0.0106, 
0.0189, 0.0199, 0.5394, 0.3937 and 0.7929, respectively.   
Tissue identity is indicated using distinctive colors and labels. Lung (orange), BAT (brown 
adipose tissue, brown), Epi (epididymal fat, yellow), SKM (skeletal muscle, coral), liver 
(dark red), heart (pink), spleen (light blue), kidney (dark green), brain (gold), SubQ 
(subcutaneous fat, gray). 
The statistical significance is calculated using linear regression analysis. The Pearson’s 
correlation coefficient (r) and p-value for each correlation are described in each graph, 

















































5’ GAAGACTGGTAATGCCGGTCCAAGATCTGCCTGTGGTGTCATTG 3’ 
 
Site-directed 
mutagenesis of SOD1 
(SOD1-P144S). 
Forward primer 
prCMA010  5’ CAATGACACCACAGGCAGATCTTGGACCGGCATTACCAGTCTTC 3’  
Site-directed 
mutagenesis of SOD1 
(SOD1-P144S). 
Reverse primer 
prCMA003 5’ GCTTCTTGTACCACCAACTCTTTGGCTCCATTGG 3’  
Site-directed 
mutagenesis of TDH3 
(TDH3-C154S). 
Forward primer 
prCMA004 5’ GCTTCTTGTACCACCAACGCTTTGGCTCCATTGG 3’  
Site-directed 
mutagenesis of TDH3 
(TDH3-C154S). 
Reverse primer 
prCMA017 5’ CAAATAAAACATAATGGATCCATAATGGTTCAAGCAGTCG  3’  





prCMA018 5’ CAAGTATATTCTCGAGAACATTAGTTGGTTAGACAC 3’  
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